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Mammals have the ability to synthesise endogenous hydrogen sulfide via desulfhydration 
enzymes though the physiological effects are still relatively unclear particularly in the 
inflammatory response. Endogenous hydrogen sulfide has been shown to be both pro and anti-
inflammatory in numerous models of disease in animals. Common aspects of these studies are the 
reported dysregulation of tissue cystathionine -lyase (CSE) expression (the major hydrogen 
sulfide producing enzyme in the periphery) and the use of D,L-propargylglycine (PAG) to inhibit CSE 
activity. However, PAG is not a specific inhibitor and very few studies have correlated CSE 
dysregulation with changes in endogenous tissue hydrogen sulfide levels. Therefore the aims of 
this thesis were to investigate pancreatic and macrophage CSE dysregulation in acute pancreatitis, 
to correlate this dysregulation with changes in endogenous hydrogen sulfide levels/ hydrogen 
sulfide modified proteins and to determine the effect of CSE gene deletion on disease severity and 
the inflammatory response. Results in this thesis show that acute pancreatitis directly mediated 
upregulation in pancreatic CSE expression which was a gap in the existing body of knowledge. I 
have also found novel evidence of acute pancreatitis induced upregulation of CSE in macrophages 
with in vitro studies using plasma from pancreatitic mice and elucidated the molecular 
mechanisms involved. CSE gene deletion resulted in an amelioration of acute pancreatitis with 
reduced plasma amylase levels, pancreatic and lung neutrophil infiltration, oedema as well as 
acinar cell damage. There was also a reduction in pancreatic pro-inflammatory mediators, MCP-1, 
MIP-2, IL-6, and PGE2 as well as NFB activation. Similar findings were found in vitro using 
isolated primary pancreatic acini. The results of this thesis incontrovertibly show that CSE exerts 
pro-inflammatory effects in acute pancreatitis and corroborates with previous studies using PAG. 
It also shows upregulation of CSE in stimulated macrophages thus suggesting a role for 
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Although essential in a host’s defense against infections and injuries, inflammation itself contributes 
to the pathophysiology of many diseases (1) ranging from chronic conditions such as arthritis to acute 
conditions such as sepsis. It is also thought to be a contributing factor in the development of cancer 
(2, 3). It was touted as the secret killer by the Times magazine (4) and the socioeconomic cost and 
burden of all these inflammatory related diseases combined would be enormous. A better 
understanding of the inflammatory response has brought about advances in treating diseases over the 
years, however there is still much to be understood especially in light of new players to the game. 
Hydrogen sulfide is one such new player. In this chapter, I will introduce the various sources of 
endogenous hydrogen sulfide, its reported physiological roles and the proposed methods by which it 
exerts its effect. I will then relate these findings to the inflammatory response with a focus on acute 
pancreatitis followed by the aims of this thesis. 
1.1 Hydrogen sulfide 
Hydrogen sulfide is a colourless gas that has the characteristic odour of rotten eggs. It is readily soluble 
in water (~80 mM at 37oC (5)) to form an equilibrium between the species shown below along with 
reported dissociation constants (5, 6): 
 
Environmental sources of atmospheric hydrogen sulfide include biogenic sources of marine as well as 
terrestrial origins, natural sources such as volcanic and anthropogenic sources such as biomass burning 
(7). hydrogen sulfide has long been known for its toxicity with the first description dating 300 years 
back (8). The effects of hydrogen sulfide toxicity is now well documented and range from mild 
pulmonary irritation to death (8). However it was not until the end of the 20th century that the 
perception of hydrogen sulfide was to be altered from that of a purely toxic molecule to one that 
possesses physiological relevance akin to oxygen, nitric oxide and carbon monoxide. 
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The discovery and purification of the major hydrogen sulfide synthesizing enzymes dates as far back 
as to 1958 (Cystathoinine--lyase, CSE) (9) and 1968 (Cystathoinine--synthase, CBS) (10), however 
these enzymes were then better known for their roles in the transsulfuration pathway. The capacity 
for these enzymes to synthesize hydrogen sulfide in-vivo by mammals was first demonstrated by 
Stipanuk et al (11) in 1982. However it took a little over 10 years after that for the landmark study by 
Abe et al (12) which was the first published report detailing the potential role of endogenous hydrogen 
sulfide as a neuromodulator. Since then, there has been an explosion of publications attempting to 
determine the possible physiological roles of hydrogen sulfide.  
1.2 Endogenous hydrogen sulfide 
Currently there are two known sources of endogenous hydrogen sulfide; the enzymatically derived 
source and the labile hydrogen sulfide source. The enzymatic source is mostly thought to be a 
byproduct of enzymes in the transsulfuration pathway. There is also an overlap between these two 
sources as the enzymatic driven synthesis of hydrogen sulfide is thought to fuel the generation of labile 
hydrogen sulfide that in turn serves as a readily available pool of hydrogen sulfide. This section will 
describe the nature and interplay of these two sources in more detail. 
1.2.1 Enzymatic source 
There are currently three known enzymes that are capable of synthesizing hydrogen sulfide; 
cystathionine--lyase (CSE) (EC 4.4.1.1), cystathionine--synthase (CBS) (EC 4.2.1.22) and 3-
mercaptopyruvate sulfurtransferase (3MST) (EC 2.8.1.2). Of these three enzymes both CSE and CBS are 
cytosolic while MST is found in the mitochondria (13). The tissue distributions of these three enzymes 
are varied in location as well as levels of expression. The liver and kidney are the two organs that 
express all three enzymes at high levels (14-16). CBS is also expressed in the brain, lung, stomach and 
pancreas (14) while CSE is found in the stomach, small intestine, pancreas and smooth muscle (16-18) 
and 3MST in the brain, heart, lung, thymus and testis (15). There is also varied expression levels of CSE 
and CBS in tissues where both enzymes are co-expressed; the liver and kidney express higher levels of 
CSE compared to CBS, 60 and 20-fold respectively (19). 
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CSE and CBS are enzymes involved in the transsulfuration pathway and are directly involved in the 
generation of hydrogen sulfide as a byproduct through their diverse catalyzed reactions (20). Under 
physiological conditions, the major reaction catalyzed by CSE in the generation of hydrogen sulfide is 
via the ,-elimination of cysteine (21) : 
 
 
while the major reaction catalyzed by CBS in the generation of hydrogen sulfide is via the condensation 
of cysteine and homocysteine to produce cystathionine (20) : 
 
 
3MST on the other hand catalyzes the conversion of 3-mecaptopyruvate to pyruvate resulting in the 
formation of a 3MST persulfide. This persulfide moiety then requires specific reducing agents such as 
thioredoxin and dihydrolipoic acid to release hydrogen sulfide (22). Therefore it is perceived that the 
major contributors of endogenous hydrogen sulfide are CSE and CBS (19) although it has been shown 
that 3MST does contribute to endogenous hydrogen sulfide generation in certain tissues (23, 24). 
Figure 1.1 summarises the pathways of CSE, CBS and 3MST mediated hydrogen sulfide synthesis and 




Figure 1.1 Major endogenous hydrogen sulfide synthesising pathways. The transsulfuration pathway 
involves the conversion of homocysteine to cysteine by CBS and CSE. These enzymes are also responsible 
for the majority of endogenous hydrogen sulfide synthesis through reactions shown in black. 
The relative contribution of CSE and CBS to endogenous hydrogen sulfide synthesis is dependent on 
the expression levels of each enzyme, the concentration of their preferred substrates and the extent 
of CBS allosteric activation by S-adenosylmethionine (AdoMet) (19, 20). For example, both CSE and 
CBS were found to contribute equally to hydrogen sulfide synthesis at high substrate concentrations 
of cysteine and homocysteine in the liver; however at physiologically relevant substrate concentrations 
(100 M cysteine and 10 M homocysteine) and taking into account the ratio of CSE to CBS (60:1) 
present in the liver, the contribution of liver hydrogen sulfide synthesis by CSE was estimated to be 
around 97 % and CBS 3 % (19). Taken together, the differential enzymatic expression and substrate 
preference suggests that the contribution of each enzyme to endogenous hydrogen sulfide synthesis 
may have separate roles to play in the physiology of different cells and tissues. 
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1.2.2 Labile source 
Apart from enzymatic synthesis of free hydrogen sulfide, there are bound sulfur sources that could 
release free hydrogen sulfide upon acidification or reduction of the parent molecule; these sources are 
termed acid-labile sulfide and DTT-labile sulfide (or sulfane sulfur) respectively (25). The relative 
amounts of free sulfide present in these discreet pools in biological samples are still a subject of 
continuous study as more sensitive and specific methods are continuously developed. At present, 
human plasma acid-labile sulfide is reported to be in the low micromolar range followed by sulfane 
sulfur and free sulfide, both of which are at similar low nanomolar concentrations (26). An initial study 
on tissue labile sulfide levels reported low nmol/g levels in several murine tissues; the brain was 
reported to contain 12.5 nmol/g and 18.5 nmol/g of acid labile and sulfane sulfur respectively (27). 
However much higher levels of bound sulfide were reported recently in tissue homogenates (28), as a 
comparison the mouse brain was shown to contain 161 nmol/g protein and 1481 nmol/g protein of 
acid-labile and sulfane sulfur respectively. These differences could be attributed to the different 
methods employed in each study; fluorescence based HPLC (27) and direct measurement with gas 
chromatography (28).  
The major source of acid-labile sulfide are iron-sulfur cluster containing proteins (29), these proteins 
are ubiquitous, diverse and serve a wide array of functions (30). Although the iron-sulfur cluster 
containing proteins provides a substantial source of labile sulfide, it is an unlikely physiological 
endogenous source as a maximum of pH 5.4 is required to release the bound sulfur as sulfide (28). 
Sources of sulfane sulfur include thiosulfate, thiosulfonates, polysulfides and protein persulfides (29). 
Although reducing agents are present in the cell (ie glutathione (GSH) and cysteine), it has been shown 
that the alkalization of the cytoplasm is required for effective release of hydrogen sulfide from these 
sulfane sulfur sources (28). This has been shown in rat astrocytes where high concentrations of 
extracellular K+ are normally present when nearby neurons are excited (28). 
Among the available sources of sulfane sulfur, protein persulfides are particularly intriguing as they are 
not synthesized de novo as a persulfide but are a product of a cystiene thiol modification by the 
addition of divalent sulfide molecule resulting in the formation of an R-S-SH; this process is termed s-
sulfhydration akin to s-nitrosylation (31). A large number of proteins have been reported to be basally 
s-sulfhydrated and the addition of exogenous hydrogen sulfide further increases the level of s-
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sulfhydration (31) (discussed further in section 1.4.2). Hydrogen sulfide has also been shown to be 
scavenged in proteinaceous biological solutions such as plasma (32), tissue homogenates (28, 33) and 
single protein solutions containing cysteine residues (32). These scavenged hydrogen sulfide was then 
partially retrieved by applying a reducing agent to the homogenates (28, 33). This suggests that protein 
persulfides could serve as both a source as well as a sink of endogenous free hydrogen sulfide. 
 
Figure 1.2 Endogenous source of hydrogen sulfide in mammals. Endogenous source of free hydrogen 
sulfide can be derived from two sources, enzymatic and labile sulfide. The enzymatic source of hydrogen 
sulfide involves the actions of the transulfuration pathway enzymes; cystathionine--lyase (CSE) (EC 
4.4.1.1), cystathionine--synthase (CBS) (EC 4.2.1.22) and 3-mercaptopyruvate sulfurtransferase 
(3MST) (EC 2.8.1.2). Both CSE and CBS are able to catalyse the synthesis of hydrogen sulfide through 
multiple reactions, however L-cysteine and L-cysteine + homocysteine are the preferred substrates for 
CSE and CBS respectively under physiological conditions (20, 21). The generation of hydrogen sulfide by 
3MST is not direct and utilises 3-mecraptopyruvate as its substrate (generated by cysteine 
aminotransferase (CAT) from L-cysteine). 3MST catalyses the conversion of 3-mercaptopyruvate to 
pyruvate resulting in the generation of a persulfide moiety on its cysteine residue, the reduction of this 
persulfide yields free hydrogen sulfide (22). Acid labile sulfide is a source of hydrogen sulfide that is 
liberated under acidic conditions, a major source are the iron-sulfur clusters of non-heme iron-sulfur 
proteins. Sulfane sulfur atoms are defined as divalent sulfur bonded only to other sulfur and is released 
as hydrogen sulfide upon reduction. Sulfane sulfur containing molecules such as protein persulfides are 
thought to be generated from the interaction of hydrogen sulfide and cysteine residues of proteins (31) 




1.2.3 Endogenous levels of hydrogen sulfide 
There is still very little consensus as to the levels of endogenous free hydrogen sulfide. This is due to 
the difficulty in accurately measuring hydrogen sulfide in a biological solution. Among the issues 
associated with measuring hydrogen sulfide is its volatility and difficulty in distinguishing free sulfide 
from labile sulfide. Hydrogen sulfide in its gaseous form readily diffuses out of solution resulting in loss 
of hydrogen sulfide, this makes sample preparation complicated particularly from tissues that require 
some form of homogenization step. As mentioned in section 1.2.2, there is a readily available source 
of labile hydrogen sulfide that could be released upon acidification or reduction, certain detection 
methods that employ such conditions may overestimate actual levels of free hydrogen sulfide, this 
include the methylene blue method (11) that was widely used in the initial hydrogen sulfide studies. 
The methylene blue method is a spectrophotometric approach involving the incorporation of sulfide 
into methylene blue in the presence of acidic N,N-dimethyl-p-phenylenediamine and ferric chloride as 
the oxidising agent (34) (further elaborated in section 1.2.4). Initial reports that used the direct 
spectrophotometric methylene blue method of measuring free hydrogen sulfide showed high 
micromolar hydrogen sulfide levels of between 30 to 300 M in circulation (32) and in tissues (35). 
More recent methods however have shown low or sub nanomolar concentrations of circulating 
hydrogen sulfide (36) and pmol per g levels in tissue (37). These estimations were made by direct 
measurement using gas chromatography (35, 37) as well as an indirect hydrogen sulfide derivatized 
and separation method using monobromobimane as the derivatizing agent followed by separation and 
detection by HPLC (36). The reason for the big divide has been thought to be due to the harsh acidic 
nature of the methylene blue assay that could potentially liberate acid labile sulfide from the biological 
matrices (25, 29, 37). However, despite the improvement of recent methods over the direct 
spectrophometric methylene blue method, it has recently been argued that even the reported low 
micromolar levels of free sulfide in plasma (36) and pmole per g levels in tissue (37) should yield a 
detectable odour by the human nose which it does not (38). Therefore, it is still unclear as to what the 
actual levels of free sulfide are in circulation and in tissues. 
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Gas chromatography/flame photometric Rat Liver ND 112 nmol/ g (39) 
or chemiluminescence  Heart ND 274 nmol/ g (39) 
 Mouse Liver 17 nM (~17 pmol/ g)  (35) 
  Brain 14 nM (~14 pmol/ g)  (35) 
 Mouse Liver < 0.1 nmol/ g ~150 nmol/ g (37) 
  Heart < 0.1 nmol/ g ~300 nmol/ g (37) 
  Brain < 0.1 nmol/ g ~90 nmol/ g (37) 
 Mouse Heart 6 umol /g  (40) 
 Mouse Heart 25 umol/ g  (41) 
      
Ion chromatography Rat Brain 46 nmol/ g  (42) 
      
Methylene blue using RP-HPLC Rat Liver 145 nmol/ g  (43) 
  Brain 69 nmol/ g  (43) 
      
Methylene blue assay using Mouse Plasma ~35 M  (44) 
spectrophotometry  Plasma ~50 M  (45) 
      
Monobromobimane derivatisation/  Mouse Plasma ~0.8 M ~ 3.5 M (26) 
RP HPLC  Plasma 0.2 – 0.3 M  (46) 
  Liver ~175 nmol/ g prot  (47) 
      
Fluorescent probes Mouse Plasma 56 µM  (48) 
  Brain 7.1 µmol/ g  (48) 
 Mouse Blood 32 µM  (49) 
 Mouse Brain ~1.7 µmol/ g prot  (50) 
Table 1 Reported levels of endogenous free and acid-labile hydrogen sulfide content in tissues and 
plasma. This table shows current reported endogenous hydrogen sulfide levels as measured by various 
methods of detection. ND = not detectable, g = wet weight of tissue. 
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1.2.4 Methods of detecting free hydrogen sulfide 
The detection of free hydrogen sulfide is complicated due to the gaseous nature and chemistry of the 
molecule. As a gaseous molecule there is the issue of passive loss due to volatility. However the 
proportion of hydrogen sulfide that exists as either the deprotonated gaseous form (H2S), monoanion 
(HS-) or dianion (S2-) species is dependent on the pH of the environment according to the reported 
dissociation constants (5, 6) : 
 
 
Since there are only very rare situations where the internal pH could reach pH 12, the predominant 
species of physiological hydrogen sulfide would exist as either the gaseous or monoanion form. At pH 
7.4 and 37oC, ~20% of sulfide exists as hydrogen sulfide gas, while at pH 7.4 and 25oC ~30% of sulfide 
exists as hydrogen sulfide gas. Therefore methods of measuring endogenous free hydrogen sulfide 
should be able to detect both species (H2S and HS-) as well as take into account possible loss of the 
gaseous form due to volatility, all of which are tightly linked to the pH of the solution. The reactivity of 
dissociated HS- is high, as it is more readily oxidized than H2S (51) thus adding another layer of 
complexity as the less volatile HS- species though readily soluble in aqueous solutions is susceptible to 
oxidation by dissolved oxygen within buffers (52). The most commonly observed products and 
intermediates are polysulfides (Sn2-; 2 < n < 5), thiosulfate (S2O32-), sulfite (SO32-), and sulfate (SO42-) 
(51) as shown below: 
 
Therefore attempts to detect and measure free hydrogen sulfide in biological material should take into 
account factors such as volatility of the hydrogen sulfide species, effect of pH on sulfide dissociation, 
oxidation of free sulfide, selectivity of the probe/detection towards both HS- and H2S species as well 
as possible liberation of bound sulfide (discussed in section 1.2.2) due to assay conditions. To date, 
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there have been several methods developed to detect and measure endogenous levels of hydrogen 
sulfide. These detection methods for sulfide have evolved from simple spectrophotometric assays to 
the more recently used techniques such as high pressure liquid chromatography, gas chromatography, 
and polarographic, electrochemical and chemiluminescent detection that are highly specific and 
sensitive with much lower detection limits. However, each technique has certain advantages as well 
as limitations in the attempt to detect and measure bioavailable free hydrogen sulfide. 
These methods can be generally broken down into two categories which involve either direct detection 
of free sulfide or prior derivatisation. Direct detection of sulfide can be made in real-time using 
electrochemical polarographic sensors and as an end point measurement with fluorescent probes and 
gas chromatogtaphy. Electrochemical polarographic sensors developed by Doeller et al are made up 
of an anode, cathode and electrolyte assembly protected from solution constituents by H2S permeable 
polymer sleeves (53, 54). As such, these sensors are specific but only capable of detecting the gaseous 
hydrogen sulfide species and have been utilised to detect hydrogen sulfide production by cells and 
intact tissue incubated with L-cysteine as the hydrogen sulfide enzyme producing substrate (53-55), 
but has not yet been used to measure hydrogen sulfide content in biological fluids or tissues. 
An array of fluorescent probes have also been developed to detect and measure hydrogen sulfide. The 
general concept of these probes revolve around modification of a fluorophore resulting in quenching. 
These modified fluorophores are designed to be sensors and upon reacting with hydrogen sulfide 
restores the fluorescent properties of the fluorophore. There are three methods of modification; 
alteration of an amine to an azide or nitroso group at a favourable position which would render it more 
susceptible to reduction by hydrogen sulfide over other reductants (56-59), conjugation with a 
dicopylamine or an azamacrocyclic group to promote Cu2+ coordination and quenching which would 
then react with sulfide ion to form CuS thus removing the Cu2+ ion (60, 61), and finally conjugation with 
a hydrogen sulfide specific Michael acceptor which involves two steps of first reduction of the most 
electrophilic component to form a free thiol followed by a Michael addition reaction that would either 
cleave off a quencher or to complete the fluorophore structure (62, 63). Coupled with techniques such 
as two photon microscopy and fluorescence resonance energy transfer, the lower limit of detection of 
hydrogen sulfide using fluorescent sensors have been reported to be in the low nanomolar region (64, 
65). However despite the improvements in selectivity and sensitivity of these probes, there is very little 
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demonstration of its ability to quantify endogenous levels of hydrogen sulfide with only three reports 
so far in plasma and brain tissue of mice (48-50). There is also the issue of specificity; in reports using 
the reducing ability of hydrogen sulfide as the sensing method, hydrogen sulfide has been shown to 
be more reactive over other thiol species such as reduced glutathione and cysteines by about 100x at 
best. However the intracellular glutathione levels are in the order of ~10 mM and for the sensors to be 
specific the levels of hydrogen sulfide needs to be within the 0.1 mM to 10 mM range which is unlikely 
given the current perceived levels of endogenous hydrogen sulfide. 
Another direct method of measuring hydrogen sulfide is by gas chromatography which offers the most 
sensitive option so far with lower detection limits in the pM range. Most reports that utilise gas 
chromatography to measure free tissue hydrogen sulfide employ a chemiluminescent sulfur detector 
(35, 37, 40, 41) and among them Levitt et al 2011 describes the most detailed method that takes into 
account the volatility of the gaseous hydrogen sulfide species during sample preparation and potential 
release of acid labile sulfide during measurement (37). This method involves homogenisation of tissues 
at pH 9.3 to ensure the stability of hydrogen sulfide by shifting the equilibria to the soluble anion 
species (HS-), the pH is then lowered to ~5.8 to shift the equilibria to the gaseous species (H2S) under 
air tight conditions to evolve free hydrogen sulfide out of solution and into the headspace which is 
then subsequently sampled and detected. Levitt et al 2011 reported very low levels of free tissue 
hydrogen sulfide in various murine tissues that were less than 0.1 nmol per g of wet weight including 
heart tissue. In contrast there were two other publications that reported 6 and 25 µmol per g of wet 
weight in murine heart tissue using the similar method described by Levitt et al 2011 with the 
exception of homogenisation in PBS at pH 7.4, which should in principal result in lower detection levels. 
The methods of derivatising hydrogen sulfide prior to detection have the benefit of trapping and 
stabilising free hydrogen sulfide prior to detection. The spectrophotometric approach utilising 
methylene blue as the colorimetric sensing dye (methylene blue method) has been the earliest and 
most widely used method used to measure endogenous levels of hydrogen sulfide down to low 
micromolar levels (12, 18, 42, 44, 66-69). In the methylene blue method, plasma or tissue 
homogenates (typically prepared at physiological pH) are reacted with zinc to fix free hydrogen sulfide 
through the formation of an insoluble ZnS precipitate. Subsequent reaction with N,N-dimethyl-p-
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phenylene diamine under acidic conditions liberates S2- from ZnS and reacts with the diamines to form 
methylene blue in the presence of an oxidising agent, usually ferric ion(34): 
 
 
The optical density of the resulting methylene blue (coefficient constant of 91,500 mol-1 cm-1 (70)) is 
measured at 670 nm wave length and the corresponding quantity of sulfide is read from a previously 
prepared calibration curve using sulfide salts. The entire assay is carried in a tube making it simple, 
however this also raises the issue of possible acid labile sulfide release from the biological matrix thus 
confounding the measurement with artifactually high results (25). Another criticism of the methylene 
blue is that the absorbance measured at 667nm does not obey Beer’s law, however it was shown that 
this can be counteracted with the use of an appropriate ratio of N,N-dimethyl-p-phenylendiamine and 
iron(III)chloride to sulfide to achieve an optimal stoichiometry (71). 
Derivatisation of hydrogen sulfide with monobromobimane under alkaline conditions (pH 9.3) to a 
stable and fluorescent sulfide dibimane product forms the basis of another method of detection 




This method has been used to measure free hydrogen sulfide in plasma through detection of the 
fluorescent sulfide dibimane product using reversed phase – high performance liquid chromatography 
for increased specificity and is capable of detecting hydrogen sulfide down to low nanomolar levels 
(36). This method has been mainly employed in measuring plasma levels (46, 72-76) with only one 
instance of use with liver tissue (47). A point to note is that the specificity of monobromobimane 
towards hydrogen sulfide and the ability to resolve between sulfide dibimane and other fractions have 
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come into question following a report attempting to compare spiked sulfide samples in buffer, plasma 
and whole blood using the monobromobimane as well as polarographic sensor method (38). 
 
 
Figure 1.3 Recent methods developed to detect and measure endogenous levels of free hydrogen 
sulfide. This table summarises the current methods that have been developed as well as those that are 
currently used to detect and measure free hydrogen sulfide in cells, plasma and/or tissues. The 
polarographic sensor method was developed by Doeller et al (53); there are multiple probes designed 
to detect hydrogen sulfide (mentioned in text); the most practical and comprehensive method of gas 
chromatography method was developed by Levitt et al (37); the monobromobimane derivatisation/ RP-
HPLC method was developed by Shen et al (36); and the methylene blue/ spectrophotometry method 
was first adopted in measuring endogenous hydrogen sulfide by Warencyia et al (42) 
1.3 Physiological effects of hydrogen sulfide 
The first published report detailing a direct physiological role of hydrogen sulfide was with regards to 
neuromodulation (12). Hydrogen sulfide has been shown to regulate neurotransmission by facilitating 
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the induction of hippocampal long term potentiation via selective enhancement of the NMDA receptor 
mediated responses through cyclic AMP; this was demonstrated by treating primary brain cells with 
exogenous hydrogen sulfide (1-100M NaHS) (12, 77). Following this finding, hydrogen sulfide (0.1 to 
10 mM NaHS) was also reported to modulate hypothalamo-pituitary-adrenal axis function by reducing 
potassium induced corticotropin-releasing hormone (CRH) release in rat hypothalamic explants (78). 
Endogenous hydrogen sulfide (using CBS and CSE inhibitors) and exogenous hydrogen sulfide (0.2-2.5 
mM NaHS) have also been reported to elicit excitatory action in enteric neurons involving transient 
receptor potential vanilloid 1 (TRPV-1) receptors on extrinsic afferent terminals leading to increased 
chloride secretion in human and guinea-pig colonic submucosa/mucosa preparations(79). 
By far the most widely studied role of hydrogen sulfide is its ability to induce smooth muscle relaxation 
and its implication in cardiovascular related conditions and diseases. This was first demonstrated by 
Hosoki et al (80) using exogenous hydrogen sulfide (NaHS) on pre-contracted ileum, portal vein and 
thoracic aorta of experimental animals with reported EC50 values of 180 M, 160 M and >1 mM 
respectively. A subsequent report by Zhao et al (18) further demonstrated that the hydrogen sulfide 
induced smooth muscle relaxation effect was mediated via the opening of KATP channels at 
NaHS/hydrogen sulfide concentrations of > 100 M using aortic rings. These initial findings have been 
further corroborated and extended to other smooth muscle containing tissues involving the airways 
(81-83), gastrointestinal tract (84-86) and the cavernosum (84, 87, 88). These studies have used both 
hydrogen sulfide synthesising enzyme inhibitors as well as a variety of exogenous hydrogen sulfide 
donors such as NaHS, Na2S and GYY4137 (morpholin-4-ium 4 methoxyphenyl(morpholino) 
phosphinodithioate) with effective concentrations ranging from 100 M to 10mM. 
Following the finding that hydrogen sulfide regulates KATP channel activity, subsequent studies have 
looked at the role of hydrogen sulfide on pancreatic islet cell insulin secretion which is reported to be 
regulated by KATP channels (89). Hydrogen sulfide has been reported to stimulate pancreatic islet KATP 
channels at a dose of 100 M resulting in an inhibition of insulin secretion in pancreatic islet cell lines; 
INS-1E (90), HIT-T15 (91) and MIN-6 (92). The activation of KATP channels caused membrane 
hyperpolarisation as a result of K+ efflux thus preventing the opening of voltage dependent Ca2+ 
channels; this prevents the influx of Ca2+ and secretion of insulin (91). A later study by Tang et al had 
corroborated these findings by showing that the L-type voltage-dependent Ca2+ channel was closed in 
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primary isolated islet cells treated with NaHS and the converse effect was observed with cells treated 
with a CSE inhibitor, D,L-propargylglycine (PAG) (93). Increased hydrogen sulfide synthesising enzyme 
expression and activity have been reported in the pancreas and liver of streptozocin-induced diabetic 
rats (94) and the inhibition CSE with PAG was shown to increase serum insulin level as well as lower 
hyperglycemia in Zucker diabetic rats (95). 
Another well studied aspect of hydrogen sulfide is its involvement in cytoprotection in response to 
oxidative stress. As a reducing agent, hydrogen sulfide has been shown to scavenge hypochlorous acid 
(96) and peroxynitrite (97) in vitro resulting in the protection of human neuroblastoma cell line, SHSY5Y 
against oxidative stress. Protection was observed with NaHS concentrations of 30 to 250 M per 125 
M hypochlorous acid and 300 M peroxynitrite used. However it has been noted that the 
concentration of free tissue sulfide is far lower than other classical reducing agents such as GSH 
(intracellular level of 0.5 – 10 mM (98)) and therefore direct interaction of hydrogen sulfide with 
oxidants probably could not account completely for its protective effect (99). An indirect reducing 
effect was reported whereby hydrogen sulfide has been shown to enhance cystine/cysteine 
transporters thus resulting in increased GSH synthesis and distribution into the mitochondria with 
antioxidative tissue protecting effects (100, 101). Another proposed mechanism for the anti-oxidative 
effect of hydrogen sulfide is through the disruption of the upstream activator of the mitochondrial 
redox signalling molecule, p66shc. This has been shown to occur via the s-sulfhydration of the cysteine-
59 residue of p66shc thus interfering with the phosphorylation of the serine-36 residue and ultimately 
preventing its activation (102). 
Hydrogen sulfide has also been shown to play a nociceptive role with majority of the reports pointing 
towards a pronociceptive effect. Exogenous hydrogen sulfide was found to elicit pronociceptive 
response in the paw (1 nmol per rat and mouse paw)(103-105), colon (5 nmol per mouse 
intracolonically)(106, 107) and pancreas (500 nmol per rat pancreas)(108, 109) of mice and rats 
following administration of NaHS. Inhibition of endogenous hydrogen sulfide synthesis with 
propargylglycine (PAG) also resulted in an attenuation of pronociceptive signalling associated with 
conditions such as pancreatitis (108), bladder cystitis (110), spinal injury (111) and endotoxaemia 
induced paw oedema (105). Hydrogen sulfide has been shown to mediate pronociception through 
sensitization of the Cav3.2 T-type calcium channel (108, 110, 111) and the calcium channel transient 
16 
 
receptor potential ankyrin-1 (TRPA1) (105, 112, 113). Hydrogen sulfide has also been shown to activate 
the nociceptive transient receptor potential vanilloid-1 (TRPV1) in airway inflammation (114) and gut 
signalling (79) though not in the context of pain development. 
Endogenous hydrogen sulfide synthesized via CSE regulates cellular apoptosis. This has been 
demonstrated primarily in pancreatic cells (17, 69, 115) and also observed in lung tissue (116). In 
pancreatic beta cells, endogenous hydrogen sulfide was found to be anti-apoptotic in response to 
glucotoxicity in vitro (17) and in vivo (117) as well as pro-apoptotic in streptozocin induced diabetes in 
rats (115). In pancreatic acinar cells, CSE inhibition increased apoptosis in response to pancreatitis (69). 
Exogenous hydrogen sulfide has also been shown to influence apoptosis. Direct treatment with 
hydrogen sulfide in the micromolar range was shown to be pro-apoptotic in pancreatic acinar cells 
(118), human aortic smooth muscle cells (119) and human pulp stromal cells (120) without any 
underlying pathological conditions. However, exogenous hydrogen sulfide has been found to play an 
anti-apoptotic role when administered during pathologies. It was found to be anti-apoptotic in 
cardiomyocytes in response to myocardial infarction (100 M NaHS treated cardiomyocytes and 54 
mol NaHS/ kg treated rat) (121, 122), hepatocytes and tubular kidney cells in response to ischemia 
reperfusion injury (13 mol Na2S/ kg mouse and 100 mol NaHS/ kg rat respectively) (123, 124) as well 
as lung tissue in response to allergy (116). Although the role of hydrogen sulfide in apoptosis is mixed, 
there appears to be a pattern distinguishing the effects of endogenous versus exogenous hydrogen 
sulfide and whether there is an underlying pathology. 
Hydrogen sulfide has long been known to disrupt the mitochondrial respiratory chain by inhibiting 
cytochrome C oxidase (125). However low levels of exogenous hydrogen sulfide (6-8 nmol/min (126) 
and 0.1-1 M (127)) have also been shown to increase mitochondrial ATP production in colonocyte 
(126) and liver cells (127) while excursion out of this narrow range ( > 6-8 nmol/min (126) and 3-30 M 
(127)) were shown to inhibitory. Endogenous hydrogen sulfide has also been shown to produce a 
similar effect; activation of vascular smooth muscle cells (vSMCs) was reported to cause CSE 
translocation from the cytosol to the mitochondria which lead to increased mitochondrial hydrogen 
sulfide synthesis (from <0.1 to 0.5 nmol/g/min), hydrogen sulfide content (from 4 to 12 nmol/g) and 
ATP production, CSE gene deletion abolished these effects (128). Mitochondrial 3MST was also shown 
to contribute to ATP turnover via hydrogen sulfide synthesis (127). Supplementation of liver 
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mitochondrial lysates with 3-maercaptopyruvate (3-MP), a substrate of 3MST, resulted in a dose 
dependent increase in hydrogen sulfide synthesising activity up to 10 mol/g/min with 30 M 3-MP, 
and intact mitochondria exhibited dose dependent increased ATP turnover when treated with 
increasing concentrations of 3-MP (10 to 100 nM). These effects were abolished with 3-MST 
knockdown using siRNA (127). The hydrogen sulfide mediated contribution to mitochondrial ATP 
turnover has been shown to occur via reduction of sulfide quinone oxidoreductase (SQR) (127, 129). 
Hydrogen sulfide enters the mitochondrial respiratory chain by reducing SQR at its cysteine disulfide 
such that a persulfide group is formed at one of the cysteines (SQR-SSH) The electrons are fed into the 
respiratory chain via the quinone pool (Qox ⁄Qred), and finally transferred to oxygen by cytochrome 
oxidase (complex IV) (126, 129). 
A striking observation of the studies mentioned here is the amount of exogenous hydrogen sulfide 
used to treat cells and animals appears to be multiple orders more than the amount of free tissue 
hydrogen sulfide reported (based on Levitt et al’s measurements which is currently the most sensitive 
and specific method (37)). Assuming we used Levitt et al.’s reported liver levels of free hydrogen sulfide 
(Table 1) to extrapolate the total amount present in a mouse or rat, an average mouse (25 g) would 
have less than 2.5 nmol free hydrogen sulfide per mouse and an average rat (150 g) 15 nmol/ rat. These 
values are much lower than the reported low micromole and high nanomole levels of exogenous 
hydrogen sulfide injected into mice and rats and used to treat cells. However it would be interesting 
to note that a detailed study by Vitvitsky et al (33) on endogenous hydrogen sulfide turnover has shown 
a high rate of hydrogen sulfide synthesis in mouse liver supplemented with 0.1 mM cysteine; 484 
umol/h/kg which could be extrapolated to 12.1 umol /h/mouse and 72.6 umol/h/rat for comparison. 
The authors also describe a high turnover rate of endogenous hydrogen sulfide due to its rapid 
catabolism and consumption thus suggesting an underestimate of the true rate of endogenous 
hydrogen sulfide synthesis. As a result of this high turnover, their calculated steady state of hydrogen 
sulfide level in the liver is 29 nmol/kg, (extrapolated to ~0.725 nmol/ mouse and 4.35 nmol/ rat – 
assuming weights described before) which once again is below the exogenous hydrogen sulfide doses 
used to treat these animals and in vitro cells. However, this reported high rate of synthesis and 
turnover suggests a constant state of endogenous hydrogen sulfide flux and the detectable levels of 
free tissue hydrogen sulfide at any point in time would not truly reflect the amount that is being 
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generated. Therefore the question of whether the exogenous hydrogen sulfide doses used to elucidate 
its physiological effects is physiologically relevant is still an open one. Additionally, many of these 
studies also used endogenous hydrogen sulfide synthesising inhibition to corroborate their findings 
thus supporting the physiological relevance of these reported hydrogen sulfide mediated roles. 
 
 
Figure 1.4 Possible physiological effects of hydrogen sulfide. Illustration of the current known 
physiological effects of hydrogen sulfide. 
1.4 Hydrogen sulfide reactivity and mode of action 
The major catabolic pathway for hydrogen sulfide is via a series of redox conversions in the 
mitochondria that ultimately leads to the formation of thiosulfate (130). This pathway is mediated by 
three enzymes, sulfidequinoneoxido-reductase (SQR) is first reduced by hydrogen sulfide at the 
19 
 
external disulphide to form a thiol (R-SH) and a persulfide (R-S-SH). This two electron oxidation of 
hydrogen sulfide reduces the FAD prosthetic group, which uses ubiquinone as an electron acceptor. 
The sulfur atom on the persulfide is a reactive sulfane (S0), which is oxidized by a sulfur dioxygenase 
enzyme encoded by the gene ETHE1, consuming O2 and H2O to form sulfite (H2SO3). The final reaction 
is catalyzed by a sulfur transferase, rhodanase, which produces thiosulfate (H2S2O3) by transferring a 




Apart from this catabolic pathway, hydrogen sulfide has recently been shown to physiologically react 
with other molecules owing to the nucleophilic capacity of the hydrosulfide ion (HS-) (131). The pK1 of 
hydrogen sulfide is 6.76 at 37oC, therefore at pH7.4 about four fifths of hydrogen sulfide is present as 
the reactive HS- ion (28). Spiked exogenous hydrogen sulfide is quickly scavenged in biological solutions 
such as plasma (32), tissue homogenates (33) and even a pure protein solution of 5% BSA (32) with 
reported half-lives of 120 s in mouse liver homogenates (33) and 130s in rat plasma (32). Currently, 
there are three general forms of hydrogen sulfide interaction within the biological milieu reported 
under physiological conditions; as a reductant (132), through protein s-sulfhydration (31) and 
interaction with metal ion containing molecules (133). The discovery of these interactions have also 
led the elucidation of the direct targets and mechanisms by which hydrogen sulfide exerts its observed 
physiological effects. This section will describe the reported targets of hydrogen sulfide interactions 




Due to the nucleophilic nature of the predominant hydrogen sulfide (HS-) species under physiological 
conditions, most of the hydrogen sulfide interactions in the biological milieu are a result of its reducing 
ability. However, in this section the capacity of hydrogen sulfide as a reductant will be described in the 
context of an antioxidant and its interactions with endogenous free radicals. Hydrogen sulfide has been 
shown to scavenge free radicals such as peroxynitrite (96) and hypochlorite (HOCl) (97) in cultured 
neuronal cells. An equimolar solution of GSH and hydrogen sulfide have been shown to be equally 
effective in preventing protein nitrotyrosination by peroxynitrite (96) and protein oxidation by 
hypochlorite (97) which resulted in a protection of cultured neuronal cells against oxidative stress. The 
proposed mechanism of hydrogen sulfide reaction with peroxynitrite by Carballal et al involves the 
nucleophilic attack of the anionic form of hydrogen sulfide (HS−) on the peroxidic oxygen of 
peroxynitrous acid, leading to the formation of nitrite and dihydrogen disulfide presumably with the 
formation of sulfenic acid (HSOH) as intermediate : 
 
Nagy et al reported a mechanism of hydrogen sulfide reaction with hypochlorite analogous to that 
described for cysteine in which the initial oxidation step is followed by the formation of a dihydrogen 
disulfide (HSSH) (134): 
 
However Carballal et al reported that the likelihood of hydrogen sulfide serving as a physiologically 
relevant antioxidant appears unlikely compared to other abundant intracellular thiols such as GSH and 
cysteine with similar rate constants to a variety of oxidants including peroxynitrite (hydrogen sulfide : 
4.8×103 M−1 s−1, GSH : 1.3×103 M−1 s−1, cysteine : 4.5×103 M−1 s−1 , pH 7.4, 37 OC) and hypochlorite 
(hydrogen sulfide : 8×107 M−1 s−1, pH 7.4, 37 OC and GSH : ≥107 M−1 s−1, cysteine : 3.2×107 M−1 s−1, pH 
7.4, 25 OC)(99) due to the lower bioavailable levels of endogenous hydrogen sulfide. 
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These claims were countered by Fillipovic et al that reported a slightly higher hydrogen sulfide 
mediated peroxynitrite scavenging rate constant (4.8×103 M−1 s−1, pH 7.4, 37 OC) attributed to the 
difference in hydrogen sulfide source and method employed. They have reported the mechanism to 
be associative than multi-step free-radical as expected for other thiols without the need for oxygen 
consumption. This is in agreement with a primary formation of a new reaction product characterized 
by spectral and computational studies as thionitrate (HSNO2). The proposed reaction mechanisms are 
as follows: 
 
Fillipovic et al further demonstrated the protective effect of hydrogen sulfide against an equimolar 
concentration of peroxynitrite in cultured HeLa and Jurkat cells against oxidative stress (135). The 
authors discussed that intracellular biochemical reactions are greatly affected by the constraints of 
high internal concentrations of macromolecules and cellular architecture thus creating a crowded or 
volume occupied space. In such a situation, the relative size, shape and diffusibility of a molecule could 
significantly alter its reactions rates (136). This speaks in favour of hydrogen sulfide from the more 
ubiquitous intracellular reductant GSH being a smaller and highly diffusible molecule without the need 
of specific transporters (135) (137). 
1.4.2 Protein persulfide formation/ s-sulfhydration 
The existence and biological significance of protein persulfides or sulfane sulfur containing proteins 
predates the earliest report of hydrogen sulfide mediated physiological relevance (138, 139). In 1970, 
Cavallini et al had shown the capacity for exogenous hydrogen sulfide (in the form of dissolved sodium 
sulfide) to cleave disulfide bonds of purified proteins under controlled experimental conditions to yield 
protein persulfides (138), however it was not certain then if this process occurred under physiological 
conditions and more so, if endogenously synthesised hydrogen sulfide could contribute to the 
generation of protein persulfides. Therefore in the advent of current hydrogen sulfide studies, the 
formation of protein persulfide has once again resurfaced and thought to be a possible mechanism by 
which hydrogen sulfide may exert its observed physiological effects (140). 
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In 2008, Mustafa et al had reported the ability of hydrogen sulfide to s-sulfhydrate proteins to yield a 
protein persulfide using a modified biotin switch assay (31). They had subsequently estimated that 10 
to 25% of numerous liver proteins are s-sulfhydrated under physiological conditions and that the 
resulting protein persulfides possess altered activity compared to the thiol counterparts; for example 
s-sulfhydrated GAPDH and beta-actin showed a 30% enhanced activity and polymerization ability 
respectively compared to their thiol counterparts (31). Following this report, there have been an 
increasing number of studies that identified specific inducible s-sulfhydrated proteins under 
(patho)physiological conditions presumably through the action of hydrogen sulfide; they include the 
Kir 6.1 subunit of the KATP channel (141), p65 subunit of NFB (142), Protein tyrosine phosphatase 1B 
(143), Kelch-like ECH-associated protein-1 (144) (145), p66Shc (102) and mitogen-activated protein 
kinase kinase 1 (146). The s-sulfhydration of these proteins either led to its enhanced activity or 
inhibition and suggests a direct mechanism by which endogenous and exogenous hydrogen sulfide 
exerts its (patho)physiological effects; they include vasorelaxation via activation of the KATP channels 
(141), cytoprotection via NF-E2 p45-related factor 2 (Nrf2) (144, 145) and Poly (ADP-ribose) 
polymerase activation (146), apoptotic control via NFB activation (142) and anti-oxidative effect via 
inactivation of p66Shc in the mitochondria (102). The methods used to identify protein persulfides will 
be elaborated in section 2.1.2. 
Despite the growing reports on the incidences of physiological hydrogen sulfide mediated protein 
persulfide formation, there has been little information on the nature of this reaction. A direct reaction 
between hydrogen sulfide (H2S or HS-) and free thiols (R-SH) to form a persulfide is not possible as both 
sulfurs are in the same oxidation state of -2. Hydrogen sulfide has however been reported to generate 
protein persulfides when it reacts with oxidised free thiols and disulfides (147, 148). Therefore protein 
s-sulfhydration has been postulated to take place by two methods; (i) nucleophilic attack of sulfide on 
oxidised cysteine residues such as cysteine sulfenic acids (R-Cys-SOH) or cysteine disulfides (R-S-S-
R)(147); (ii) reaction between cysteine thiols and oxidised sulfide species such as polysulfides (R-S-Sn-
S-R) as the So atom in polysulfides with its 6 valence electrons is known to enter and exit sulfur 
structures readily with the thiosulfoxide tautomer as an intermediate (134, 148). These reactions are 








Figure 1.5 Formation of protein persulfides (s-sulfhydrated proteins) by hydrogen sulfide. Protein 
persulfides can be formed by (i) nucleophilic attack of sulfide on oxidised cysteine residues such as 
cysteine sulfenic acids (a) or cysteine disulfides (b) and (ii) reaction between cysteine thiols and oxidised 
sulfide species such as polysulfides (c) as the So atom in polysulfides with its 6 valence electrons is known 
to enter and exit sulfur structures readily with the thiosulfoxide tautomer as an intermediate (148). 
The biological relevance of a persulfide protein as opposed to its thiolated state has been the subject 
of continuous study. It has been shown that persulfides are better nucleophiles, reductants and acids 
compared to their thiol counterparts due to the α effect (149, 150) and this is thought to create a 
“hyperactivated” state of thiol containing proteins that possess this functional group (147). A direct 
example of this is the enhanced reducing ability of the classic antioxidant GSH; GS-SH was shown to be 
20 and 5 fold more efficient at reducing ferric iron than GSH and hydrogen sulfide respectively (147). 
This is supported by a subsequent report that further showed high and maintained levels of 
endogenously produced GSH persulfide and other cysteine persulfides in the plasma, cells and tissues 
of humans and mammals (151). 
The formation of protein persulfide through the reducing ability of hydrogen sulfide provide a possible 
direct link between hydrogen sulfide and its observed (patho)physiological effects. Apart from 
modifying protein interaction and activity, the sulfane sulfur group of the persulfides also serves as a 
source of hydrogen sulfide as mentioned in section 1.2.2. The amount of sulfane sulfur present in 
human circulation was estimated to be ~1 µM using DTT as the reducing agent to liberate sulfane sulfur 
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followed by free hydrogen sulfide derivatisation to a fluorescent thionine end product and detection 
by HPLC (152). 
1.4.3 Interaction with metal ions and metal containing proteins 
Metal ions are ubiquitous in living organisms and are responsible for numerous biological roles such 
as charge conductance and signalling, mediating redox reactions, essential cofactors for enzymatic 
activity and as structural supports (153). Hydrogen sulfide is able to bind to metal ions particularly in 
its S2- state in an aqueous solution to form metal sulfide precipitates (154). This has been employed by 
some microorganisms as a strategy to scavenge extracellular metal ions and therefore prevent heavy 
metal accumulation and toxicity (155, 156). However evidence of physiological hydrogen sulfide 
binding to free metal ions in mammals and humans and its biological significance is scarce. There has 
been one study that links hydrogen sulfide ability to activate T-type Ca2+ channels via the chelation of 
luminal Zn2+ ions in the colon of mice, thus explaining the pro-nociceptive effect of intracolonic 
administration of exogenous hydrogen sulfide (107). 
The binding of hydrogen sulfide to metal ion containing proteins however is better established (157). 
The most well documented incidence in humans is the binding of hydrogen sulfide to haemoglobin to 
form sulfhaemoglobin due to occupational and environmental exposure thus impairing the transport 
of oxygen in the affected individual (158). Early studies have also shown hydrogen sulfide to interact 
with other heme containing proteins such as catalase (159) and lactopreoxidase (160) in vitro resulting 
in an inhibition of activity. More recent studies have shown hydrogen sulfide to interact and inhibit the 
myeloperoxidase (MPO) enzyme (161-163). This was proposed to occur via the interaction of the 
enzyme in its MPOFe(II) or MPOFe(III) state with hydrogen sulfide to form a ferrous-MPO-hydrogen 
sulfide complex which therefore acts as a sink because it traps MPO in an inactive form when sulfide 
is present (163). The reported IC50 for this sulfide mediated inhibitory mechanism of MPO is 1 M in 
the presence of 5-60 M peroxide range (163) suggesting its biological relevance. Apart from iron 
containing proteins, hydrogen sulfide was also shown to inhibit the enzymatic activity of the 
angiotensin converting enzyme (ACE) in endothelial cells through the interaction of hydrogen sulfide 
with zinc(II) ion in the active centre of the protein (133). 
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Approximately a quarter to a third of all proteins require metals to carry out their functions (164). 
These metal ions may confer redox capabilities in the case of iron containing enzymes or 
structural/recognition motifs such as zinc fingers among many others (164). Therefore the ability for 
hydrogen sulfide to bind to metal ions within proteins provide an avenue for which it may modulate 


























Table 2 Summary of hydrogen sulfide reactivity and mode of action. Description of methods of 
hydrogen sulfide interaction within the biological milieu reported under physiological conditions; as a 
reductant (132), through protein s-sulfhydration (31) and interaction with metal ion containing 
molecules (133) Abbreviations; PTP1B - protein-tyrosine phosphatase 1B, Keap1 - Kelch-like ECH-
associated protein 1, Nrf2 - NF-E2 p45-related factor 2, MEK1 - mitogen-activated protein kinase kinase 
1, PARP-1 - poly(ADP-ribose)ation polymerase-1. 
Method Mechanism Reported targets Biological relevance Ref 





The sulfur in hydrogen sulfide 
exists in the lowest oxidation 
state of -2 and can only be 
oxidised. Therefore, hydrogen 
sulfide functions as a 
nucleophile and readily reacts 




Hypochlorite Cytoprotection (97, 99) 





Superoxide ? (166) 






hydrogen sulfide mediated 
formation of protein persulfides 
by reacting with thiol or thiol 
derivatives on cysteine groups 
of proteins. Either an oxidised 
form of hydrogen sulfide is 
reduced by the protein thiol or 
an oxidised form of protein thiol 
is reduced by hydrogen sulfide. 
Persulfide formation is reported 
to alter protein activity due to 
the 'hyperactivated' state of the 





Kir 6.1 and SUR2B 
subunit of kATP 
channel 


















Activation of PARP-1; 
DNA damage repair 
(146) 




Two types of interaction: 
i) Complete transfer of 
electrons between sulfur and 
metal via redox reaction 
ii) Binding of sulfur to metal to 
form a coordinate complex 
Cytochrome C 
Oxidase 
Suspended animation (168) 
Hemoglobin Enzyme inhibition (158) 
Catalase Enzyme inhibition (159) 
Lactoperoxidase Enzyme inhibition (160) 
Myeloperoxidase Enzyme inhibition (161-163) 
ACE Enzyme inhibition (133) 
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1.5 Hydrogen sulfide and inflammation 
1.5.1 Inflammation 
Inflammation is a complex set of interactions among soluble factors and cells that stem from an injury 
or insult. These interactions lead to the activation of the immune system to contain and neutralize the 
source of the insult followed by resolution and tissue repair. These complex interactions can be broken 
down to a generic pathway consisting of inducers, sensors, mediators and effectors (169). The progress 
along this pathway relies on a series of checks and balances to ensure an appropriate and regulated 
activation of the inflammatory response followed by subsequent resolution (170). The main inducer 
and sensor of inflammation involves the recognition of microbes by the innate immune system. This 
occurs via the recognition of highly conserved features on microbes (pathogen associated molecular 
patterns (PAMPs)) or specific endogenous molecules (damage associated molecular patterns (DAMPs)) 
by transmembrane and cytosolic pattern recognition receptors (PRR) such as Toll-like receptors (TLR), 
Nod-like receptors (NLR) and RIG-1 like receptors (RLR) in innate response cells (171).The bulk of early 
sensing by the innate system is performed by tissue resident macrophages, dendritic cells and mast 
cells (171). Activation of the PRRs on these cells initiates a signalling cascade that results in the 
synthesis and release of inflammatory mediators which can be grouped into seven categories; 
vasoactive amines (i.e. histamine and serotonin), vasoactive peptides (i.e. substance P and fibrin 
degradation products), fragments of complement components (C3a, C4a and C5a), lipid mediators 
(eicosanoids and platelet-activating factors), cytokines (TNF-, IL-1, IL-6 etc.), chemokines (MCP-1, 
MIP-2 etc.) and proteolytic enzymes (i.e. elastin, cathepsins and matrix metalloproteinases) (169). 
The release of these mediators then activates the effectors comprising of tissues and cells resulting in 
the recruitment of activated immune response cells to the site of injury/infection through 
extravasation (172) to contain and neutralize the insult. 
Typically, neutrophils are the first of the immune cells to be recruited to the site of inflammation 
followed by monocytes (171). Neutrophils possess an arsenal of potent effector mechanisms to 
achieve its microbicidal role including phagocytosis as well as production of reactive oxygen species 
(i.e. O2-, H2O2 and HOCl), proteinases (ie serine-proteases, metalloproteases, thiol-proteases, and 
aspartate proteases) and bactericidal proteins (i.e. bacteriacidal/permeability increasing protein, 
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defensins and lactoferrin) (173). Together, these effector molecules are able to degrade proteins, 
disrupt lipids and damage DNA. Recruited and activated neutrophils then undergo a process that 
mobilizes its defense machinery that involves full assembly of NADPH oxidase at its plasma membrane 
thus generating the reactive oxygen species that would in turn serve as a substrate for MPO enzyme 
to generate HOCl, a potent oxidant, as well as express a slew of pro-inflammatory cytokines and 
chemokines that further propagate the inflammatory response (173). A prolonged activation of 
neutrophils and mast cells would in turn condition the activation of professional antigen presenting 
cells, most notably the dendritic cells (DCs) (170). These activated DCs would then pick up antigens 
from the site of insult and travel to the lymph nodes where they would activate the naïve T and B 
lymphocytes thus initiating the adaptive immune response (174). 
Successful elimination of the source of insult should progressively lead to the termination of the 
inflammatory response and ultimately resolution. This process involves the progressive decrease in 
neutrophil recruitment (via changes in cytokine and chemokine profile to a more anti-inflammatory or 
resolution state) and neutrophil apoptosis and clearance by macrophages that in turn inhibit the pro-
inflammatory cytokine, chemokine and eicosanoid production of the ingesting macrophages (173). 
Despite the numerous points of control, the immune response is not a faultless system, aberrant and 
hyperactivation of the immune response can occur leading to immunopathological events at the 
detriment of the host (175). Aberrant and chronic activation of the immune response leads to 
autoinflammatory and autoimmune diseases; both are initiated by the innate immune response but 
the latter involves the adaptive immune response as well (176). This occurs when the immune system 
recognizes and reacts with endogenously synthesized molecules resulting in a loss of tolerance. Pattern 
recognition receptors (PRRs) and in particular TLRs play a crucial role in the early detection of PAMPs 
as well as DAMPs resulting in the subsequent activation of the innate and adaptive immune response. 
It is thought that this pathway in immune activation results in the onset of autoinflammatory and 
autoimmune diseases initiated through apoptosis and subsequent presentation of autoantigens from 
the dying cells to antigen presenting cells (177). The activity of nucleases and proteases during the 
apoptotic process could potentially generate neo-epitopes that can be recognized as foreign. Neo-
epitopes could also be formed by other forms of post-translational modification or through structural 
modifications brought about by environmental factors. These autoantigens also serve as 
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autoadjuvants as they are recognized by the innate system therefore activating the whole cascade of 
immune response (177). Autoimmune and autoinflammatory diseases are associated with chronic 
pathologies such as Crohn’s disease, PAPA syndrome, systemic lupus erythematosus and rheumatoid 
arthritis (176). While these conditions are debilitating, they rarely lead to direct mortality. However, 
chronic inflammation brought about in such pathologies are strongly linked to the development of 
cancer (2). 
Another type of immunopathology involves the hyper-responsiveness of the immune system towards 
pathogenic or non-pathogenic stimuli. Localized inflammation is a physiological protective event 
targeted at controlling and eliminating the source of an insult, however loss of this control results in 
an overly activated immune response and could lead to the development of a systemic response 
known as systemic inflammatory response syndrome (SIRS) (178). SIRS is associated with a massive 
increase in plasma pro-inflammatory cytokines such as TNF-, IL-1 and IL-6 thus initiating inflammatory 
events distant to the source of the insult. If left unresolved, SIRS could progress to multiple organ 
damage syndrome (MODS) and failure to maintain homeostasis without intervention resulting in high 
mortality rate of between 40% - 98% depending on the number of organs affected (179). SIRS and 
MODS are common complications in pathogenic derived pathology such as sepsis (30%) and non-
pathogenic derived pathology such as acute pancreatitis (24%), burns (40%) and trauma (30%) (178). 
During the progression of SIRS, the body launches an anti-inflammatory effort in order to regulate the 
immune response. This involves a systemic release of anti-inflammatory molecules such as 
interleukins-4, -10, -11, and -13; transforming growth factor-beta; colony-stimulating factors; soluble 
receptors to tumour necrosis factor; and receptor antagonists to IL-1 (180). The result is immune 
suppression, which can sometimes be profound. If the compensatory anti-inflammatory reaction is 
sufficiently severe, it will manifest clinically as anergy, an increased susceptibility to infection or both. 
This response is termed compensatory anti-inflammatory response syndrome (CARS) (180). Therefore 
there exists a continuum in systemic immunopathologies between SIRS and CARS where one may 
predominate over the other with mid-points where both responses exist and is termed mixed anti-
inflammatory response syndrome (MARS). 
The activation of the inflammatory response though essential is generally associated with collateral 
damage to surrounding healthy host tissue as the arsenal employed by the immune response cells are 
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not able to distinguish between self and non-self (ie reactive oxygen species and proteases), 
particularly with respect to the innate immune response cells and neutrophils in particular. This 
activation is usually regulated and kept under control though over-compensation leading to 
suppression of the immune response may arise. Therefore dysregulation of the inflammatory response 
leads to disorders and disease (170) and a better understanding of the machinery and signalling 
involved in the inflammatory response could lead to potential therapeutic targets in 
immunopathological conditions. However such therapeutics should take into account the 
inflammatory state of the disease as the choice of immunomodulation therapies would depend on 
whether SIRS or CARS predominate upon presentation. 
 
 
Figure 1.6 Illustration of the innate inflammatory response. Pathogenic insult initiates an 
inflammatory response by either releasing pattern associated molecular pattern molecules (PAMPs) (ie 
lipopolysaccharide) or causing damage and lysis in host cells resulting in release of damage associated 
molecular pattern molecules (DAMPs). These molecules are sensed by the surrounding cells and 
resident macrophages resulting in macrophage activation. Activated macrophage releases a slew of 
pro-inflammatory mediators consisting of cytokines, chemokines and eicosanoids. These mediators 
cause physiological changes in vascular endothelial cells such as expression of adhesion molecules and 
leakiness of the vasculature resulting in recruitment and extravasation of circulating neutrophils and 
monocytes. These cells then migrate to the site of injury/insult following the chemokine/ eicosanoid 
gradient to neutralise and eradicate the source of the injury/insult. This could involve the generation of 
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ROS, digestive enzymes, metal ion chelators and phagocytosis. Recruited inflammatory cells also 
generate pro-inflammatory cells in response to inflammatory cues at the site of injury thus propagating 
the inflammatory response. Once the source of injury/insult is neutralised, the inflammatory response 
switches to a resolution phase, failure to do so results in an uncontrolled inflammatory response. 
1.5.2 Hydrogen sulfide physiology and inflammation 
Hydrogen sulfide has been shown to be involved in various physiological aspects related to the 
inflammatory response. As mentioned in section 1.3, endogenous hydrogen sulfide is involved in 
maintaining vascular tone by acting as a vasodilator. The vasodilatory effect is shown to be primarily 
mediated through the relaxation of smooth muscle cells via activation of the KATP channels (141). 
Hydrogen sulfide could also influence vasotone via reduction of circulating angiotensin II, a known 
vasoconstrictor (181), by inhibiting ACE activity (133). Elevated levels of the renin-angiotensin system 
(RAS) activity have been demonstrated in diseases such as hypertension, cardiovascular diseases 
(myocardial infarction and atherosclerosis), kidney diseases and diabetes (182). Alterations in vascular 
tone affects blood flow and the inflammatory response. For example, vasodilation leads to increased 
blood flow and in an inflammatory response, this would increase the recruitment of leukocytes to the 
site of injury (183). Also, severe fall in blood pressure (hypotension) leading to dysfunction or failure 
of major organs is associated with systemic inflammatory conditions such as sepsis and endotoxemia. 
An increase in endogenous hydrogen sulfide has been associated with the development of sepsis, 
endotoxin and hemorrhagic induced shock (184, 185) though recent views suggest a more cautious 
interpretation largely due to the difficulty and variable methods employed in estimating endogenous 
levels of free hydrogen sulfide (186). In addition, perturbation of endogenous hydrogen sulfide levels 
by inhibition with PAG or use of a hydrogen sulfide donor such a NaHS was found to both increase 
mean arterial pressure in hemorrhagic induced shock (184) as well as decrease mean arterial pressure 
in septic mice (187) respectively. In the latter, it was further shown that the increased microvascular 
permeability by treatment with NaHS improved leukocyte recruitment to the site of infection thus 
improving the survival outcome in severe sepsis (187) which was in contrary to another report that 
corroborated hydrogen sulfide trafficking of leukocytes (188) but this was shown to have deleterious 




In an inflammatory response, there is an accumulation of cytotoxic substances produced by the 
immune cells to neutralize and eliminate the source of the insult. These cytotoxic substances such as 
reactive oxygen/nitrogen species and pro-inflammatory cytokines do not distinguish between host and 
pathogen resulting in damage of the surrounding healthy host cells. This collateral damage is 
particularly devastating in autoimmune and autoinflammatory diseases where inflammatory response 
persists without the presence of a pathogen or the inability to eradicate a pathogen. Hydrogen sulfide 
has been shown to exert cytoprotective effects largely via its antioxidant and anti-apoptotic roles (190, 
191), as mentioned in section 1.1.2 and 1.3.1. Administration of hydrogen sulfide to autoinflammatory 
pathologies such as myocardial infarction (121, 122) and ischemia reperfusion (123, 124, 192) was 
found to lessen the severity of healthy tissue destruction owing to its cytoprotective properties. 
Nociception occurs via sensory neurons comprising of small diameter C-fibre and A fibres (193). 
Excitation of these neurons via harmful stimuli such as thermal extremes, noxious chemicals and 
excessive pressure elicits a pain response as a method to sense harm. However, the excitation of these 
neurons have also been associated with the elicitation of an inflammatory response; stimulated 
sensory neurons release pro-inflammatory neuropeptides such as substance P (SP) and calcitonin 
gene-related peptide (CGRP) that interact with endothelial cells, mast cells, immune cells, and 
arterioles to initiate an inflammatory response termed neurogenic inflammation (194). As mentioned 
in section 1.1.2 hydrogen sulfide has been shown to sensitize nociceptors such as T-type calcium 
channel (108, 110, 111), TRPA1 (105, 112, 113) and TRPV1 (79, 114). Among these three receptors, 
TRPV1 and TRPA1 activation and association with neurogenic inflammation have been well established 
(195, 196). Functional TRPV1 and TRPA1 receptors are also present on non-neuronal cells such as 
keratinocytes and immune cells and similar to sensory neuronal cells, the activation of these receptors 
also influence the inflammatory response of these non-neuronal cells (197). Therefore the ability of 
hydrogen sulfide to sensitize nociceptors suggests a possible role of hydrogen sulfide in promoting 
neurogenic inflammation. This has been demonstrated in studies of airway inflammation (114) and 




Figure 1.7 The effect of hydrogen sulfide on the inflammatory response based on its reported 
physiological roles. As a vasodilator, hydrogen sulfide could lead to increased blood flow and vascular 
permeability leading to increased recruitment of leukocytes, vasodilation could also contribute to 
hypotension and shock. Hydrogen sulfide is also reported to be cytoprotective mainly due to its 
antioxidant (direct and indirect) and apoptotic effects. This could lessen the amount of collateral 
damage to the surrounding healthy cells due to ROS generated by neutrophils and macrophages, 
additionally cellular death by apoptosis is more favourable over necrosis as it does not lead to 
uncontrolled release of DAMPs. As a nociceptor, hydrogen sulfide has the potential to elicit a 
neurogenic inflammatory response by stimulating the release of pro-inflammatory neuropeptides such 
as substance P (SP) and calcitonin gene-related peptide (CGRP) that interact with endothelial cells, mast 
cells, immune cells, and arterioles to initiate an inflammatory response. 
1.5.3 Direct effects of hydrogen sulfide on the inflammatory response 
Apart from physiological events that influence the inflammatory response, hydrogen sulfide has also 
been shown to directly modulate the inflammatory response by activating molecules of the 
inflammatory cascade or reacting with the effector molecules generated by the immune response 
cells. 
NFB is a family of transcription factors that plays an important role in inflammation by promoting the 
transcription of pro-inflammatory genes (199). Endogenously synthesized as well as exogenously 
administered hydrogen sulfide has been associated with both activation and inhibition of NFB in 
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response to inflammation. Endogenous hydrogen sulfide has been shown to activate liver and lung 
NFB following sepsis (200) and pancreatic NFB following pancreatitis (69). On the contrary, 
endogenous hydrogen sulfide is also associated with inhibition of NFB in the kidney following renal 
ischemia/reperfusion injury (124) and in macrophages upon LPS activation (201). Exogenously 
administered hydrogen sulfide increased NFB activation in primed monocytes (202), liver and lung 
following sepsis (200), LPS activated macrophages (203) and in the pancreas following pancreatitis 
(69). Like endogenous hydrogen sulfide, exogenous hydrogen sulfide has also been reported to inhibit 
NFB activation in the heart (122), retinal (204) and renal tissue (124) following ischemia/reperfusion 
injury as well as in LPS treated macrophages (201, 203). In the reports cited above, the hydrogen sulfide 
mediated modulation of NFB had been attributed to activation or inhibition of upstream signalling 
events. However, more recent reports have shown that hydrogen sulfide is able to directly s-
sulfhydrate the p65 subunit of NFB on the cysteine-38 residue. The initial report of this finding 
showed that s-sulfhydration of the p65 subunit activates NFB (142), however a subsequent report 
that corroborates hydrogen sulfide mediated p65 subunit sulfhydration showed an opposite inhibitory 
effect (205). This was thought to be due to the different conditions under which the observation was 
made; physiological versus pathophysiological (205). Taken together, these findings propose a 
mechanism by which hydrogen sulfide may directly influence the progression of an inflammatory 
response through the modulation of NFB activity. 
Nrf2 is another transcription factor that has been shown to be activated by hydrogen sulfide. Nrf2 is 
the primary transcription factor that binds to the antioxidant response element (ARE) in the regulatory 
regions of multiple genes and plays a key role in the suppression of the inflammatory response via 
regulation of the cytoprotective and antioxidant defense system (206). Nrf2 activity is negatively 
regulated by Keap-1 that functions an adaptor protein for a Cul3-based ubiquitin E3 ligase and binds 
to Nrf2 under normal conditions thus promoting its degradation by the proteasome (207). Hydrogen 
sulfide has been shown to sulfhydrate Keap-1 at cysteine 226 and 613 as well as cysteine 151 thus 
promoting its inactivation (144) and disassociation (145) from Nrf2 leading to activation of Nrf2. 
Exogenously administered hydrogen sulfide has been shown to exert an anti-inflammatory response 
through activation of Nrf2 in myocardial ischemia (208) (41), sepsis (209), diabetic nephropathy (210) 
and hemorrhagic shock (211). 
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Reactive oxygen and nitrogen species such as superoxide, nitric oxide, hydrogen peroxide, 
peroxynitrite and hypochlorus acid are among the effector molecules generated by immune response 
cells in an attempt to eradicate invading pathogens (212). Although effective, these potent free radicals 
are also capable of causing damage to surrounding healthy tissue through oxidative stress. As 
mentioned in section 1.4.1, hydrogen sulfide has been shown to be a strong antioxidant capable of 
scavenging peroxynitrite and hypochlorous acid with similar or greater reducing potential to 
ubiquitous endogenous antioxidants such as GSH and cysteine (99, 135). Administration of exogenous 
hydrogen sulfide has been shown to lessen the effect of oxidative stress in neuronal cells exposed to 
peroxynitrite (96), hypochlorous acid (97), glutamate (101) and beta amyloid (213). However, it is 
important to note that endogenous levels of hydrogen sulfide are substantially lower than the more 
common antioxidant, GSH, and it has been hypothesized that the possible direct contribution of 
hydrogen sulfide as a physiological antioxidant would be negligible. In fact most of the observed 
antioxidative protection afforded by hydrogen sulfide has been attributed to its ability to increase 
intracellular antioxidants such as GSH (214) (101). Despite the unfavourable endogenous levels, the 
relevance of hydrogen sulfide as a physiologically direct antioxidant has been argued owing to its small 
and diffusible nature making it more favourable in the crowded and confined environment of a cell 
compared to larger molecules such as GSH (215). 
Hydrogen sulfide has been shown to modulate the activity of metal ion containing proteins by directly 
interacting with the metal ion (refer to section 1.3.3). It has been shown to inhibit MPO activity in 
primary human polymorphonuclear leukocytes (161) and in its purified form (162, 163) with an IC50 of 
~1 M (163). MPO is a crucial protein in the arsenal of innate immune response cells; it is responsible 
for the generation of large quantities reactive oxygen species with the purpose of killing pathogens. 
Hydrogen sulfide has also been shown to inhibit angiontensin-converting enzyme (ACE) activity in 
endothelial cells (133); the product of ACE is angiotensin II, the effector molecule of the renin-
angiotensin system (RAS). RAS has been classically known for its role in maintaining blood pressure 
and water balance, however recent evidence have shown it to be involved in key events of the 
inflammatory process. Angiotensin increases vascular permeability via release of prostaglandins, 
regulates expression of adhesion molecules and chemokines by resident cells as well as directly 




Figure 1.8 Illustration of direct reported effects of hydrogen sulfide on the inflammatory response. 
hydrogen sulfide effect on the inflammatory response through its capacity as a reductant and ability to 
s-sulfhydrate as well as interact with metal ion containing proteins. hydrogen sulfide has been shown 
to directly reduce reactive oxygen species such as peroxynitrite and hypochlorous acid, it is also capable 
of reducing extracellular cystine to cysteine thus facilitating transport via cysteine transporters (ASC) 
where it can serve as a substrate for GSH synthesis. Hydrogen sulfide is also known to s-sulfhydrate and 
regulate several key proteins related to the inflammatory response; activation of NFB – transcription 
factor of numerous pro-inflammatory proteins, activation of Nrf2 – transcription factor of numerous 
anti-oxidative related proteins, p66shc – initiator of mitochondria mediated generation of ROS. 
hydrogen sulfide is also reported to interact and inhibit the activity of key metal ion containing proteins; 
myeloperoxidase – responsible for the synthesis of inflammatory cell ROS, angiotensin converting 
enzyme – converts angiotensin I to angiotensin II which is reported to contribute to the inflammatory 




1.5.4 Pro- or anti-inflammatory? 
As described in section 1.5.2 and 1.5.3, it appears that hydrogen sulfide has the ability to function as 
both a pro and anti-inflammatory mediator via direct and indirect means. Indeed, the literature has 
equally mixed findings showing both pro and anti-inflammatory roles of hydrogen sulfide in multiple 
models of inflammatory diseases in animals. Animal studies aimed at elucidating the role of 
endogenous hydrogen sulfide through inhibition of the hydrogen sulfide producing enzyme, CSE, have 
shown both pro (44, 66, 189, 216-219) and anti (187, 220-224) inflammatory effects. Similarly, 
administration of exogenous hydrogen sulfide has also showed similar conflicting outcomes of pro (44, 
45, 69, 189, 216, 218) and anti (187, 221, 223-229) inflammatory effects. These contrasting findings 
are further exemplified in similar models of inflammation such as sepsis (187, 189, 198, 209), 
pancreatitis (66, 69, 230), LPS induced endotoxemia (44, 231) and burn injury (45, 229) where both pro 
and anti-inflammatory effects of hydrogen sulfide have been reported. 
Although the common aim of these studies is to determine the role hydrogen sulfide in the 
inflammatory response, there are differences between them that could result in the conflicting 
outcome. Firstly there is the issue of different animal models being used thus resulting with differing 
pathogenesis and subsequent elicitation of the inflammatory response. Hydrogen sulfide has been 
shown to be highly reactive with diverse physiological and pathophysiological roles. Therefore the 
interaction between hydrogen sulfide and different animal models may yield different outcomes that 
may be related to the pathogenesis of the disease of study. 
Studies that administer exogenous hydrogen sulfide pose a much larger complication. To begin with, 
there is still very little agreement as to the amount of hydrogen sulfide present in circulation and 
tissues due to the difficulty in measuring free hydrogen sulfide (refer to section 1.2.3). Without 
accurately knowing physiological or pathophysiological levels of circulating and tissue free sulfide, it 
would be difficult to determine the amount of hydrogen sulfide to administer that would be 
(patho)physiologically relevant. This could create artifactual findings independent of the true role of 
endogenous hydrogen sulfide in the inflammatory response. Additionally, in studies with similar 
models of inflammation, there are inconsistencies with the dosage, source of hydrogen sulfide and 
route of administration. For example in the cecal ligation and puncture model of sepsis in mice, there 
are three research groups that utilise different dosage and route of administration. The groups that 
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administered NaHS at 100 mol/kg (187, 209) reported an anti-inflammatory effect while 180 mol/kg 
(189) was found to be opposite. In addition, one group used Lawesson’s reagent (that slowly releases 
hydrogen sulfide (232)) as one of their hydrogen sulfide source and there were differences in the 
timing of the doses (187). Another example is the burns injury model with one group administering 
180 mol/kg intraperitoneally (45) and another at 36 mol/kg subcutaneously (229) with reports of 
pro- and anti-inflammatory effects respectively. These differences make it difficult to directly compare 
different studies and suggest caution when interpreting the role of hydrogen sulfide in inflammation 
by use of exogenous hydrogen sulfide donors. 
Apart from simple salts such as NaHS and Na2S that result in a large instant bolus release of hydrogen 
sulfide, there are also slow releasing donors that provide a sustained low level release of hydrogen 
sulfide, they include GYY4137 and S-diclofenac, a hydrogen sulfide-releasing dithiol-thione moiety 
attached by an ester linkage to diclofenac. These sustained slow releasing hydrogen sulfide donors 
have been shown to exert an anti-inflammatory effect in models of inflammatory diseases where NaHS 
was previously shown to be pro-inflammatory; this has been shown in pancreatitis (69, 230), LPS 
induced endotoxemia (44, 231) as well as LPS stimulated macrophages (203). Slow releasing hydrogen 
sulfide donors have also been shown to have anti-inflammatory effects in animal models of 
carrageenan induced hind-paw oedema (233), myocardial ischemia reperfusion injury (234) and acute 
knee joint inflammation (235). Interestingly, there have been no reports to date showing slow releasing 
hydrogen sulfide donors to be pro-inflammatory. This clearly suggests that the inflammatory effects of 
hydrogen sulfide are strongly dependent on the dose and rate of release/synthesis. This could perhaps 
relate to the affinity of hydrogen sulfide to its target molecules; at low concentrations of hydrogen 
sulfide it would most likely interact with the most abundant molecules present based on affinity, while 
at high concentrations of hydrogen sulfide it would be able to interact with less abundant molecules 
too. In an inflammatory response, there are large amount of reactive oxygen species generated as well 
as oxidised GSH (GS-SG) which could be the preferred target of hydrogen sulfide thus conferring an 
anti-inflammatory role. At higher concentration of hydrogen sulfide, it could interact with receptors 
and signalling molecules that are relatively less abundant thus initiating pro-inflammatory signalling 
response, for example NFB (236). 
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Most studies looking at endogenous sulfide synthesis in inflammatory models use PAG as a 
pharmacological inhibitor to inhibit CSE activity; CSE is thought to be main contributor of hydrogen 
sulfide synthesis in the peripheral tissues while CBS in the brain (237). PAG is an irreversible inhibitor 
that targets pyridoxal-5-phosphate dependent enzymes, this includes the racemization, 
decarboxylation, transamination and  &  elimination class of enzymes (238). Apart from CSE, PAG 
has also been shown to selectively inhibit methionine--lyase (239), D,L amino acid oxidases (240), 
alanine transaminase (241) and aspartate aminotransferase (242). In a review by Whiteman et al (243), 
several non-CSE related effects of PAG that could directly or indirectly affect the inflammatory 
response have been discussed. It had also been noted that PAG rapidly accumulates in the circulation 
and D-PAG is metabolized to a yet unknown metabolite leading to renal injury. Therefore the non-CSE 
mediated actions of PAG coupled with the variety of pathologies as well as dosage regimes could 
potentially result with observable effects independent of endogenous hydrogen sulfide generation and 
explain the conflicting observation of both pro and anti-inflammatory effects of endogenous hydrogen 
sulfide. 
Despite the limitations and contradicting results described above, the growing body of evidence 
suggests that CSE does play a role in the inflammatory response and this could be mediated through 
endogenous hydrogen sulfide synthesis. The current understanding of hydrogen sulfide role in 
inflammation could be further developed and made more accurate through the development and use 
of more sensitive and specific methods of detecting free hydrogen sulfide in biological solution and 
selective inhibitors towards endogenous hydrogen sulfide synthesizing enzymes. 
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Route hydrogen sulfide donor Route 
Pro-inflammatory        
Cecal ligation and puncture 
induced sepsis 
Ms 
PAG (50mg/kg) 1h 














ip   Leukocyte infiltration (44) 

















ip   Leukocyte infiltration (219) 
Burns injury (30% exposure for 
8s) 
Ms 
PAG (50mg/kg) 1hr 




ip Leukocyte infiltration (45) 
Caerulein induced Pancreatitis Ms 
PAG (100mg/kg) 
1hr pre or post 
ip   Leukocyte infiltration (66, 244) 
Sodium Taurocholate induced 
pancreatitis 
Rt 
PAG (80mg/kg) 1h 
post 
ip 







Cisplatin induced renal 
damage 
Rt 
PAG (5mg/kg) BD 
for 4d 




Gentamicin induced renal 
damage 
Rt 
PAG (25mg/kg) OD  
for 10d 
ip 






Haemorrhagic Shock Rt 
PAG (50mg/kg) 
30min pre bleed 




Carrageenan induced hind 
paw edema 
Rt 
PAG (50mg/kg) 1h 
pre 




        
Anti-inflammatory        
Cecal ligation and puncture 
induced sepsis 
Ms 









Cecal ligation and puncture 
induced sepsis 
Ms   
NaHS (100umol/kg) 1h 





LPS induced endotoxemia 
10mg/kg ip 
Rt   
S-Diclofenac 




nitric oxide, NFB 
(232) 
LPS induced endotoxemia 
4mg/kg iv 
Rt   






Burns injury (40% exposure for 
10s) 






Caerulein induced Pancreatitis Ms   
ACS15 (15mg/kg) 1h pre 
or post 
ip Leukocyte infiltration (230) 
Renal ischaemia reperfusion, 
45min 
Rt 
PAG (50mg/kg) 1h 
pre 





Renal ischaemia reperfusion, 
60min 
Rt   NaHS (0.15umol) post ip Leukocyte infiltration (247) 
Renal ischaemia reperfusion, 
60min 














10min pre reperfusion 
iv Nitric oxide, cytokines (224) 
Kaolin/Carrageenan induced 
knee joint arthritis 
Rt   
Na2S (5nmol/joint) 24h 
post 
ia Leukocyte infiltration (227) 












Carrageenan induced hind 
paw edema 
Rt   
S-Diclofenac (11.8-
47.2umol/kg) 3h pre 
ip 
Leukocyte infiltration, 




BD for 7d 
ip 
NaHS (1.7mg/kg/) BD, 













NFB, oxidative stress, 
adhesion molecule 
(122) 
        
Table 3 Summary of studies investigating the role of hydrogen sulfide in animal models of 
disease/injury. This table shows reported role of hydrogen sulfide in the inflammatory response of 
various models of disease/injury in animals. These studies have either used the hydrogen sulfide 
synthesizing enzyme inhibitor, PAG or hydrogen sulfide donors as a means of modulating endogenous 
hydrogen sulfide levels. There are mixed results showing both pro and anti-inflammatory effects of 
hydrogen sulfide even with similar models of disease/injury. However there appears to be differences 
between studies such as variation in the choice of hydrogen sulfide donors, route of administration and 
dosage regime as well as method of inducing disease/injury. (Ms – mouse, Rt – rat, Pg – pig, OD – once 
daily, BD – twice daily, ip – intraperitoneal, sc – subcutaneous, iv – intravenous, ia – intraarticular, ic – 
intracolonic) 
1.5.5 Therapeutic potential of hydrogen sulfide? 
In order to consider hydrogen sulfide modulation as form of therapy, our current understanding of it 
should afford us satisfactory knowledge of the following; (1) predictable effect or outcome, (2) 
identification of an established and relatively specific target, and (3) useable/suitable therapeutic 
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window of application. Unfortunately with the current knowledge of hydrogen sulfide, we are still 
unable to definitively answer or demonstrate these points, particularly with respect to the 
inflammatory response. 
As demonstrated in section 1.5.4, there are still very conflicting effects of hydrogen sulfide (by means 
of exogenous introduction or endogenous inhibition) on the inflammatory response, granted this could 
be due to several factors such as different disease models and methods of hydrogen sulfide 
modulation. However, this only contributes to the second point of target specificity. Hydrogen sulfide 
is a highly nucleophilic and diffusible gaseous molecule therefore making it highly motile and reactive. 
There is currently no known specific ‘receptor’ for hydrogen sulfide which brings into question what 
would the hydrogen sulfide-inflammatory studies above be targeting to bring about the effects? There 
are reports of its ability to react with thiol groups of numerous proteins to form protein persulfides 
thus increasing or decreasing its activity (refer to section 1.4.2 for details). This is by far the only well 
studied aspect and could speak of the various physiological effects ascribed to hydrogen sulfide, some 
of which are directly related to the inflammatory response (NFB and Nrf2). These reports of direct 
hydrogen sulfide mediated effects are unfortunately few and far between and require more studies to 
confirm its validity as well as to define its implication on the inflammatory response. It is also subject 
to the question of specificity, if endogenous hydrogen sulfide is synthesised for a specific purpose, how 
does it reach its intended protein target without eliciting other effects? As a consequence, how could 
hydrogen sulfide modulating therapies do the same? 
It is apparent at this stage that our current understanding of hydrogen sulfide is insufficient to warrant 
any therapeutic potential to be realised anytime soon. Despite this, the numerous studies showing 
hydrogen sulfide effect on the inflammatory response (Table 3) warrants more efforts into 
understanding and determining the direct effects which may offer potential therapeutic strategies. For 
example NFB, an important pro-inflammatory transcription factor, has been shown to be s-
sulfhydrated resulting in increased transcriptional activity. Monocytes/macrophages are shown to 
significantly increase CSE expression upon activation which could suggest the possible involvement of 
CSE/ endogenous hydrogen sulfide in the inflammatory function of these cells, possibly via modulation 
of NFB activity. Assuming this is true, specific targeting of monocyte CSE activity/ endogenous 
hydrogen sulfide synthesis could help dampen the inflammatory response while still preserving the 
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function of these cells. A demonstration of this potential has been shown in in vitro siRNA knockdown 
studies of LPS stimulated macrophages (249, 250) whereby monocyte NFB activation and pro-
inflammatory cytokine release was reduced as well as in in vivo targeted knockdown of CSE in 
monocytes (251) where the inflammatory response was attenuated. However further studies are 
required to confirm the involvement of hydrogen sulfide and to determine the possible mechanism of 
its affect. 
This would bring us to the third point of therapeutic window. Most of the pre-clinical studies including 
the monocyte targeted study above employ hydrogen sulfide intervention strategies before, during or 
shortly after disease onset. However, immunopathologies are generally associated with 
hypreactivation and/ or persistent activation of the immune response which may progress to an 
untimely deactivation (CARS) that may lead to subsequent susceptibility to secondary infections. Most 
patients are admitted when the disease have progressed and are possibly in the CARS state, therefore 
making the monocyte dampening therapy irrelevant. However there are incidences of 
immunopathologies where the window of opportunity is wider such as chronic inflammatory 
conditions like rheumatoid arthritis. 
Therefore, with the current state of knowledge, it appears that hydrogen sulfide in itself does not 
possess or activate unique physiological effect or pathways respectively. However it appears to be able 
to modify certain protein activity and therefore exert indirect effects to known physiological processes. 
Therefore further insights into where hydrogen sulfide is being made, its targets and how that affects 
the inflammatory response could result in possible therapeutic strategies aimed at specifically 
attenuating or enhancing that hydrogen sulfide mediated pathway(s). 
1.6 Acute pancreatitis 
Acute pancreatitis is a common condition that accounts for more than 220,000 hospital admissions in 
the United States each year (252) with a mortality rate of 10 % to 15 % (253). A mild form of pancreatitis 
is characterized by localized self-limiting inflammation of the pancreas and resolves without the need 
of any intervention. Severe necrotizing pancreatitis is an uncontrolled form resulting in a systemic 
inflammatory response leading to multiple organ dysfunction and mortality primarily due to acute 
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respiratory distress. Following onset of a systemic inflammatory response, a compensatory anti-
inflammatory response is initiated to regulate and dampen its effect. In certain cases, the 
hyperactivated state of the immune response during a systemic inflammation is followed by an 
excessive compensatory anti-inflammatory response which overly suppresses the immune system and 
facilitates nosocomial infections including infected pancreatic necrosis, one of the most feared 
complications of the disease. This makes treatment of acute pancreatitis difficult as the 
immunomodulation therapies aimed at dampening the initial hyperactivation of the immune response 
needs to be delivered in a timely fashion. The associated risk factors of acute pancreatitis are primarily 
gall stones and excessive alcohol intake (252), however, the precise aetiology of acute pancreatitis is 
still not completely understood. It is accepted that the pancreatic acinar cells of the exocrine pancreas 
plays a central role to the pathogenesis and progression of the ensuing inflammatory response. 
Currently, premature zymogen and NFB activation in pancreatic acinar cells are believed to be the 
two major initiators (254). 
1.6.1 Current understanding of acute pancreatitis aetiology 
1.6.1.1 Premature zymogen activation 
Uncontrolled premature zymogen activation results in autodigestion of the pancreas thus causing the 
release of intracellular contents rich in proteases and damage associated molecular pattern molecules 
(DAMPs) that elicit an inflammatory response. The mechanisms underlying premature zymogen 
activation have been the subject of intense study and has so far revealed shown to involve multiple 
events. Pathologic pancreatic acinar cell calcium influx is one; this entails a sustained global rise in 
cytosolic calcium influx (Ca2+i) as opposed to transient spikes observed in physiological responses (255). 
This response is reported in experimental models of pancreatitis and its blockade leads to inhibition of 
trypsinogen activation (256). Endoplasmic reticulum membrane Ryanodine Receptors (RyR) (257) and 
plasma membrane store operated calcium channels (SOCs) (258) have been implicated as important 
sources of Ca2+i. The Ca2+ dependent activation of zymogens is thought to occur via calcineurin (a 
calcium dependent phosphatase) (259). 
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Other events leading to premature zymogen activation include the localisation of lysosomes and 
zymogens which allows lysosomal cathepsin B to cleave and activate zymogens (260, 261), however 
this requires additional conditions such as low pH which significantly enhances the catalytic activity of 
cathepsin B (262). The acidification of these vacuoles is thought to occur via vacuolar ATPase (vATPase) 
which pumps protons into the vacuoles (263). Finally, autophagy, although a protective response for 
cells has been shown to be both beneficial as well as deleterious in the progression of the disease in 
relation to premature zymogen activation (264, 265). The protective form of autophagy is thought to 
be more selective and involve zymogen granules thus termed zymophagy, the upregulation of 
zymophagy resulted in decreased trypsinogen activation and disease severity (265). In addition, the 
balance between lysosomal cathepsin B (activates tryosinogen) and cathepsin L (degrades trypsin) is 
also thought to affect the autophagy response as prematurely activated trypsinogen would undergo 
degradation by cathepsin L but during pancreatitis this is retarded due to imbalance between 
cathepsins B and L (266). 
1.6.1.2 Activation of NFB and the inflammatory response 
NFB is a known pro-inflammatory transcription factor that is highly activated at sites of inflammation 
in diverse diseases (199). Although both zymogen and NFB activation are observed in pancreatitis, it 
has been shown that induction of pancreatitis in mice lacking trypsinogen-7, the critical enzyme 
required for zymogen activation, the disease still progressed without affecting the activation of 
pancreatic NFB (267). This points strongly to the capacity of pancreatic cells in directly generating 
pro-inflammatory cues that subsequently elicit a full blown inflammatory response, independent of 
preceding zymogen activation. Current data suggests that pathologic Ca2+i (268) as well as activation 
of novel isoforms of protein kinase C (269-272) are responsible for NFkB activation. Mechanisms other 
than calcium or PKC dependent pathways have also been suggested, notable among these being 
angiotensin 2 acting through AT2 receptors (273) and p38/MAPK pathways (274, 275). Recently, the 
role of acinar cell injury by itself to activate inflammatory cascades was explored. It was found that cell 
injury may lead to release of damage-associated molecular pattern (DAMP) molecules such as high-
mobility group box 
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protein 1 (HMGB1), DNA, ATP, and heat shock protein 70 causing the activation of DAMP receptors 
(TLR-9 and P2X-7 recognized as important ones)(276). Activation of DAMP receptors induces formation 
of a cytosolic complex termed the inflammasome that is implicated in initiating inflammatory cascade 
during pancreatic injury (277). 
1.6.1.3 Bacterial infection – the second hit 
The initial injury that occurs in acute pancreatitis is characteristically sterile and involves the 
mechanisms described above (276). However, depending on the severity, the progression of acute 
pancreatitis is also associated with bacterial infection termed as the ‘second hit’. In severe acute 
pancreatitis, there is a disturbance in intestinal motility and permeability; ineffective motility leads to 
bacterial overgrowth in the small bowel and coupled with increased permeability promotes bacterial 
translocation through the intestinal mucosa resulting in bacteraemia and infections at remote sites 
(including peripancreatic or pancreatic necrosis) (278). Infected peripancreatic or pancreatic necrosis 
in patients with acute pancreatitis is associated with 30% mortality (279). The overall mortality in acute 
pancreatitis is about 5%, 50% of which is caused by infected necrosis (280) thus highlighting the 
importance of secondary bacterial infection as a cause for acute pancreatitis associated mortality. 
Therefore intestinal function plays a pivotal role in the progression of this disease with regards to the 
secondary bacterial infection. There are currently multiple pathophysiological factors that are thought 
to contribute towards intestinal barrier dysfunction during pancreatitis. Of greater importance is 
possibly the reduction in intestinal blood flow (281) mediated by the vasoconstrictor endothelin (282), 
particularly that affecting the colonic mucosa leading to ischaemia and reperfusion injury thus leading 
to damage and disruption of the intestinal barrier (282, 283). Other factors include increased intestinal 
ICAM-1 expression leading to subsequent recruitment of leukocytes (284) as well as malnutrition that 
is associated with intestinal mucosal atrophy (285) and altered intestinal (286) and systemic immune 
defenses (287), which lead to an increase in intestinal permeability (288) with subsequent 
translocation of bacteria and endotoxin (289). 
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1.6.2 Acinar cell derived inflammatory mediators 
Apart from releasing intracellular contents rich in DAMPs due to cell damage, intact pancreatic acinar 
cells are capable of actively synthesizing and releasing a spectrum of potent pro-inflammatory 
mediators that include chemokines, cytokines and substance P upon hyperstimulation. It is interesting 
to note that these cytokines and chemokines share a common transcriptional regulator, NFB (290). 
In fact, NFB has been shown to be the key regulator of increased cytokine and chemokine synthesis 
in acini in response to hyperstimulation and pancreatitis (291-293). While substance P expression is 
not shown to be regulated by NFB, it has been shown upregulate chemokine expression and release 
in pancreatic acini via an NFB mediated pathway (294). MCP-1 and MIP-2 are chemokines that have 
been shown to be upregulated and released by acini in response to pancreatitis (291, 293, 295). These 
chemokines recruit monocytes/macrophages to the site of injury, and in pancreatitis, peritoneal 
macrophages are thought to play an active role in propagating the inflammatory response following 
acinar cell injury (296, 297). Pro-inflammatory cytokines such as IL-1, TNF- and IL-6 have also been 
shown to be upregulated and released by acini in vitro and in vivo (292, 293). Substantial quantities of 
these cytokines have been detected as early as 30 mins in the pancreas (298) (299) and 1 h in peritoneal 
fluid (300) of pancreatitic rats after induction. Together, these cytokines are able to activate and direct 
the progression of an inflammatory response by activating immune response cells, upregulating 
expression of endothelial cell adhesion molecules and inducing the acute phase protein response (301, 
302). Substance P is a known mediator of neurogenic inflammation that is a potent chemoattractant, 
stimulates immune response cells, and promotes vascular permeability (303). Pancreatic acinar cells 
have been shown to increase substance P synthesis and release in response to caerulein 
hyperstimulation (304) and this is supported with evidence of increased pancreatic substance P levels 
in a caerulein model of acute pancreatitis (305). Substance P has also been shown to stimulate 
chemokine synthesis in pancreatic acini (294). Together, these mediators have been shown to 
contribute to the disease severity as evidenced by the protection afforded through genetic deletion of 
TNF- receptor (306), IL-1 receptor (306), substance P (305) and pharmacological inhibition of MCP-
1 (307). These mediators however were not associated with the development of the disease; this 
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would suggest that their role is more related to the ensuing inflammatory response of pancreatitis 
resulting in aberrant and uncontrolled recruitment and activation of immune cells. 
1.6.3 Immune response cells in acute pancreatitis 
Inflammatory mediators, though essential in the activation and progression of the inflammatory 
response are not directly responsible for the pathology observed in autoinflammatory diseases such 
as acute pancreatitis. The crucial effector element responsible for both the controlled eradication of 
invading pathogens as well as uncontrolled damage of healthy host tissue is the immune response cell. 
These cells possess the arsenal for potent and mass cell/tissue destruction through the harsh oxidizing 
chemicals and proteases that it is able to synthesize (refer to section 1.4). Macrophages and 
neutrophils are the predominant cell types involved in the inflammatory response of acute pancreatitis 
(308). 
Due to their proximity, resident peritoneal macrophages are thought to be the key inflammatory cells 
to be initially activated and thus contribute to the inflammatory response in acute pancreatitis (297). 
Peritoneal macrophages are in direct contact with ascitic fluid secreted by the pancreas. This fluid 
generated in severe acute pancreatitis contains pancreatic enzymes and cytokines (300, 309). In vitro 
treatment of macrophages with peritoneal fluid harvested from pancreatitic rats resulted in activation 
of NFB and upregulation and secretion of TNF- (310, 311). This activation has been shown to occur 
when specific pancreatic enzymes such as elastase, carboxypeptidase A and lipase come in direct 
contact with macrophages (312). Activated macrophages are then capable of synthesizing and 
secreting large quantities of inflammatory cytokines and chemokines (313) thus propagating the 
inflammatory response. In severe pancreatitis, neutrophils represent the largest subset of 
inflammatory cells present in the pancreas and peritoneal cavity (296, 300). Neutrophil infiltration 
increases over the course of the disease (300) and this is driven by the accumulating pro-inflammatory 
cytokines and chemokines that are synthesized and released by the inflamed pancreas and resident 
pancreatic and peritoneal macrophages (308). 
Neutrophils are capable of causing more devastating damage than macrophages through the reactive 
oxygen species and proteases that they generate. Inhibition of polymorphonuclear cell (mostly 
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neutrophils) recruitment through use of ICAM-1 neutralising antibodies have shown substantial 
reduction in pancreatic MPO activity and oxidative damage, demonstrating the capacity of neutrophils 
to generate reactive oxygen species and directly contributing towards oxidative stress (314). 
Neutrophil depletion studies using anti-PMN serum has also shown substantial reduction of 
metalloprotease particularly in the gut followed by lowered bacterial translocation, highlighting the 
role of neutrophils in pancreatitis associated gut dysfunction (315). 
Peritoneal monocyte/macrophage depletion prior to induction of pancreatitis was shown to lessen the 
systemic inflammatory response as evidenced by lowered peritoneal and serum cytokines, lowered 
neutrophil infiltration and lung injury (296). However it was noted that there was no change in 
pancreatic injury, this suggests that the peritoneal macrophages have an important role to play in 
propagating the inflammatory response but not in the pathogenesis of severe pancreatitis. A similar 
finding was observed in neutrophil depletion studies with substantial lung protection and diminished 
mortality (316, 317). This highlights the importance of the innate inflammatory cells in pancreatitis, 






Figure 1.9 The inflammatory response associated with acute pancreatitis. The precise aetiology of 
acute pancreatitis is still not clearly understood but it is known to involve premature activation of 
zymogens and activation of NFB in pancreatic acinar cells. This leads to the uncontrolled release of 
digestive enzymes that serve as DAMPs as well as the synthesis and release of pro-inflammatory 
mediators such as cytokines, chemokines and eicosanoids. These mediators are released into the 
peritoneal cavity resulting in the activation and recruitment of resident pancreatic and peritoneal 
macrophages thus initiating the cascade of innate inflammatory response and the recruitment of 
neutrophils. Together, these inflammatory cells synthesize and contribute to the accumulation of a 
large amount of pro-inflammatory mediators such as ROS, proteases, chemokines, cytokines and 
eicosanoids in the ascitic fluid of the peritoneal cavity. This fluid is then channelled into the lymphatic 
system and drains into the circulation via the thoracic duct into the left subclavian vein resulting in a 
systemic inflammatory response. The lungs are the first organ to be bathed with these inflammatory 
mediators and it acts as a sponge to soak it up with its extensive network of vasculature leading to lung 
injury, the leading cause of mortality associated with this disease. 
1.6.4 Effect of endogenous hydrogen sulfide in pancreatitis 
So far, there have been several but limited in vivo and in vitro studies on the effect of endogenous 
hydrogen sulfide in pancreatitis. All of these studies have employed the use of PAG as a 
pharmacological inhibitor of endogenous hydrogen sulfide synthesis and in doing so targeted CSE 
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activity specifically. Although PAG is selective towards CSE among the hydrogen sulfide synthesizing 
enzymes, it is also known to inhibit activity of other enzymes (see section 1.5.4). Both in vivo and in 
vitro studies corroborate well showing that CSE expression plays a deleterious role in pancreatitis (66, 
304, 318, 319). So far there has been one report showing increased pancreatic acini CSE expression 
and hydrogen sulfide synthesizing activity in response to caerulein stimulation in vitro (304); inhibition 
of CSE resulted in a reduction of the classic signs associated with pancreatitis such as acinar cell injury, 
plasma amylase and pancreatic neutrophil infiltration (as evidenced by MPO activity) in vivo (66). In 
vivo studies have attributed this protection to a reduction in pancreatic chemokines (318), potent 
drivers of the inflammatory response (see section 1.6.1.3), and this is supported by in vitro findings 
using caerulein stimulated pancreatic acini (318). Additional in vitro findings showed a CSE mediated 
upregulation and expression of pancreatic acini adhesion molecule, ICAM-1, in response to caerulein 
stimulation via activation of NFB and Src family kinases (319). Lastly, elevated levels of pancreatic 
substance P, a known neurogenic inflammatory mediator (see section 1.4.4.1), was attenuated 
following CSE inhibition in pancreatitis (244) and this was also observed in vitro (304). Taken together, 
these PAG inhibitor studies have established a pro-inflammatory role for CSE/endogenous hydrogen 
sulfide in pancreatitis. Current findings suggest an important role for CSE enzymatic products in the 
activation of NFB and downstream inflammatory mediators such as MIP-2, MCP-1 and ICAM-1 in 
the pancreas. This CSE mediated activation of NFB in turn is thought to occur via substance P. There 
is however still limited studies on in vivo CSE expression in the progression of pancreatitis and its effect 
on other inflammatory mediators such as cytokines and eicosanoids. 
Another aspect of hydrogen sulfide effect on the exocrine pancreas that has not been studied in the 
context of pancreatitis is its ability to increase pancreatic acini intracellular calcium levels (320). There 
was a dose dependent biphasic increase with an initial rapid rise followed by a long-lasting elevation. 
This was found to be mediated by hydrogen sulfide-evoked nitric oxide production via an endothelial 
nitric oxide synthase-nitric oxide-soluble guanylate cyclase-cyclic guanosine monophosphate-protein 
kinase G-Gq-protein-phospholipase C- inositol 1,4,5-trisphosphate pathway to induce calcium release. 
As mentioned in section 1.6.1.1, persistent increase in acini intracellular calcium is associated with 
premature zymogen activation, a major initiating factor in acute pancreatitis. Therefore increases in 
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endogenous hydrogen sulfide levels could contribute to the progression of the disease. However, there 
are no published reports demonstrating this link at present. 
Currently, reports on the role of CSE/endogenous hydrogen sulfide in pancreatitis have been focused 
on its effect in the pancreas and the pancreatic acini and none on the effect in immune response cells, 
particularly the innate response cells. Though they may not be directly involved in the aetiology of the 
disease, they are the key effector cells of the inflammatory response (see section 1.5.1 and 1.6.3), 
therefore understanding the effect of CSE/endogenous hydrogen sulfide in these cells could not only 
offer insights into pancreatitis but the inflammatory response in general. Thus far, there have been 
several but limited studies looking at the role of CSE/endogenous hydrogen sulfide in innate response 
cells, macrophages in particular. Oh et al were the first to show that CSE is expressed in macrophages 
and was upregulated upon LPS activation (201) and later corroborated by Zhu et al (55). Both studies 
showed a CSE/endogenous hydrogen sulfide downregulation of iNOS expression and NO production in 
LPS activated macrophages by hydrogen sulfide mediated through an NFB-heme oxygenase/CO 
dependent pathway. This anti-inflammatory effect of CSE/endogenous hydrogen sulfide was also 
shown in oxidized-LDL (ox-LDL) activated macrophages; basal CSE/endogenous hydrogen sulfide was 
shown to inhibit NFB activation followed by subsequent cytokine and chemokine synthesis and 
oxidized-LDL treatment resulted in downregulation of CSE expression causing activation (205, 321). 
Interestingly, there have also been reports suggesting a pro-inflammatory role of CSE/endogenous 
hydrogen sulfide instead in LPS stimulated macrophages resulting in increased production of pro-
inflammatory cytokines via an NFB dependent pathway (249, 250). These conflicting findings could 
be influenced by macrophage plasticity which allows these cells to transition between a pro and anti-
inflammatory state (297). It is still early days in the research on CSE/endogenous hydrogen sulfide in 
immune cells and more studies are required to paint a clearer picture on the role(s) of CSE/endogenous 
hydrogen sulfide in the activation and regulation of these cells. In relation to pancreatitis, it is still yet 





Figure 1.10 The role of CSE/endogenous hydrogen sulfide in pancreatitis. The illustration on the left 
shows the current reported effects of CSE expression/endogenous hydrogen sulfide in pancreatic acinar 
cells following caerulein hyperstimulation. Caerulein stimulation has been reported to increase CSE 
expression in pancreatic acinar cells leading to increased expression of substance P and activation of 
NFB. Substance P is a known neurogenic inflammatory mediator and has been shown to elicit 
pancreatic acinar cell chemokine release. NFB is a transcription factor for pro-inflammatory genes, 
CSE mediated activation of NFB was linked to increased expression of the adhesion molecule ICAM-1. 
These effects were abrogated by pre-treating cells with PAG, a CSE inhibitor. In vivo CSE inhibition also 
showed a protective effect in response to pancreatitis in mice. There was attenuation in disease severity 
as evidenced by lowered pancreatic and lung leukocyte infiltration as well as acinar cell injury. This was 
attributed to a reduction of pancreatic pro-inflammatory mediator production, namely chemokines and 
cytokines. 
1.7 Current knowledge and gaps on the effect of CSE/endogenous hydrogen 
sulfide in acute pancreatitis and the inflammatory response 
1.7.1 Specificity of CSE inhibition in in vivo models of inflammatory disease 
CSE has been shown to be the key inflammatory modulating hydrogen sulfide synthesizing enzyme in 
animal models of disease (1-12). So far, studies aimed at elucidating the role of CSE in inflammation 
have mostly employed the use of PAG (1-6,8-15) and to a lesser extent, siRNA in in vitro systems 
(16,17). However as mentioned in section 1.4.3 there is still little agreement as to the actual role of 
hydrogen sulfide in inflammation and the use of PAG has been highlighted as one of the possible 
contributing factors due to its non-specific inhibitory activity (reviewed by (243)). Therefore alternative 
methods of CSE inhibition such as the use of CSE deficient animals would highly useful in affirming the 
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role of CSE in inflammation by avoiding any non-specific effects of pharmacological inhibitors like PAG. 
At the time this thesis was conceived and carried out there had been no reports on the use of CSE 
deficient animals in models of inflammatory disease. 
1.7.2 The effect of CSE in acute pancreatitis 
Acute pancreatitis is a form of sterile inflammatory disease in its less severe form, and therefore a 
useful model to study the inflammatory response independent of pathogenic effects; this is particularly 
useful in the field of hydrogen sulfide whereby bacteria are capable of producing hydrogen sulfide 
which in turn also affects them. To date, all published studies with regards to the role of hydrogen 
sulfide in acute pancreatitis using PAG have shown CSE to be pro-inflammatory (66, 69, 318, 322). 
CSE/endogenous hydrogen sulfide has been shown to mediate the expression of key inflammatory 
mediators in the pancreas; MCP-1, MIP-2, TNF- and NFB (301, 307). 
1.7.2.1 CSE and eicosanoids in acute pancreatitis 
There are currently no reports on the effect of CSE/endogenous hydrogen sulfide on eicosanoids, a 
potent modulator of the immune response (323), in acute pancreatitis. Eicosanoids are small lipid 
based signalling molecules comprising of prostaglandins and leukotrienes that are regulated mainly 
through the action of two enzymes cyclooxygenase-1 and cyclooxygenase-2. These molecules are able 
to direct the progression of the inflammatory response by modulating vascular permeability, cell 
adhesion as well as chemoattraction and activation of leukocytes (324). Therefore measuring acute 
pancreatitis mediated changes in eicosanoid levels in relation to CSE expression would provide 
additional insight into the role of CSE/ endogenous hydrogen sulfide in the progression of the disease 
as well as contribute towards the current understanding of CSE effect in the inflammatory response at 
large. 
1.7.2.2 CSE dysregulation in acute pancreatitis 
Although CSE dysregulation has been reported in various models of disease (44, 45, 189, 223, 325-
330), there was no direct evidence of change in pancreatic CSE expression in acute pancreatitis or the 
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determination of the source at the early phase of this thesis. Also, there currently aren’t many studies 
looking at CSE dysregulation in macrophages, the drivers of the innate inflammatory response. All of 
these studies involve in vitro stimulation with single purified molecules such as LPS and ox-LDL (55, 
201, 205, 249, 250, 321) and there are currently no reports linked to in vivo disease models of 
inflammation. Demonstration of macrophage CSE dysregulation in response to an in vivo inflammatory 
stimuli would further strengthen its role in the function of these immune cells at therefore the 
inflammatory response at large. 
1.7.2.3 Correlating CSE dysregulation with changes in endogenous hydrogen sulfide levels and 
elucidating the direct targets of hydrogen sulfide 
Since the discovery of hydrogen sulfide role in inflammation, there have been a great number of 
studies looking at the downstream effects of endogenous hydrogen sulfide synthesized by CSE in 
association with known inflammatory events such as cytokine and eicosanoid synthesis (14,18,19), 
regulation of adhesion molecules expression (10,13,20), and immune cell modulation (16,17) to name 
a few. However there is little information on the mechanisms leading up to CSE overexpression, its 
correlation with endogenous hydrogen sulfide levels and the mechanism by which hydrogen sulfide 
would directly affect the inflammatory response. Therefore by correlating CSE dysregulation with 
changes in endogenous hydrogen sulfide levels and elucidating the mechanism by which it could 
directly affect the inflammatory response, this would greatly support currently claims of the role of 
CSE/ endogenous hydrogen sulfide as an inflammatory mediator. 
 




Figure 1.11 Illustration of current knowledge on CSE/endogenous hydrogen sulfide effect on acute 
pancreatitis and macrophages as well as aims of this thesis. CSE/endogenous hydrogen sulfide has 
been shown to play a pro-inflammatory role in acute pancreatitis through pharmacological inhibition 
studies using PAG, however there are limitations to using PAG namely its non-specific inhibitory effect. 
Therefore using mice genetically deficient in CSE would be a useful alternative method. In vitro studies 
have shown macrophages to upregulate CSE expression in response to LPS or ox-LDL stimulation and 
this resulted in both pro and anti-inflammatory effects. In acute pancreatitis, there has been indirect 
evidence of increased pancreatic CSE expression by measuring hydrogen sulfide synthesizing activity. It 
would therefore be worthwhile to directly determine if pancreatic CSE is upregulated following 
pancreatitis as well as investigate the effect of the disease on macrophage CSE expression status and 
the possible pathways that lead to CSE dysregulation in macrophages. Finally it would be interesting to 
correlate possible dysregulation of CSE observed in acute pancreatitis and macrophages with changes 
in protein s-sulfhydration state, a potential means of direct hydrogen sulfide mediated effect. 
1.8 Aims of this thesis 
I have investigated the role of endogenous hydrogen sulfide synthesised by CSE in the inflammatory 
response using acute pancreatitis as the disease model. My hypotheses were that CSE contributes to 
the inflammatory response in acute pancreatitis by increasing endogenous hydrogen sulfide 
synthesis and genetic deletion of CSE would lessen the severity of acute pancreatitis and the 
associated inflammatory response. The overall aim is to validate previous reports on the inflammatory 
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role of CSE/ endogenous hydrogen sulfide in acute pancreatitis by means of genetic deletion instead 
of pharmacological inhibition and to investigate the relevance of CSE expression in the immune 
response. The specific aims are shown below with a brief outline following: 
 
1) To refine an existing simple high-throughput method that would fulfil the criteria for specific and 
sensitive detection of free hydrogen sulfide in tissue with standard laboratory equipment. 
 
2) To correlate CSE dysregulation with changes in hydrogen sulfide mediated protein modifications 
(s-sulfhydrated proteins) as an indicator or footprint of CSE mediated hydrogen sulfide synthesis. 
 
3) To determine changes in CSE expression in the pancreas and macrophages in response to acute 
pancreatitis, and the molecular mechanisms involved. 
 
4) To determine the effect of CSE on the inflammatory response and disease severity using mice 
genetically deficient in CSE as an alternative to pharmacological inhibition. 
 
1) To refine an existing simple high-throughput method that would fulfil the criteria for specific and 
sensitive detection of free hydrogen sulfide in tissue with standard laboratory equipment 
 This work was based on a zinc precipitation of hydrogen sulfide and wash technique by Gilboa-
Garber (21). An alkaline-zinc reagent was used to simultaneously precipitate free hydrogen 
sulfide and keep proteins in solution without releasing endogenous acid labile sulfide. The ZnS 
precipitate was then separated, washed, and the amount of sulfur present measured. 
 
2) To determine changes in CSE expression in the pancreas and macrophages in response to acute 
pancreatitis, and the molecular mechanisms involved. 
 Investigated the biotin-switch (22) and tag-switch (23) methods of detecting s-sulfhydrated 




3) To determine changes in CSE expression in the pancreas and macrophages in response to acute 
pancreatitis, the molecular mechanisms involved. 
 For the in vivo acute pancreatitis studies, pancreatic CSE expression levels were measured by 
western blot and immunohistochemistry. Immunohistochemistry also served to determine the 
location/cell type where this occurs. 
 For the macrophage CSE expression in vitro studies, LPS, a known activator of macrophages 
was used as a positive control to optimise methods of CSE expression measurement by 
western blotting and quantitative PCR as well as the concentration of pharmacological 
inhibitors used to elucidate the underlying molecular mechanisms. 
 Acute pancreatitis associated macrophage CSE expression was then determined by in vitro 
stimulation with plasma of pancreatitic mice using the optimised methods established above. 
Prior to this, the activation of macrophages with plasma of pancreatitic mice was analysed by 
measuring pro-inflammatory cytokine and chemokine secretion in order to establish its 
relevance. 
 
4) To determine the effect of CSE on the inflammatory response and disease severity using mice 
genetically deficient in CSE as an alternative to pharmacological inhibition 
 The effect of CSE deficiency was studied using an in vivo murine model of caerulein induced 
Acute pancreatitis as well as in vitro using primary pancreatic acini stimulated with caerulein 
to induce a pancreatitis like state. 
 Disease severity was determined through the classical pathophysiological events associated 
with acute pancreatitis; increased plasma amylase, increased pancreatic and lung MPO activity 
(a sign of neutrophil infiltration), pancreatic and lung oedema as well as acinar cell damage 
 The inflammatory response was assessed by measuring NFB activation as well pro-
inflammatory mediators such as cytokines, chemokine and eicosanoids in the pancreas from 
in vivo experiments and in the supernatant of pancreatic acini from in vitro experiments 
 
As a result of this thesis, I hope to fill in the gaps in the current knowledge of the role of 
CSE/endogenous hydrogen sulfide on acute pancreatitis and macrophages as illustrated in Figure 1.11. 
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2 Measuring tissue hydrogen sulfide content and protein s-sulfhydration 
2.1 Introduction 
2.1.1 Measuring endogenous free tissue sulfide 
The detection and measurement of endogenous levels of bioactive molecules provide researchers with 
vital information of its relevance to certain physiological or pathophysiological events. A measured 
increase or decrease in response to a particular stimulus would establish a strong correlative role in 
line with the purpose of the study. Additionally, accurate estimates of endogenous levels would 
provide a more physiologically relevant framework for in vitro studies in the attempt to elucidate the 
role of these molecules that would in the longer term translate to in vivo findings. 
The ability for endogenous hydrogen sulfide synthesis was first demonstrated by Stipanuk et al (1982) 
(11) using the methylene blue method of detecting free hydrogen sulfide. Briefly, the method involves 
the initial trapping of free sulfide by zinc acetate to form an insoluble zinc sulfide (ZnS) precipitate and 
in contact with an oxidizing agent such as ferric chloride in a strongly acid solution, it reacts with the 
N,N-dimethyl-p-phenylendiammonium ion to yield methylene blue that is readily detectable by 
spectrophotometry with a maximum spectra at 667nm and coefficient constant of 71,090 M-1 cm-1 




This reaction is thought to involve the initial oxidation of N,N-dimethyl-p-phenylendiamine by Fe3+ to 










A more detailed reaction scheme has been described by Kuban et al (332) as shown in Figure 2.1. The 
initial step requires the oxidation of N,N-dimethyl-p-phenylendiamine to form a radical cation (Figure 
2.1a), this reaction is highly facile and the stable product is known as Wurster’s red (333). This is 
followed by the addition of hydrogen sulfide to the cation-radical and further electron transfer, as 
shown in Figure 2.1b. The intermediate mercapto derivative of N,N-dimethyl-p-phenylendiamine 
would then add to a second cation radical, followed by further oxidation, to yield the sulfide-bridged 
dimer (Figure 2.1c). A third 2-electron oxidation sequence, followed by addition of the amino group to 
the imine functionality, favoured by proximity (Figure 2.1d), with subsequent loss of ammonia (Figure 
2.1e) would complete the synthesis. If hydrogen sulfide was substituted with a mercaptan, the second 
addition of step (c) in Figure 2.1 is blocked. Unlike methylene blue, the mercaptan products is thought 
to be an S-alkonium phenothiazinium dication and the spectral characteristics of the orange-red 




Figure 2.1 Detailed reaction scheme for generation of methylene blue from N,N-dimethyl-p-
phenylendiamine and hydrogen sulfide under oxidising conditions with iron(III)chloride. (a) Oxidation 
of N,N-dimethyl-p-phenylendiamine by Fe3+ to form a stable cation radical, Wurster’s red (b) Addition 
of hydrogen sulfide to the cation-radical and further electron transfer (c) Addition of mercapto 
derivative of N,N-dimethyl-p-phenylendiamine intermediate in step (b) to a second cation radical, 
followed by further oxidation to yield the sulfide-bridged dimer (d) A 2-electron oxidation sequence, 
followed by addition of the amino group to the imine functionality, favoured by proximity (e) 




The methylene blue assay is simple to perform with the requirement of some basic chemicals and the 
use of a standard spectrophotometer. As such, it has been widely used in the detection of free sulfide 
in biological solutions such as plasma (12, 18, 44). Early studies showed substantial micromolar levels 
of free endogenous hydrogen sulfide (12, 32, 35, 42, 43) that established the notion of its physiological 
significance leading to an exponential growth in hydrogen sulfide studies with regards to its diverse 
physiological and pathophysiological roles. However, it was not until recently that these high levels 
were suggested to be an overestimate possibly due to labile sulfide that is released. This was thought 
to be the result of the highly acidic conditions of the methylene blue assay thus releasing bound acid-
labile sulphide (25, 29). Other criticisms of the methylene blue is that the absorbance does measured 
at 667nm does not obey Beer’s law, however it was shown that this can be avoided with the use of an 
appropriate ratio of N,N-dimethyl-p-phenylendiamine and iron(III)chloride to sulfide to achieve an 
optimal stoichiometry (71). Several other methods of detection have been employed since the initial 
hydrogen sulfide studies; these include the use of polarographic electrodes (32, 54), gas 
chromatography (37, 41), liquid chromatography with monobromobimane derivitization (36)}(73), and 
hydrogen sulfide specific fluorescent probes (49, 50, 61, 335) (further elaborated in section 1.2.4). 
The development of newer methods of detection have in principal improved the levels of detection as 
well as increased specificity, however there are still some drawbacks or limitations to these methods. 
The polarographic sensor though specific and sensitive has very low through put, is only able to detect 
the gaseous hydrogen sulfide form and in the current set up is suited mainly to measure hydrogen 
sulfide synthesis. The specificity and sensitivity of fluorescent probes have increased over time, 
however there is the issue of background fluorescence in tissues and plasma that has to be accounted 
for. Recent methods have tried to account for this by generating internal standards using spiked 
hydrogen sulfide into the homogenate or plasma of study and taking the difference with zinc 
precipitated sulfide samples as the zero reference (48-50). However the reported values were a few 
orders off from the gas chromatography and monobormobimane/ RP-HPLC method described by Levitt 
et al and Shen et al respectively (36, 37). The Levitt et al and Shen et al methods appear to be the best 
methods so far which takes into account hydrogen sulfide stability during sample preparation and 
employs methods that are highly sensitive and specific. However both of these methods require the 
use of specialised instruments that are not commonplace in most laboratories. Furthermore the level 
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of throughput is not high particularly with the gas chromatography method described by Levitt et al. 
In contrast, the spectrophotometric methylene blue assay that is still widely used is simple and of high 
throughput though it suffers from heavy criticism due to the harsh acidic conditions of the assay which 
could liberate endogenous acid labile sulfur. 
Despite the development of newer methods of endogenous hydrogen sulfide detection such as the 
polarographic sensor, fluorescent probes, gas chromatography and monobromobimane 
derivatisation/HPLC, there does not seem to be a consensus among researchers to favour or adopt a 
particular method of detection. In fact apart from the monobromobimane derivatisation/HPLC 
method which has been used and cited 6 times (46, 47, 72, 73, 75, 76), none of the other methods 
have been used (cited) much or at all to measure endogenous levels of hydrogen sulfide. The 
polarographic sensor has been used mainly to measure ex vivo or in vitro hydrogen sulfide synthesis 
(55). There are currently no original research articles that have used or cited the use of fluorescent 
probes to measure endogenous levels of hydrogen sulfide. The gas chromatography method 
developed by Levitt et al has not been used or cited. However there are other gas chromatography 
methods that have been used although with a slightly different protocol, one under highly acidic 
conditions that could potentially liberate acid labile sulfur (328) and the other two had samples 
homogenised at pH 7.4 which could result in loss of gaseous hydrogen sulfide during preparation (40, 
41). It would be interesting to note that these gas chromatography based methods also used a sulfur 
chemiluminescent detector but have all reported free tissue hydrogen sulfide levels that are 2 to 6 
orders higher than that reported by Levitt et al. Despite its limitations and the main criticism of 
overestimating levels of endogenous free hydrogen sulfide (presumably via liberation of acid labile 
sulfide), the spectrophotometric method remains a popular method of measurement (67-69). The 
review by Kolluru et al (214) provides an excellent comparison of the advantages and disadvantages of 
these methods and this is summarised in Table 4. 
Method Advantages Disadvantages Ref 
    
Polaragraphic sensor 
(hydrogen sulfide electrode) 
- Sensitive detection (nM) 
- Real time detection 
- Low through-put 
- Detects only hydrogen sulfide 
species 




   not content 
- Requires specialised instrument 
    
Fluorescent probe - Easy protocol 
- Direct visualization of production 
- Moderate detection sensitivity   
  (nM to µM) 
- Possible substance interference 
- Prolonged incubation time 
- Proof of principle but not used to  
  measure hydrogen sulfide content 
(48, 56-
62) 
    
Gas chromatography/ 
chemiluminescence 
- Sensitive detection (nM–pM) - Chemiluminescence detects total   
  sulfur 
- Limited through-put 
- Requires specialised instrument 
(37, 40, 
41, 328) 
    
Methylene blue assay 
(Spectrophotometric) 
- Simple protocol 
- High through-put 
- Hydrogen sulfide fixing step 
- Limited detection sensitivity (low 
µM) 
- Possible liberation of acid labile 
sulfur 
(12, 42) 
    
Monobromobimane 
derivatisation/ RP-HPLC 
- Sensitive detection (nM) 
- Relatively stable derivative 
- Requires specialised instrument 
- Limited through-put 
(36) 
    
Table 4 Advantages and disadvantages of various recent methods of detecting endogenous levels of 
free hydrogen sulfide. This table provides an account for the comparison of current methods developed 
and used to measure endogenous levels of hydrogen sulfide based on their advantages and 
disadvantages. 
Methylene blue method, despite its own limitations, continues to be a popular method to detect 
endogenous levels of hydrogen sulfide (69, 336-341). Possible reasons for the poor reception of these 
apparently improved methods and continued use of the methylene blue assay in the detection and 
quantification of endogenous hydrogen sulfide could be due to the specialised equipment required 
that is not commonplace and that they are not standard laboratory techniques. This is an area of 
concern that needs to be addressed. In the initial period of my Phd, I did not have access to a gas or 
liquid chromatography instrument and therefore sought improvise the current spectrophotometric 
method of detecting hydrogen sulfide using methylene blue. The main aim was to improve specificity 
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towards free hydrogen sulfide by circumventing the harsh acidic conditions of the assay as well as to 
improve the sensitivity. If successful, this method could be more readily adopted and utilised in the 
field of hydrogen sulfide as a means of measuring endogenous levels of free hydrogen sulfide. 
2.1.2 Hydrogen sulfide mediated s-sulfhydration (persulfide formation)? 
There has been numerous studies demonstrating the (patho)physiological effects of endogenous and 
exogenous hydrogen sulfide as described in section 1.3. However there are few that show the direct 
mechanism by which hydrogen sulfide exerts its effect, in other words the target effector molecules 
of hydrogen sulfide. To date there are 3 methods by which hydrogen sulfide has been reported to do 
so; as an antioxidant, through s-sulfhydration (formation of protein persulfides) and binding to metal 
ions/ metal ion containing proteins (elaborated further in section 1.4). There has been much 
contention on the detection of free hydrogen sulfide levels partly due to the transient and highly 
reactive nature of hydrogen sulfide. This led us to speculate that the measurement of protein 
persulfide levels could serve as a signature or indicator of hydrogen sulfide levels instead. In doing so, 
we would also be able to determine the effector molecules of hydrogen sulfide and further our 
understanding of the mechanisms behind hydrogen sulfide mediated effects. 
I chose to pursue a method of protein persulfide detection that would allow visualisation and 
comparison of global protein persulfide levels. The intention was to use this method to determine if 
there were changes in protein persulfide levels under inflammatory conditions of acute pancreatitis 
which is the subject of study in chapter 5. The reason for measuring global levels is due to the 
uncertainty of which protein might undergo persulfidation changes and it would be costly to target 
multiple specific proteins. I elected to use a modified biotin-switch technique which was initially 
developed to detect s-nitrosylated proteins (342) and modified for this purpose (31). This method is 
reported to detect and semi-quantitate global levels of s-sulfhydrated proteins by probing for biotin 
labelled proteins on a western blot making it an appealing choice for assessing overall changes in 
endogenous sulfhydration state. It was developed and employed by Mustafa et al and was the first 
report showing the ability of hydrogen sulfide to directly s-sulfhydrate proteins under physiological 
conditions (31). In this modified biotin switch technique, thiols are first alkylated with methyl 





and s-sulfhydrated proteins (persulfides) were postulated to remain unreacted and be available for 




Concerns over the chemistry behind this biotin switch method proposed by Mustafa et al 2009 (31) 
was later raised with regards to the use of MMTS as the selective thiol (R-SH) blocking agent which 
was thought to not react with persulfides (R-S-SH), it had later been shown that MMTS has similar 
reactivity towards nucleophiles such as thiols and persulfides (343). During the course of my thesis, 
another research group (Zhang et al 2014 (344)) had proposed a tag-switch technique that was 
reported to address the non-specific of MMTS blocking. They employed the use of a thiol blocking 




this was followed by a tag-switching reagent, CN-biotin (containing both the nucleophile, cyanoacetate 





Thiol adducts from the reaction of R-SH and MSBT are thioethers, which are not expected to react with 
the nucleophile cyanoacetate. In this thesis I had initially used the biotin switch technique to detect 
endogenous levels of protein s-sulfhydration as well as the biotin-tag switch method subsequently. An 





Figure 2.2 Illustration of the Biotin switch and Biotin tag-switch methods of detecting s-sulfhydrated 
proteins. Both free thiol (-SH) and persulfide (-S-SH) groups have similar chemical properties making it 
difficult to distinguish them. This figure describes two methods of labelling protein persulfides with 
biotin tags for subsequent detection using western blot with streptavidin-HRP probes. The Biotin switch 
method (31) entails the use of a thiol blocking agent (MMTS) and subsequent labelling of free 
persulfides with biotin tagged HPDP. The Biotin tag-switch method (344) uses a thiol blocker (MSBT) 
that binds to both free thiols and persulfides, this is followed by labelling of MSBT blocked persulfides 





The initial aim of this chapter was to develop a robust and high throughput method of detecting 
endogenous free hydrogen sulfide in tissues that should be technically simple and not require the use 
of highly specialised equipment. 
The method was based on a zinc precipitation of hydrogen sulfide and wash technique by Gilboa-
Garber (345). Tissue homogenates were treated with an alkaline-zinc reagent that would 
simultaneously precipitate free hydrogen sulfide and keep proteins in solution. This would facilitate 
the separation of hydrogen sulfide (in the form of an insoluble ZnS precipitate) from the rest of the 
homogenate which contains labile sulfide by centrifugation. The ZnS pellet would then be washed with 
water to remove residual contaminants. The detection of sulfide could then be performed using any 
desirable method; in this case methylene blue was used requiring the use of a standard 
spectrophotomter. 
Additionally, this chapter will also investigate published methods of detecting protein s-sulfhydration 
in an attempt to compare protein s-sulfhydration state between tissues of wild-type and CSE deficient 
mice as well as to correlate changes in CSE expression with protein s-sulfhydration state as an indicator 
or footprint of CSE mediated H2S synthesis. 
2.3 Materials and methods 
2.3.1 Materials 
N,N-dimethyl-p-phenylenediamine dihydrochloride (NNDP) (Sigma) was prepared in a 7.2 N HCl 
solution. Iron(III)chloride (FeCl3) (Merck) was prepared in a 1.2 N HCl solution. Na2S nonahydrate 
(Sigma) is known to contain impurities which can interfere with sulfide measurement. Therefore, 
before use, Na2S crystals were washed with water and dried under vacuum (34). These crystals were 
then dissolved and diluted into buffer in polypropylene microfuge tubes. Trichloroacetic acid (TCA), 
sodium hydroxide (NaOH) and zinc acetate were obtained from Merck. 
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2.3.2 The methylene blue assay without zinc precipitation for determination of sulfide 
levels (‘current’) 
The methylene blue assay has previously been used to determine sulfide levels in biological solutions 
(44, 189). This assay was labelled as the ‘current’ method for convenience and clarity. In this method, 
500 µL of a sample (Na2S standard solution or tissue homogenate) was mixed with 350 µL of zinc 
acetate (1% w/v), 133 µL of 20 mM NNDP, 133 µL of 30 mM FeCl3 and 250 µL of TCA (10% w/v). The 
mixture was then incubated for 10 min at RT to allow the colour to develop, before centrifuging at 
15,000 g for 10 mins. The clear supernatant was read for absorbance on a spectrophotometer at 670 
nm (Molecular Devices, Spectramax M5). 
2.3.3 The methylene blue assay with zinc precipitation for the determination of sulfide 
levels (‘modified’) 
The zinc precipitation methodology was based upon a modified protocol that was originally developed 
by Gilboa-Garber (345). In this thesis, this assay will be labelled as the ‘modified’ method for 
convenience and clarity. 500 µL of a sample (Na2S standard solution or tissue homogenate) was added 
to 400 µL of a pre-mixed 1% w/v zinc acetate (350 µL) and 1.5 M sodium hydroxide solution (50 µL). 
This was followed by centrifugation at 1200 g (using a swing-out-rotor) for 5 min to pellet the ZnS that 
had been formed. The supernatant was then aspirated off and the pellet washed with 1.5 mL of Milli-
Q water by vortexing thoroughly, followed by a centrifugation at 1200 g for 5 min. The supernatant 
was then aspirated off and the pellet reconstituted with 160 µL of Milli-Q water. At this point, the 
detection of sulfide present as ZnS within the pellet could be performed by any means chosen. The 
methylene blue method was chosen for its simplicity and ability to be read on a standard 
spectrophotometer. To do so, the ZnS suspension was mixed with 40 µL of pre-mixed dye (20 µL of 20 
mM NNDP & 20 µl of 30 mM FeCl3). The solution was then incubated for 10 min to allow the color to 
develop, before the absorbance was read on a spectrophotometer at 670 nm. 
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2.3.4 Determination of the effects of pH on the stability of sulfide solutions 
For the pH stability studies, a 100 µM Na2S standard solution was prepared in 50 mM sodium 
phosphate buffer at pH 6, 7, 7.5, 8, 8.5, and in 50 mM sodium carbonate buffer at pH 9 and 10. The 
tubes were then incubated for the designated time intervals at room temperature. To determine 
sulfide concentrations at each time point, 100 µL aliquots of the 100 µM Na2S standard solutions were 
transferred to individual tubes and sulfide levels were fixed by the addition of 60 µL zinc acetate (1% 
w/v). After the final time point, 40 µL of pre-mixed dye (20 µL of 20 mM NNDP & 20 µL of 30 mM FeCl3) 
was added to each tube and incubated for 10 min for the color to develop before reading on a 
spectrophotometer at 670nm. 
2.3.5 Comparison of the original and modified methods for detecting sulfides 
A series of standard Na2S solutions were prepared using serially diluted Na2S dissolved in 50 mM 
sodium carbonate buffer at pH 9. The sulfide content of each standard was then independently 
evaluated using both the original and modified assays. Additionally, to determine if zinc precipitation 
was effective in detecting sulfide in biological material, a standard curve was prepared using Na2S 
added to liver homogenate (40 mg/mL) and processed using the modified method. A set of Na2S 
standards was prepared in a 25 µL serial dilution to yield a final concentration of 0 to 8.33 M in 500 
L when buffer or liver homogenate is subsequently added. These sets of Na2S standards were 
precipitated with 400 µL of the zinc acetate and NaOH mixture, followed by addition of 500 µL liver 
homogenate or buffer alone and processed as described above either by the original or modified 
method. 
2.3.6 Measuring tissue sulfide using the modified method 
Use of animal tissues for this work was approved by University of Otago Animal Ethics committee 
(Protocol no 57/11). Tissues were harvested from 6 BALB/c mice euthanized with pentobarbital and 
immediately frozen on dry ice and stored at -80oC. On the day of experiment, 40 mg of tissue was 
weighed out and immediately immersed in 1 mL of buffer (described below). Samples were then 
homogenized and sonicated on ice followed by centrifugation at 15,000 g for 10 min at 4oC. 500 µL of 
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the clear supernatant was then used for the zinc precipitation assay as described. To determine free 
sulfide levels, a 40 mg piece of each tissue was prepared (as described above) in a 50 mM sodium 
phosphate buffer pH 6 and a 50 mM sodium carbonate buffer pH 9. Based on the reported hydrogen 
sulfide dissociation constant (6), at pH 6, >90% of free sulfides should exist as the neutral hydrogen 
sulfide species which is highly volatile and easily lost by dissipation into the atmosphere. At pH 9, >90% 
of free sulfides should exist as the anionic HS- which is retained in solution. Free tissue sulfide was then 
calculated by deducting the value of total sulfides measured at pH 6 from pH 9.  
In one set of experiments, a pH titration was performed to determine if the amount of measured 
sulfides in tissue adhered to the expected dissociation constant of hydrogen sulfide. This experiment 
was carried out with mice livers processed in 50 mM sodium phosphate buffer at pH 6, 6.5, 7, 7.5, 8 
and 50 mM sodium carbonate buffer pH 9 using the method described above. 
2.3.7 Free sulfide scavenging in a biological solution 
The modified method was used to detect free sulfide in liver homogenates that were spiked with a 
known amount of Na2S before or after the addition of the zinc acetate and NaOH mixture to trap the 
free sulfides. A buffer only comparison was used to determine the amount of spiked sulfide that was 
retrieved. Liver homogenates were prepared as described in 1.2.6. The reagents were added in the 
following order; Condition 1 (Na2S + Zn -> spike), 400uL zinc acetate + NaOH mixture > 25uL Na2S 
standard (0.5mM) > 500uL liver homogenate/buffer, Condition 2 (Na2S -> spike -> Zn), 500uL liver 
homogenate/buffer > 25uL Na2S standard (0.5mM) > 400uL zinc acetate + NaOH mixture. Samples 
were then processed as per section 1.2.3. 
2.3.8 Measurement of protein s-sulfhydration 
The detection of s-sulfhydrated proteins was based on the method described by Mustafa et al (31).S-
sulfhydration was detected using a biotin switch assay, in which free thiols (R-SH) are blocked by a 
highly specific free sulfhydryl-reactive compound, methyl methanethiosulfonate (MMTS). The free s-
sulfhydrated thiols (R-S-SH) are then labeled with N-(6-(biotinamido)hexyl)-3′-(2′-pyridyldithio)-
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propionamide (biotin-HPDP), a compound that interacts with sulfhydryl groups. The reason for the 
selectivity of MMTS towards free thiols and not s-sulfhydrated thiols however, is unclear (31, 343). 
Liver lysates were prepared by homogenizing ~50 mg tissue in 1mL HEN buffer (250mM HEPES, 1mM 
EDTA, 0.1mM Neocuproine, 0.1mM Deferoxamine, 1x protease inhibitors) using a bead beater. 
Homogenates were spun at 20,000 g for 30 mins at 4 OC and the clear supernatant was used for the 
assay. Protein concentrations of the clear lysates were measured empirically using a Bradford Assay 
and averaging the value of multiple dilutions of each sample. All samples were then diluted to a 
concentration of 0.7 mg/mL with HEN buffer. 356 L (250 g of protein) of each lysate was then treated 
with or without 100 M Na2S for 30 min at 37OC followed by precipitation with 1 mL of ice cold acetone 
at -20oC for 20 mins and centrifugation at 950 g at 4OC for 5 mins. Pellets were resuspended in 396 L 
of HEN + 2.5% SDS and blocked with 4uL of MMTS (2mM) for 30 mins on a thermomixer set at 50OC 
and 1400rpm followed by acetone precipitation as described before. Pellets were rinsed twice with 
70% acetone (in HEN buffer) and solubilized in 450 L of biotin-sulfhydryl binding buffer (HEN + 2.5 % 
SDS, 0.8mM biotin-hpdp. Samples were incubated on a rotator in the dark for 3 h followed by acetone 
precipitation as described before. Pellets were solubilized in 400 L HEN +1 % SDS and acetone 
precipitated once more. Finally the pellet containing biotin labelled proteins were solubilized with 30 
L HEN/10 + 1 % SDS and 90 L neutralization buffer (20mM HEPES, 100mM NaCl, 1mM EDTA and 0.5 
% Triton-X 100). 
Samples were run on a 10 % SDS-PAGE gel and transferred onto a PVDF membrane. Blots were then 
blocked with 5 % BSA made in TBST (0.1 % v/v) for 1 h followed by an overnight incubation in 1:1,000 
streptavidin-HRP (R&D Systems, USA) made in blocking buffer. Blots were then washed 4 times for 5 
mins each in TBST followed by incubation with a chemiluminescence substrate (Western Lightning 
Ultra by Perkin Ellmer, Netherlands) for 1 min and visualized on a chemi-doc system (Uvitec, UK). 
Finally, blots were stained coomasie to assess equal protein loading between wells. 
In a separate set of experiments, MMTS was replaced with methylsulfonyl benzothiazole (MSBT) and 
biotin-hpdp was replaced with a biotin-linked cyanoacetate (CN-biotin) while maintaining similar 
concentrations respectively. This was to test an alternative method of detecting s-sulfhydrated 
proteins as reported by Zhang et al (344). 
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2.3.9 Data analysis 
Data are presented as means + S.E.M. Statistical analysis was performed using the Graphpad Prism 
Software version 5.03. Multiple comparisons were made using ANOVA with a Bonferonni post-hoc 
analysis. A p value of less than 0.05 was considered significant. pK value was determined using a non-
linear fit (variable slope). 
 
2.4 Results 
2.4.1 Effect of pH on stability of sulfides measured by methylene blue assay 
The methods by Levitt et al and Shen et al (36, 37) describe the use of an alkaline pH in the preparation 
of samples to avoid loss of hydrogen sulfide present in the gaseous form. This observation was 
replicated here and tested over several pH values to determine the optimal pH that would effectively 
retain free hydrogen sulfide. It also helped determine if the HS- species of free sulfide is readily 
detected by the methylene blue assay. The data showed that sulfides generated from Na2S were more 
stable when prepared in an alkaline buffer where HS- is the predominant species and this was 
detectable using the current methylene blue assay (Figure 2.3). This would be in agreement with the 
volatility of the neutral hydrogen sulfide species and the stability of the anionic HS- species in solution. 
The observed sulfide stability at pH 9 and 10 was similar, which follows the predicted percentage of 
HS- to be at 99% at pH 9 and 99.9% at pH 10. It would therefore be beneficial to prepare samples in 
buffers no less than pH 9 to retain the maximal amount of free sulfides in the stable form of HS-. There 
was also a noticeable difference in absorbance at 0 mins. These differences could be attributed to the 
volatility of predominant sulfide species being the gaseous form (hydrogen sulfide) as the pH decreases 
with respect to the pKa1 of sulfide (~7 at 25 oC (6)). This, coupled with the time it took to dissolve the 
sodium sulfide salt and pipette the replicates into the zinc acetate solution may result in some sulfide 























Figure 2.3 The effect of pH on the stability of sulfide in solution. Known amounts of Na2S were 
dissolved at RT in 50 mM sodium phosphate buffer (pH 6 to 8.5) or 50 mM sodium carbonate buffer 
(pH 9 and 10) to afford a solution with a calculated sulfide concentration of 100 µM. The solutions were 
then fixed with zinc acetate at specified time points and sulfide levels determined by the current 
method. Bars represent mean ± S.E.M. (n=3) 
2.4.2 Zinc precipitation method of detecting sulfides 
The ZnS precipitation and wash method (modified method) was first postulated by Pomeroy et al (346) 
and put into practice by Gilboa-Garber (345) as a way of detecting inorganic sulfide in biological 
solutions. These findings were replicated in the present study and showed that this is a robust method 
with greater sensitivity in comparison to without zinc precipitation; standard curves constructed using 
both methods (described in section 2.3.5) showed tight deviations and high degree of correlation 
(current method in buffer : R2 =0.9981, modified method in buffer : R2 =0.9979) (Figure 2.4). There was 
also a higher degree of sensitivity in the modified assay with a discernible lower limit of 0.13 nmole 
(OD670 = 0.0070 ± 0.0014) compared to 0.52 nmole (OD670 = 0.0051 ± 0.0003) without zinc precipitation 
(Figure 2.4). In our attempt to use this modified method with hydrogen sulfide spiked tissue 
homogenates, we found that the ratio of zinc acetate, NaOH and sample was not optimal for the 
removal of biological material while still retaining the ZnS pellet. We therefore optimized the ratio to 
7 parts of zinc acetate (1% w/v) to 1 part of NaOH (1.5 M), and this solution was thoroughly mixed and 
allowed to stand until a granular precipitate formed. This mixture was then used in a 4:5 ratio with the 
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supernatant of a tissue homogenate (~40 mg/mL). A standard curve was constructed with mouse liver 
homogenates spiked with pre-precipitated Na2S using the modified method (described in section 2.3.5) 
and was able to yield a linear regression value of 0.9920 that was slightly elevated compared to the 
standard curve constructed with buffer only. This could be attributed to the endogenous sulfide from 
the tissue itself. 

























Figure 2.4 Analysis of the capacity of the methylene blue and zinc precipitation assay to quantify 
soluble sulfide levels. A standard curve of serially diluted Na2S was prepared in 50 mM sodium 
carbonate buffer pH 9, sulfide levels were then determined using either the current assay () or the 
modified method (). Additionally, precipitated serially diluted Na2S was spiked into liver homogenate 
(40 mg/ml) prepared in 50 mM sodium carbonate buffer (pH 9) and detected using the modified 
method (). The inset is a scaled-up representation of the 4 lowest points of the curves. Bars represent 
mean ± S.E.M. (n=3) 
2.4.3 Measuring tissue sulfide with the modified method 
The pH at which free sulfides are measured within tissue homogenates is dependent on the buffer the 
tissues are homogenized in. We predicted that homogenates prepared at pH 6 would contain free 
sulfides predominantly as the neutral species (hydrogen sulfide), and that these species should readily 
77 
 
volatalize during the process of sample preparation and therefore not be detected by the assay. 
However homogenates prepared at pH 9 should contain free sulfides predominantly as the anionic 
species, and these should remain in solution, allowing their detection. To confirm this pH dependency 
in free tissue sulfides, a titration was used to measure sulfides present in liver homogenates as a 
function of pH (Figure 2.5). The results showed a curve that closely represented the expected 
dissociation of hydrogen sulfide with a measured pK of about 7.01 (pKa1 of hydrogen sulfide at 25oC ~ 
7, (6)). Interestingly, there were reasonably detectable levels of tissue hydrogen sulfide at pH 6, this 
could be due to the release of bound sulfide under strong alkaline conditions upon addition of the zinc 
acetate and NaOH solution to the tissue homogenate (will be discussed further in section 2.4.5). 

























Figure 2.5 Estimation of sulfide in liver homogenate over different pH. solution. Sulfide content was 
measured in mouse liver homogenates (40mg/ml) prepared in 50mM sodium phosphate buffer pH 6, 
6.5, 7, 7.5, 8, 8.5 and 50mM sodium carbonate buffer pH 9 using the modified method. The curve is 
concordant with the dissociation of hydrogen sulfide with a measured pK value of 7.01. Based on these 
findings, we assumed the difference between sulfides measured at pH 9 and pH 6 as the estimated free 
sulfides present in the tissue. Bars represent mean ± S.E.M. (n=3) 
Based on these observations we proposed that this modified method is able to quantify free tissue 
hydrogen sulfide based upon the differential detection over the pH range (schematic of method shown 
in Figure 2.6). As the assay conducted at pH 9 measured both free and bound sulfide, while the assay 
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conducted at pH 6 only measured background/ bound sulfide, the amount of free tissue sulfides could 
be determined by deducting the measured sulfides in homogenates at pH 6 from pH 9. Using this 
approach we analyzed a range of tissues and found appreciable amounts of free sulfide in the: lung, 
liver, kidney and pancreas of BALB/c mice (Figure 2.7). The kidney had the highest amount of 0.119 ± 
0.011 nmole per mg of tissue weight, while the lung had the lowest amount at 0.013 ± 0.002 nmole 
per mg of tissue weight. 
 
 
Figure 2.6 Schematic of proposed modified method of measuring free tissue sulfide. This figure 
provides an overview of the modified method. Briefly, aliquots from a piece of tissue were obtained 
(~50 mg) and homogenised in a sodium phosphate and sodium carbonate buffer of pH 6 and 9 
respectively. The supernatant of each homogenate were then treated the same way by undergoing an 
alkaline-zinc precipitation step of free sulfide followed by pelleting and washing of the trapped ZnS 
precipitates. The amount of sulfide present in the ZnS precipitates was then detected using the 
Methylene Blue assay and corrected for protein content in the original homogenate. Free sulfide was 






























Figure 2.7 Estimation of free tissue hydrogen sulfide in murine tissue. Free hydrogen sulfide was 
calculated by measuring the difference between hydrogen sulfide levels measured in tissue 
homogenates (40mg/ml) at pH6 and pH9 using the modified method. Bars represent mean ± S.E.M. 
(n=6) 
2.4.4 Free sulfide scavenging in a biological solution 
This experiment was aimed at determining the retrievability of free sulfide spiked directly into a 
biological solution. To do so, 12.5 nmole of sulfide was either precipitated with zinc before or after 
mixing with liver homogenate or buffer only and measured directly using the modified method. The 
control group of sulfide mixed with buffer only showed a relatively consistent measurement of 12.16 
±0.82 and 11.95±0.20 nmole with or without prior precipitation (Figure 2.8). The liver homogenate 
group showed a slightly higher sulfide measurement when the spiked sulfide was precipitated before 
mixing together (13.30±0.37 nmole), this could be due to endogenous free tissue sulfide. However this 
value was more than halved when the spiked sulfide was mixed directly with liver homogenate and 
then precipitated with zinc (5.03±0.17 nmole) (Figure 2.8). This suggests that the liver homogenate is 
able to scavenge substantial amounts of spiked free sulfide; this would have implications on the actual 






























Figure 2.8 Sulfide scavenging in liver homogenate. 12.5 nmole of Na2S was spiked into 500 L of buffer 
or liver homogenates. The solution containing Na2S was either precipitated with zinc prior to mixing 
with buffer/homogenate (Na2S + Zn -> spike) or after mixing (Na2S -> spike -> Zn). Samples were then 
measured for sulfide using the modified method. Bars represent mean ± S.E.M. (n=3). * denotes 
significant difference over corresponding liver homogenate “(Na2S + Zn -> spike)” group (p<0.05). 
2.4.5 Protein s-sulfhydration 
Attempts were made to utilise the biotin-switch assay described by Mustafa et al (31) and Zhang et al 
(344) to detect s-sulfhydrated proteins. The first method employs an alkylating agent MMTS to 
differentiate thiols and persulfides. Thiols (-SH) in proteins are first blocked by MMTS. Persulfides (-S-
SH) are believed to remain unreacted and be available for subsequent conjugation to biotin-HPDP (31). 
However, the underlying mechanism of selectivity of MMTS for thiol versus persulfide is unclear and 
studies have demonstrated that persulfides and thiols should have similar reactivity towards 
electrophiles such as MMTS (343). This issue was addressed in the second method by the tag-switch 
protocol. First, a SH-blocking reagent, MSBT, was introduced which should tag both -SH and –S-SH to 
form an R-S-BT or R-S-S-BT adduct. Next, a biotin conjugated nucleophile, CN-biotin, was used to 
selectively label the persulfide adducts (R-S-S-BT) as thiol adducts from the first step are thioethers, 
which are not expected to react with the nucleophile (344). 
However I was unable to replicate previously published findings (31, 344) using a positive control 
suggested in these studies (31, 344). Liver lysates from wild type (WT) C57BL6 mice were treated with 
or without 100 M Na2S for 30 mins at 37 oC. In a third sample, lysates were not treated with Na2S as 
well as the biotin labelling compound in order to distinguish background signals arising from 
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endogenous biotinylated proteins. Equal amount of samples were then resolved on an SDS-PAGE gel, 
blotted and probed for biotin using a streptavidin-HRP conjugate and ECL detection. There was no 
detectable difference in staining intensity or pattern between the untreated and Na2S treated samples 
using both methods (Figure 2.9) as previously reported (31, 344). Attempts were made to optimize the 
methods by varying concentration of protein, blocking reagent and detergent to determine if there 
was non-specific labelling of proteins resulting in high background signal thus masking the potential 
true difference in the s-sulfhydration state (Appendix 8.4). However there was no observable effect 
from varying these parameters. 
Unt -bioNa2S Unt -bioNa2S Unt -bioNa2S Unt -bioNa2S
Biotin Blot Biotin BlotCoomasie stain Coomasie stain
A B
 
Figure 2.9 Detecting s-sulfhydrated proteins using biotin-switch and tag-switch assays Liver lysates 
of wild type mice were assayed for s-sulfhydrated proteins using methods described by Mustafa et al 
2009 (A) and Zhang et al 2014 (B). The left panels (biotin blot) represent western blots of biotin labelled 
s-sulfhydrated proteins probed with streptavidin-HRP and visualised using ECL. The right panels 
(coomasie stain) are coomasie staining of the same blots to assess equal loading between samples. Unt 
= untreated lysate, Na2S = 100M treated lysate, -bio = untreated lysate that wasn’t incubated with 
biotin labelling compound. These blots are representative of 3 experiments. 
Therefore the initial aim of investigating changes in protein s-sulfhydration state in response to CSE 
dysregulation was abandoned. There was however an interesting finding, s-sulfhydrated proteins from 
liver lysates of CSE KO mice showed different banding pattern compared to the WT mice (Figure 2.10). 
Liver lysates from WT mice showed more signal than the CSE KO with proteins of less than 75 kD in the 
‘-bio’ lanes, suggesting higher levels of endogenous biotinylated protein present in the WT liver. This 
would suggest a novel role for CSE in the synthesis or assembly of endogenously biotinylated proteins 
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and possibly turnover and transport of biotin as well. Another consequence of this finding is that 
changes in endogenously biotinylated proteins could affect the interpretation of this assay and a non-
biotin labelled group should be included to account for this. 
Unt Na2S -bio Unt Na2S -bio
WT CSE KO
 
Figure 2.10 Comparing s-sulfhydrated protein profile in liver lysates of WT and CSE KO mice. Liver 
lysates of WT and CSE KO mice were assayed for s-sulfhydrated proteins using methods described by 
Zhang et al 2014. The figure represents a western blot of biotin labelled s-sulfhydrated proteins probed 
with streptavidin-HRP and visualised using ECL. Unt = untreated lysate, Na2S = 100M treated lysate, -
bio = untreated lysate that is not incubated with biotin labelling compound. This blot is a representative 
of 3 experiments. 
2.5 Discussion 
2.5.1 Measuring endogenous free tissue sulfide 
Early studies showing endogenous hydrogen sulfide production in mammalian tissue had helped to 
spark interest in the potential (patho)physiological role(s) of hydrogen sulfide and this has led to a new 
field of research that is still in its incipient stage. As with any field of study, progress brings about 
constant re-evaluation of the current body of knowledge. With regards to hydrogen sulfide research, 
this is most apparent when it comes to the detection and estimation of endogenous levels of free 
hydrogen sulfide. As mentioned before (section 1.2.3), the issues surrounding the measurement of 
endogenous free hydrogen sulfide are the (1) passive loss of hydrogen sulfide due to the volatility of 
the neutral species, (2) high reactivity with a variety of endogenous molecules owing to the reductive 
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potential of hydrogen sulfide (detailed description in section 1.4.1) and (3) endogenous labile sources 
of hydrogen sulfide that may be released depending on the assay conditions. These issues have been 
addressed by Shen et al (36) and Levitt et al (37) in their liquid and gas chromatography based methods. 
However, as mentioned, the uptake of these methods has been slow despite their specificity and 
sensitivity. This could be due to the specialised equipment required that is currently not commonplace 
in a typical laboratory setting and the skills to operate them thus creating an inertia towards adopting 
these methods. 
Therefore, the method described in this chapter was an attempt to refine an existing simple high-
throughput method that would fulfil the criteria for specific and sensitive detection of free hydrogen 
sulfide in tissue with standard laboratory equipment. This method was generally based on the current 
and widely used spectrophotometric method of detection in the form of the Methylene Blue assay. 
The major concerns with this assay is the potential release of acid labile sulfur from the homogenate 
thus resulting in artefactual high measurements and limited sensitivity. The refinements made as a 
result of this thesis include incorporation of an alkaline-zinc precipitation step at an optimised ratio to 
separate sulfide from other organic material and preparation of homogenates at dual pH (6 and 9), 
with the lower pH serving as a reference sample. The combination of these changes should in theory 
overcome the issue of acid labile sulfide liberation, decrease volatility of free sulfide in solution, 
increased specificity with introduction of the pH 6 reference sample as well as increased sensitivity 
with the separation and concentration of sulfide. These changes are elaborated below. 
The concept of trapping and precipitating free sulfide with zinc in the current methylene blue method 
remained appealing and the challenge was to separate the insoluble ZnS precipitate from the 
homogenate prior to detection to eliminate contaminating sources of labile sulfide. A search through 
literature yielded a protocol by Gilboa-Garber (1971) that described a method of simultaneously in situ 
precipitating free sulfide while maintaining the solubility of organic material in the assay media with 
an alkaline-zinc acetate solution (345). The ZnS precipitates were then pelleted, washed and detected 
using the methylene blue assay. The intended purpose of this modification by Gilboa-Garber was to 
remove interfering constituents such as proteins, coloured compounds, sulfur-containing substances 
and pyrophosphate thus improving the accuracy and sensitivity of the methylene blue assay (345), but 
the quick and easy separation of insoluble ZnS from the media also offers a simple yet specific method 
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of detecting free sulfide in tissue homogenates. Another attractive benefit is the flexibility of hydrogen 
sulfide detection method choice in the resulting ZnS precipitate depending on the instruments 
available. We therefore chose to use the methylene blue method for its simplicity. 
Prior to running the assays, we sought to address the issue of passive hydrogen sulfide loss in the 
process of preparing tissue homogenates. Total hydrogen sulfide in solution consists of two main 
species, the neutral hydrogen sulfide and the dissociated anionic HS-; they exist in equilibria with a pKa 
of ~7.01 at 25 oC (6). The neutral hydrogen sulfide species is gaseous and readily volatilizes out of 
solution, at pH 7.4 and 25 oC, about 30 % of total free hydrogen sulfide is present as the neutral form 
thus allowing for substantial passive loss into the atmosphere (347). This relationship is demonstrated 
in 2.4.1 where there was a clear pH dependent loss of dissolved hydrogen sulfide over time as the pH 
decreased. At pH 9 (25 oC), 99 % of the hydrogen sulfide species is predicted to exist as the stable HS- 
form in solution and this is supported by the sustained detectable levels of hydrogen sulfide at pH 9 
over a period of an hour. Therefore it would be beneficial to prepare tissue homogenates in buffers no 
less than pH 9 to avoid passive loss of endogenous free hydrogen sulfide; this is in agreement with the 
Shen and Levitt methods. These results also confirm that the methylene blue method is able to detect 
the HS- species. 
Moving forward we were able replicate the Gilboa-Garber method of free hydrogen sulfide detection 
by alkaline-zinc precipitation and wash followed by a methylene blue assay on the ZnS pellet (section 
2.4.2). Standard curves of known Na2S concentrations were constructed in buffer and produced a 
linear correlation of 0.9979. This method was also more sensitive with a discernible lower detection 
limit of 0.13 nmole (OD670 = 0.0070 ± 0.0014) compared to 0.52 nmole (OD670 = 0.0051 ± 0.0003) using 
the current methylene blue method for the detection of endogenous free hydrogen sulfide (44, 189). 
The alkaline-zinc precipitation and wash method was then tested with tissue homogenates with an 
optimized ratio of NaOH to zinc acetate to ensure complete solubilization of the organic material 
(section 2.4.3). To test if the method was detecting free hydrogen sulfide, hydrogen sulfide content 
was measured in liver homogenates over a pH range between 6 and 9 to determine if this relationship 
reflects the predicted dissociation of hydrogen sulfide at 25oC; assuming this method is able to 
measure free sulfides, there should be a drop in detectable free sulfide with the reduction of pH due 
to the volatility and loss of neutral hydrogen sulfide at pH < 9 and this correlation should yield a pKa 
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value close to 7 (6). We were able to demonstrate this relationship using this modified assay with a 
measured pKa of 7.01 (2.4.3). However there was an unexpected detectable signal in homogenates 
prepared at pH 6, we attributed this to the release of hydrogen sulfide from an alkaline labile source 
during the alkaline-zinc acetate precipitation step. The most likely source would be sulfur derived from 
iron-sulfur proteins. This bound sulfur has been shown to be liberated under alkaline-zinc conditions 
(348, 349). The same studies have also shown cysteinyl residues to be the unlikely source of sulfur 
release under alkaline-zinc conditions when incubated for short periods. Only a prolonged incubation 
of 20 h yielded detectable sulfur release from BSA (containing 35 cysteine residues per molecule) (348). 
Having shown that the modified method also detected bound sulfur, we then proposed that 
endogenous free tissue sulfide could be measured by taking the difference between hydrogen sulfide 
levels in homogenates at pH 9 and pH 6 using the same method. Theoretical calculations predict that 
>90% of free sulfide exists as the volatile neutral hydrogen sulfide species at pH 6, based on the 
dissociation constant of sulfide. (6). Therefore, the difference between hydrogen sulfide levels 
observed in homogenates at pH 9 and pH 6 would represent levels of free tissue sulfide. This, coupled 
with the physically vigorous sample preparation steps of homogenization and sonication, should 
ensure that most, if not all, of the free hydrogen sulfide present as the neutral species dissipate into 
the atmosphere during sample preparation at pH 6. Sample prepared at pH 9 however should have 
~99% of the free hydrogen sulfide present as the stable anionic form and therefore retained during 
the tissue disruption process. Using this approach we have detected appreciable amounts of free 
hydrogen sulfide in mice kidney, liver, pancreas and lungs, with the kidney having the most and lungs 
the least (2.4.3). However, these values are several orders more than what had been reported by Levitt 
et al (2011), ~75 mol per kg compared to <0.1 mol per kg in the liver. Since both aliquots of tissue 
prepared at pH 6 and 9 were subjected to the same alkaline-zinc acetate conditions resulting in a 
similar final pH value of ~ 12, the substantial high levels of free hydrogen sulfide detected could be due 
to anomalously low or high measurement at pH 6 and 9 respectively. 
A possible reason for increased free hydrogen sulfide detection at pH 9 is because the reducing activity 
of thiols is greater in alkaline conditions than at a neutral pH (350). In the presence of major cellular 
reducing substances such as GSH and cysteine at their physiologic concentrations, hydrogen sulfide 
has been shown to be released from lysates of cultured neurons and astrocytes at an alkaline pH of 
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8.4 (28). However this should also apply to the method by Levitt et al (2011) where tissue samples are 
homogenized in a pH 9.3 buffer (37) which was not the case. Another possible cause for the high 
detectable sulfide levels is the reported conversion of disulfide bonds to hydrogen sulfide under strong 
basic conditions (0.5M NaOH); OH- is thought to abstract a proton from the  carbon of the sulfur atom 
followed by , elimination and hydrogen sulfide formation (351, 352). Although a strong alkali-zinc 
solution was used in the modified protocol described in this chapter, a reference aliquot of tissue 
sulfide (pH 6) was also carried out in parallel and deducted from the sample aliquot (pH 9) and should 
therefore cancel out the effect of alkali induced formation of hydrogen sulfide from disulfides. 
An interesting observation from the measured free tissue sulfide levels however is the trend, the lungs 
showed the least while kidney was the highest followed by liver and pancreas. According to a previous 
report, the kidney has been shown to possess high levels of bound sulfur (sulfur that is release as 
hydrogen sulfide upon reduction), 324 nmol/g compared to 41 nmol/g in the liver. This disparity would 
support the argument that the measured free tissue sulfide levels in this thesis could perhaps be 
derived from bound sulfur instead. The lungs are rich in fibrous tissues that form the scaffold and 
architecture required for its function, as such about a fifth of the total dry weight is made up of collagen 
(353) among other connective tissues such as elastin. These structural proteins, collagen and elastin, 
do not contain sulfur based amino acids and thus make a poorer source of bound sulfur compared to 
soft tissues such as liver and kidneys. 
Although the merits and proof of concept of the “modified method” has been shown in this chapter, 
the reason for the still substantial disagreement in free tissue sulfide levels detected between this 
method and the one described by Levitt et al (2011) using gas chromatography (37) is unclear. Further 
efforts to compare the findings of these two methods would require setting up both methods for a 
direct side-by-side comparison which would require more time. However, this was not the major 
objective of this thesis and therefore not pursued. 
It is interesting to note that even though the levels of free sulfide reported by Levitt et al (2011) is the 
lowest detectable levels published thus far in tissues (between 30 and 9200 nmol /kg protein), it has 
been argued that such levels should still yield tissue concentrations in the high micromolar region and 
yet there is no detectable hydrogen sulfide odour by the human nose (detection limit ~1 M) (38). 
However, the highly reactive nature of hydrogen sulfide should not be overlooked as this may mask 
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the potential sum of free hydrogen sulfide generated at any one time thus leading to an 
underestimation of its significance. The results in this thesis have shown that spiked hydrogen sulfide 
is readily consumed by liver homogenates (2.4.4) and this is in line with previous reports in blood (32), 
tissue homogenates (33) and cultured cells (53) with half-lives of ~ 130s (32). While hydrogen sulfide 
catabolism occurs via the mitochondrial sulfide oxidation pathway involving SQR and sulfur 
dioxygenase enzymes to form sulfite and eventually thiosulfate, it has also been shown that a 
substantial amount of hydrogen sulfide is also consumed under anaerobic conditions (33). This points 
to another mode of hydrogen sulfide consumption other than the mitochondrial oxidation pathway, a 
plausible alternative is consumption via protein s-sulfhydration (refer to section 1.4.2) and this is 
supported by experiments involving single protein solution of BSA under aerobic and anaerobic 
conditions with a consumption rate of 1.2 µM min-1 in 5% BSA (32). BSA has one free thiol per molecule. 
Therefore, while the pursuit in detecting endogenous free hydrogen sulfide is ongoing and rife with 
issues, it would be worthwhile to also focus on detecting hydrogen sulfide mediated modification of 
endogenous substances as a marker of endogenous hydrogen sulfide levels owing to its prolific 
reactivity. This would not provide us with absolute values of hydrogen sulfide levels but may be an 
indication of instances of increased hydrogen sulfide production/release and potentially lead on to 
further discovery of its effector mechanisms. At present hydrogen sulfide has been shown to s-
sulfhydrate proteins and interact with metal-ion containing proteins apart from its antioxidant ability 
(section 1.4). Currently, reports on hydrogen sulfide-metal ion interaction have been functional studies 
and there is not much information on the nature of this interaction and whether it is direct, stable or 
detectable (107, 133, 160-163). On the other hand, there has been increasing reports of hydrogen 
sulfide linked endogenous s-sulfhydration (102, 142-146, 167, 354) since it was first reported by 
Mustafa et al (2009) (31) and the current method of detection is relatively simple. 
In light of these findings, I attempted to measure s-sulfhydrated proteins as a possible indirect method 
of determining the endogenous state of hydrogen sulfide production. Results of this effort are 
described in the next section. 
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2.5.2 Hydrogen sulfide mediated s-sulfhydration 
One of the reported direct hydrogen sulfide mediated effects is the s-sulfhydration modification of 
free thiols on proteins resulting in formation of protein persulfides and increased cysteine reactivity 
(31). S-sulfhydration has been suggested to alter protein activity by increasing or inhibiting its activity 
(31, 141-143)1 (144) (102, 145, 146). It was my intention to measure endogenous levels of s-
sulfhydrated proteins as an indirect indicator of endogenous hydrogen sulfide levels. If successful, I 
would also be able to compare levels of s-sulfhydrated proteins in an inflammatory response to 
determine if CSE dysregulation would lead to changes in the protein s-sulfhydration state, presumably 
through alteration of endogenous hydrogen sulfide synthesis. I elected to use the biotin switch (31) 
and biotin tag-swtich (344) methods to detect and semi-quantitate global levels of s-sulfhydrated 
proteins by probing for biotin labelled s-sulfhydrated proteins on a western blot, which allows for 
assessing overall changes in endogenous protein sulfhydration state. The developers of both methods 
have reported increased protein s-sulfhydration levels in liver lysates following treatment with 
exogenous hydrogen sulfide (100 M) (31) (344). I therefore used this published observation as a 
positive control to validate these methods before proceeding with my actual experimental questions. 
However I was unable to replicate the findings reported in these studies (31) (344). I had used the 
laboratory protocol provided by the authors of Mustafa et al 2009 for the biotin switch method and 
did obtain a signal but there was no increase following treatment of protein lysates with 100 µM 
hydrogen sulfide (Figure 2.9). Further investigation into the chemistry of the method yielded a 
surprising find as Pan et al (2013) had reported MMTS to react with both R-SH as well as R-S-SH which 
should in theory block all thiols and not yield any signal (343). However this background signal was also 
reported by Pan et al and thought to possibly be due to incomplete thiol blocking or via stepwise thiol-
disulfide exchange in a reaction catalyzed by trace free thiols (RSH) (343). The latter involves the 
reversible nature of MMTS blocking of thiols through reduction of a disulphide bond. Attempts were 
also made to use an alternative method, a biotin tag-switch method that replaces MMTS with another 
thiol blocker, MSBT which was reported to bind to both R-SH and R-S-SH groups. The difference with 
this method is that the subsequent labelling compound, biotin labelled cyanoacetate, would only 
specifically react with MSBT blocked R-S-SH groups because thiol adducts from the reaction of R-SH 
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and MSBT are thioethers, which are not expected to react with the nucleophile cyanoacetate. Despite 
the favourable chemistry, I was unable to detect changes in signal following treatment of tissue lysates 
with hydrogen sulfide utilising this method (Figure 2.9). Further investigation to try and decrease 
background signal by increasing MMTS concentration, decreasing protein ratio as well as varying SDS 
concentration to modulate protein denaturing (to expose free thiols) did not substantially alter or 
lower the background signal (Figure 8.7). I subsequently tried using another thiol blocker, NEM that 
has been reported to alkylate both R-SH as well as R-S-SH and is an irreversible method of blocking 
free thiols, again there was no change in background signal (Figure 8.7). Therefore the evidence points 
to a limitation in the protocol that prevents complete blocking of all endogenous free thiols (includes 
both R-SH as well as R-S-SH) which could be high enough to mask differences between untreated and 
hydrogen sulfide treated lysates. 
Despite the outcome, there was an interesting novel finding from this assay which point to a lower 
level of biotinylated proteins in the livers of CSE KO mice compared to WT. The endogenous 
biotinylation of proteins is dependent on the availability of biotin (355). Mammals are not able to 
synthesise biotin and rely on dietary sources as well as endogenous recycling from protein-bound 
biotin (356). Since the dietary conditions of the WT and CSE KO mice were similar, the observed 
difference in liver biotinylated proteins between the strains would most likely be due to the capability 
of endogenous protein-bound biotin recycling, which is mediated by the enzyme biotinidase (355). 
Biotinidase is able to both hydrolyse and release endogenous biotin and function as a carrier of biotin 
as well as biotinylate proteins (357). However, it is unclear how CSE deficiency could alter biotinidase 
activity. A possible mechanism could be an hydrogen sulfide mediated modulation of the redox status 
of the key cysteine 245 residue in the active site of biotinidase (358). An interesting point to note is 
that apart from carboxylases, histones have also been shown to be a specific acceptor of biotin 
transferred from biotinylated biotinidase and thus affect regulation of protein transcription (357). 
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3 Investigating pancreatic CSE dysregulation in response to acute pancreatitis 
3.1 Introduction 
CSE is predominantly expressed in peripheral tissues (237) and has been implicated as the key 
hydrogen sulfide synthesizing enzyme in various models of inflammatory disease (44, 45, 66, 69, 187, 
189, 217, 218, 220, 222, 223, 245). Changes in CSE expression levels have been shown in various tissues 
such as liver (44, 45, 189, 223), kidney (44, 217), lungs (45, 325, 326), gastric mucosa (327), colonic 
mucosa (328), gall bladder (329) and myocardium (330) in different models of disease and injury. These 
observed changes in CSE expression levels have been associated with the inflammatory response of 
the disease or injury and inhibition of endogenous CSE through the use of PAG to either increase or 
decrease the severity of the disease or injury (359) suggests the importance of CSE regulation with 
regards to the inflammatory response. 
The aetiology of acute pancreatitis is still not completely understood, however it is accepted that the 
pancreatic acinar cells of the exocrine pancreas plays a central role to the pathogenesis and 
progression of the ensuing inflammatory response. Currently, premature zymogen and NFB 
activation in pancreatic acinar cells are believed to be the two major initiators (254). Uncontrolled 
premature zymogen activation results in autodigestion of the pancreas thus causing the release of 
intracellular contents rich in proteases and damage associated molecular pattern molecules (DAMPs) 
that elicit an inflammatory response. NFB is a known pro-inflammatory transcription factor that is 
highly activated at sites of inflammation in diverse diseases (199). Although both zymogen and NFB 
activation are observed in pancreatitis, it has been shown that induction of pancreatitis in mice lacking 
trypsinogen-7, the critical enzyme required for zymogen activation, the disease still progressed 
without affecting the activation of NFB (267). This data points strongly to the capacity of pancreatic 
cells to directly generate pro-inflammatory cues that subsequently elicit a full blown inflammatory 
response, independent of preceding zymogen activation. Indeed, activated pancreatic acinar cells have 
been shown to upregulate the expression and secretion of pro-inflammatory cytokines and 
chemokines. In vitro caerulein stimulation of pancreatic acinar cells has been shown to upregulate 
expression and secretion of IL-6, IL-1 and MCP-1 via an NFB mediated pathway (291, 292). Acini 
isolated from rats with acute pancreatitis also showed substantially elevated levels IL-6, TNF-, MCP-
91 
 
1 and MIP-2 via an NFB mediated pathway (293). These inflammatory mediators are believed to be 
primarily responsible for the systemic manifestations of acute pancreatitis and its associated distant 
organ dysfunction (301). Studies using TNF- and IL-1 receptor knockout mice (306) and MCP-1 
blockers (307) have shown substantial protection against pancreatitis and in particular distant organ 
damage. 
CSE is found to be expressed in the pancreas and inhibition of endogenous hydrogen sulfide synthesis 
by PAG has been shown to decrease chemokine expression (318) and the severity of acute pancreatitis 
(66). In vitro studies have reported increased CSE expression in pancreatic acinar cells following 1 h 
caerulein stimulation (304). Pre-treatment of caerulein stimulated pancreatic acinar cells with PAG 
showed a reduction in secretion of chemokines (318) and expression of adhesion molecules (319). This 
CSE mediated control of pancreatic acini inflammatory reaction to caerulein stimulation is thought to 
occur via pathways leading up to NFB activation; they include substance P-TLR-4 (360) and Src family 
kinases (SFKs) (319) signalling mechanisms. Though limited, these studies points to a key role of CSE in 
the inflammatory response associated with acute pancreatitis. It still remains to be shown in vivo if 
pancreatic CSE expression is upregulated in acute pancreatitis. Additionally there have been no studies 
that attempt to elucidate the pathway leading up to increased CSE expression in pancreatic acini which 
could shed light on the pathogenesis of acute pancreatitis. 
3.2 Aim 
This chapters aims were to determine changes in CSE expression in pancreatic acinar cells and the 
pancreas under inflammatory conditions associated with pancreatitis as well as the pathway leading 
up to this. For these studies caerulein stimulated primary pancreatic acini will be used as the in vitro 
model, and careulein hyperstimulated mice as an in vivo model of inflammation. 
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3.3 Materials and methods 
3.3.1 Materials 
General cell culture reagents and PCR primers were purchased from Life Technologies, USA. LPS 
purified by phenol extraction was purchased from Sigma-Aldrich, USA. Collagenase type IV was 
purchased from Worthington-Biochem, USA. Soy derived trypsin inhibitor was purchased from Sigma-
Aldrich, USA.  
3.3.2 Caerulein induction of acute pancreatitis in mice 
Plasma was obtained from mice induced with acute pancreatitis mice using caerulein as described 
below. Plasma was pooled from individual mice treated with saline or caerulein and frozen in aliquots 
to make up a batch of working plasma to treat RAW 264.7 cells. 
All animal experimentation were approved by the Animal Ethics Committee of the University of Otago 
(Protocol C57/11) and performed according to the guidelines. Caerulein was obtained from Bachem 
(Bubendorf, Switzerland) and reconstituted in sterile saline to a final concentration of 1 mg/100 mL 
and frozen in 1.5 mL aliquots. WT and CSE KO C57BL6 mice (male, 20–25 g) were assigned randomly 
to control or experimental groups. WT mice were obtained from the Christchurch Animal Research 
Area. Animals were given hourly intraperitoneal (i.p.) injections of normal saline (0.9% wt/vol NaCl) or 
caerulein (50 g/kg) for 10 h, as described previously (305, 361). For pain relief, all mice were given 3 
subcutaneous (s.c.) doses of buprenorphine (0.2 mg/kg) per hour before treatment, as well as 3 h and 
7 h into the treatment. One hour after the last caerulein/saline injection, animals were sacrificed by 
an i.p. injection of sodium pentobarbital. Blood samples were drawn from the right ventricle using 
heparinized syringes and centrifuged (1,000 g for 10 min, 0–4 °C). Thereafter, plasma was aspirated 
and stored at -80°C for future use. 
3.3.3 Primary pancreatic acinar fragment preparation and treatment 
The media use for isolating primary pancreatic acinar cells consisted of DMEM supplemented with 
0.1% w/v BSA, 0.05% w/v trypsin inhibitor and oxygenated with 95% oxygen and 5% CO2 before use. 
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The method of isolation was based on Bruzzone et al (362). Freshly removed pancreases were placed 
in ice cold media to rinse off excess blood and then transferred to a 1.5mL microfuge tube on ice 
containing media supplemented with collagenase type IV at a final concentration of ~400 U/mL. Each 
individual pancreas was minced finely using scissors to pieces < 1mm in diameter. The minced pancreas 
was then transferred to a glass vial, topped up with collagenase solution, sealed tightly and in a 37 oC 
shaking water bath for 10 mins. After that the vial was shaken vigorously by hand for 1 min and placed 
back into the bath for a further 5 mins after which it was vigorously shaken by hand for a final 30 s. 
The digest was then briefly triturated with a large orifice plastic pasteur pipette and layered onto a 4% 
BSA solution in a 15 mL tube. This was then centrifuged at 50 g for 2 mins, the collagenase and BSA 
layers were discarded and the cells were rinsed with fresh media 2 times by centrifuging at 50g for 70 
s each time. The pellet was the triturated in fresh media and the top layer of fine tissue fragments as 
the bigger clumps settled was transferred to a fresh tube to be used for experiments. These fine 
fragments consisted of cell clusters of 5 to 20 cells and had viability of more than 90 % as determined 
by trypan blue exclusion. 
The final pancreatic fragments were distributed into 1.5 mL microfuge tubes and treated with either 
saline or caerulein at a final concentration of 100 nM. They were incubated at 37 oC on a rotator for 60 
mins after which they were harvested by centrifuging at 1000 g for 5mins and frozen at -80 oC for 
western blot analysis or processed for RNA extraction as described below. 
3.3.4 RT-PCR and real-time quantitative PCR (qPCR) 
3.3.4.1 RNA extraction 
Pellets of pancreatic tissue fragments were analysed for CSE and CBS expression using conventional 
PCR and qPCR. Total RNA was extracted using the phenol-chlorofom method with Trizol purchased 
from Life Technologies, USA. Pancreatic acinar cells contain large amount of RNases that readily 
degrade RNA upon lysis of the cells. Therefore pancreatic tissue fragments were first pelleted at the 
end of the experiment and resuspended in RNA later (Sigma-Aldrich, USA) and kept at 4 oC for 30 mins. 
Samples were then pelleted at 50 g for 1 min, resuspended in 500L Trizol and left at RT for 5mins. 
100 L chlorofom was added and tubes were shaken vigorously for 15 s and incubated at RT for 10 
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mins after which they were centrifuged at 12,000 g for 15 mins at 4 oC. The clear supernatant was then 
transferred to a fresh 1.5mL microfuge tube. 100 L isopropanol was added, tubes were mixed gently 
and incubated at RT for 10mins followed by centrifugation at 12,000 g for 10 mins at 4 oC. The 
supernatant was discarded, the RNA pellets rinsed with 1 mL chilled 70% ethanol and pelleted again 
at 7,500 g for 5 mins at 4 oC. The supernatant was then discarded and the tubes air dried at RT. Finally 
the RNA pellets were reconstituted with an appropriate volume of Milli-Q water and read on a nano 
drop to determine RNA quantity and quality.  
3.3.4.2 cDNA synthesis 
cDNA synthesis was carried out with the High-Capacity cDNA Reverse Transcription Kit (Life 
Technologies, USA) using an MMLV reverse transcriptase enzyme. A master mix of the reaction mixture 
was prepared according to the manufacturers protocol, this consisted of 2 L reaction buffer, 0.8 L 
dNTP mix (4mM), 1 L random primers, 1 L Oligo(dT)20, 1 L reverse transcriptase enzyme and 4.2 L 
Milli-Q water per reaction. Template was prepared by using 1 g of total RNA and topping up with 
Milli-Q water to a total of 10 L. For each sample, 10 L of the master mix was added to 10 L of the 
prepared template for a final reaction of 20 L in PCR tubes. Reverse transcription was performed on 
a thermal cycler (Applied Biosystems 2720, USA) using the following conditions; 25OC for 25 mins > 
37OC for 120 mins > 85OC for 5 mins > 4OC hold. Samples were then stored at -80 oC for further use. 
3.3.4.3 PCR and qPCR 
Primers for CSE, CBS, -actin were designed using the NCBI primer blast software and 18S was based 
on a publication (363) and purchased from Life Technologies (USA), details are shown in Table 5. PCR 
and qPCR were carried out with the BIOTAQ PCR kit using a TAQ polymerase enzyme (Bioline, UK). 
Amplifications were run in 20 L reaction volumes with 1 L of cDNA as the template. For conventional 
PCR, each reaction consisted of 0.5 U of Biotaq DNA polymerase, 1x NH4 reaction buffer, 2.5 mM MgCl2, 
0.2 mM dNTP, 5 M of forward primer and 5 M of reverse primer. For qPCR, a DNA dye Eva Green 
(Biotium, USA) was added to the reaction mixture described. To determine primer specificity, samples 
were run on a 1.5 % agarose gel for 35 cycles and visualised on a gel-doc system (Uvitec, UK) to assess 
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the amplicon size and presence of non-specific bands. qPCR was performed on a Roche Light Cycler 
480 II. Comparative levels of CSE expression was quantified using -actin or 18S as the reference gene 
and based on calculations described by Pfaffl et al (364). 





CSE 5’-GAATGGGATGGCGGTGGCTCG-3’ 5’-GCCCGAGCACTGGCGTTTGG-3’ 60 115 
CBS 5’-GGCTGGAAAGGTGCGGCCAT-3’ 5’-CTTGCTGGACATGCCATTGCTG-3’ 60 214,172* 
-actin 5’-CTGTCGAGTCGCGTCCACCC-3’ 5’-ACATGCCGGAGCCGTTGTCG-3’ 60 128 
18S 5’-GTAACCCGTTGAACCCCATT-3’ 5’-CCATCCAATCGGTAGTAGCG-3’ 60 151 
Table 5 PCR and qPCR primers and conditions. Shows the primers used to amplify the genes of interest 
with corresponding annealing temperature. * denotes two amplicons from splice variants. 
3.3.5 Western blotting 
Pellets of the RAW264.7, pancreatic tissue fragments and pancreatic tissue were analysed for CSE 
expression by western blot. Total cell lysate was prepared by triturating pellets in ice cold RIPA buffer 
(50 mM TRIS pH7.5, 150 mM NaCl, 1% v/v NP-40, 0.5% w/v sodium deoxycholate, 0.1% w/v sodium 
dodecylsulfate supplemented with protease inhibitors (HALT by Pierce Biotechnology, USA)) and 
incubating on ice and vortexed vigorously periodically. Pancreatic tissue lysate was prepared by 
homogenising ~50 mg tissue in ice cold RIPA buffer supplemented with protease inhibitors with a 
Labserv homogeniser and incubated on ice. After 30 mins, samples were centrifuged at 30,000 g for 
30 mins at 4 oC. The clear supernatant (total cell or tissue lysate) was collected and measured for 
protein content using the Bio-rad DC Protein Assay (Bio-rad, USA) and BSA protein standards as a 
reference. Samples were run on a 10 % w/v SDS-PAGE gel under reducing conditions with equal loading 
of 20 g of protein of each sample per well. Gels were run at a constant 200 V until the gel front had 
run out and then transferred onto a 0.45 m nitrocellulose membrane (Whatman, USA) at a constant 
100 V for 1 h using a Bio-rad system. Running buffer consisted of 25 mM TRIS, 192 mM Glycine and 0.1 
% w/v SDS while transfer buffer consisted of 25 mM TRIS and 192 mM Glycine. Blots were then rinsed 
in TBS supplemented with 0.05% Tween-20 (TBST) and blocked with 5% non fat dry milk made in TBST. 
Blots were cut at the 37 kDa Mw marking and each portion of the membrane was probed for either 
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CSE (~42 kDa) or GAPDH (~35 kDa) and HPRT (~23 kDa) at 1:1000 dilutions in blocking buffer at 4 oC 
overnight. Blots were then washed 4 times with TBST for 5 mins each and probed with the 
corresponding HRP conjugated secondary antibody (1:20,000) for 2 h at RT. Blots were then washed 4 
times with TBST for 5 mins each with a final TBS rinse for 5 mins. Blots were then incubated with a 
chemiluminescence substrate (Western Lightning Ultra by Perkin Ellmer, Netherlands) for 1 min and 
visualized on a chemi-doc system (Uvitec, UK). Bands were semi quantitated using the Alliance 4.2 
software and compared for relative intensities. Primary mouse anti CSE antibody was from Abnova 
(Taiwan), primary rabbit anti GAPDH and HPRT antibodies were from Santa Cruz Biotechnology (USA), 
secondary goat anti mouse HRP conjugated antibody was from Pierce Biotechnology (USA) and 
secondary goat anti rabbit HRP conjugated antibody was from Santa Cruz Biotechnology (USA). 
3.3.6 Immunohistochemistry of pancreatic CSE expression. 
The induction of pancreatitis is described in section 3.3.2. Pancreases from control mice and mice with 
acute pancreatitis were then harvested and stained for CSE expression. Upon harvest, pancreases were 
fixed in 4% buffered paraformaldehyde and sent to the Christchurch Hospital Histopathology 
Department to be processed and set into paraffin blocks. 4 m thick formalin fixed paraffin embedded 
tissues sections were cut using a Leica microtome and immobilized onto superfrost coated glass slides 
(Menzel-Glaser, Germany). Each slide had a pair of pancreatic sections from wild type saline and 
caerulein treated mice. Slides were left at RT to air dry for at least a week before use. Staining 
conditions were optimized using pancreatic sections from mice lacking the CSE gene, results are shown 
in appendix 8.3. 
Staining was performed with the Rabbit specific HRP/DAB (ABC) Detection IHC Kit (Abcam, Cambridge 
UK). Sections were rehydrated through a xylene-alcohol series (Xylene 1 > xylene 2 > Xylene+ethanol 
(1:1) > 95% ethanol > 70% ethanol > 50% ethanol > water) by immersing slides in each reagent for 
5mins. This was followed by an antigen retrieval step by incubating slides in a 10 mM Sodium citrate, 
0.05% Tween 20, pH 6.0 solution at 97 oC for 20 mins in a water bath. Slides in buffer were removed 
and allowed to cool to room temperature followed by immunostaining as described in the 
manufacturers’ protocol. Sections were blocked for 30 mins at RT with block buffer supplemented with 
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1% w/v BSA followed by an overnight incubation at 4oC with primary antibody; rabbit anti- CSE (Abcam, 
UK) at 1:1,000 dilution in TBS with 5% w/v BSA. This was followed by a hydrogen peroxide block for 15 
mins, secondary antibody incubation for 60 mins, streptavidin incubation for 20 mins and DAB 
substrate incubation for 30 s immediately followed by a rinse and soak in water. TBST (0.025% w/v) 
was used as the wash buffer between each step and rinsed with TBS after each wash cycle. Sections 
were then counterstained with hematoxylin, dehydrated through a xylene-alcohol series described 
above and mounted. Five fields of view (FOV) taken from the centre and four ends of the section in a 
north, east , south, west manner were taken from each section with a 20x objective lens on a Zeiss 
Axioscope.Z1 microscope. CSE staining intensity was measured using the Zeiss Axiovision 4.6.3 
software by first setting the colour selection and threshold to selectively analyse the DAB stained 
portions and excluded non-specific stained portions such as the nuclei and intensely stained artefacts. 
This allowed automated detection of positive DAB staining within each field of view. The software then 
generates a report consisting of individual sections that were deemed positively stained along with the 
percentage of area it occupies within the field of view and the corresponding staining intensity. Only 
areas that occupied > 0.1 % of the area within a field of view were considered to exclude artifacts and 
stained individual cells (monocytes and neutrophils). Sections of saline and caerulein treated 
pancreases within one slide were compared in a pair-wise manner; this is to avoid possible errors that 
may arise from differences in staining between separate slides. 
3.3.7 Pancreatic hydrogen sulfide synthesizing activity 
hydrogen sulfide synthesizing activity in pancreatic homogenates was measured with a modified 
protocol based on methods described previously (365). ~50 mg pancreatic tissue was homogenised in 
50 mM ice-cold potassium phosphate buffer (pH 7.4) using a Labserv homogeniser. The reaction 
mixture contained 100 mM potassium phosphate buffer (pH 7.4), L-cysteine (20 μl, 10 mM), pyridoxyal 
5´-phosphate (20 μl, 2 mM), saline (30 μl), and 11% w/v tissue homogenate (430 μl). The reaction was 
performed in tightly parafilm-sealed microfuge tubes (with lids taken off) and initiated by transferring 
the tubes from ice to a water bath at 37ºC. After incubation for 30 min, 1% w/v zinc acetate (250 μl) 
was injected in to trap evolved hydrogen sulfide followed by 10% v/v trichloroacetic acid (250 μl) to 
denature the protein and stop the reaction. Subsequently, N,N-dimethyl-p-phenylenediamine sulfate 
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(20 μM, 133 μl) in 7.2 M HCl was added, immediately followed by FeCl3 (30 μM, 133 μl) in 1.2 M HCl. 
Samples were left to incubate at room temperature in the dark for 20 min and subsequently pelleted. 
The absorbance of the clear supernatant was measured with a 96-well microplate spectrophotometer 
at 670 nm. The hydrogen sulfide concentration was calculated against a calibration curve of Na2S. 
Results were then corrected for the protein content of the tissue sample determined by the Bio-rad 
DC protein assay and are expressed as nmole hydrogen sulfide formed/mg protein. 
3.3.8 Statistical analysis 
Data are presented as means + S.E.M. Statistical analysis was performed using the Graphpad Prism 
Software version 5.03. Multiple comparisons were made using ANOVA with a Bonferoni post-hoc 
analysis. Comparisons of two data sets were made with an unpaired Student’s t-test except for the 
analysis of in vivo pancreatic CSE expression using IHC which was compared using a paired Student’s t-
test. A p value of less than 0.05 was considered significant. 
3.4 Results 
In vivo pancreatitis experiments have so far shown increased pancreatic hydrogen sulfide synthesizing 
activity following induction and this was abrogated with the use of PAG, a CSE inhibitor (66, 318). This 
suggests a possible upregulation of pancreatic CSE and its relevance to the progression of the disease, 
however there has not been direct evidence of CSE upregulation in pancreatitis at the time this thesis 
was conceived and carried out, apart from one in vitro study that showed increased CSE expression in 
caerulein stimulated pancreatic acinar cells (304). The following experiments were carried out to 
determine if CSE is upregulated in the exocrine portion of the pancreas in vivo during acute pancreatitis 
by western blotting and immunohistochemistry. qPCR was not used due to the difficulty in obtaining 
qood quality RNA from pancreatic tissue. 
3.4.1 Pancreatic CSE expression and activity in acute pancreatitis 
Pancreatic CSE expression and hydrogen sulfide synthesizing activity was measured in an in vivo model 
of caerulein induced acute pancreatitis in mice. Western blot analysis showed a significant ~33 % ± 8 
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% increase in pancreatic CSE expression in pancreatitic mice as compared to the saline treated control 
mice (p<0.05) (Figure 3.1a and b). There was a concomitant significant increase in pancreatic hydrogen 

























































































Figure 3.1 Pancreatic CSE expression and hydrogen sulfide synthesizing activity in acute pancreatitis. 
Pancreatic CSE expression was measured by western blot following a 10 h induction of acute 
pancreatitis in mice. hydrogen sulfide synthesizing activity was also measured using the methylene blue 
method. There was a significant increase in CSE expression as shown in the representative blot (A) and 
densitometry analysis (B). This is supported by a detectable increase in pancreatic hydrogen sulfide 
synthesizing activity (C). Bars represent mean ± S.E.M. (n=5).* denotes significant difference over saline 
control (p<0.05) 
Immunohistochemical staining of CSE was used to visualise and confirm this observation. Staining of 
pancreatic sections showed a significant increase in CSE expression in the pancreatitic mice compared 
to the saline controls (~1.11 ± 0.03 fold increase) (p<0.05) and was most evident in the exocrine portion 
of the pancreas comprising of acinar cells. Figure 3.2a represents the CSE stained pancreas of mice 



























Figure 3.2 Pancreatic immunohistochemical staining of CSE in acute pancreatitis. Formalin fixed 
paraffin embedded (FFPE) sections of control and pancreatitic mice were immunostained for CSE and 
detected by DAB yielding a brown stain in areas of positive detection. The cell nuclei in these sections 
were then counterstained with haematoxylin (purple stain). Representative sections show an 
observable increase in staining intensity of CSE in the pancreas of mice treated with caerulein (B) 
compared to the saline control (A). A densitometric analysis using the Axiovision software shows a 
significant increase in staining density (C). Bars represent mean ± S.E.M. (n=5). *denotes significant 
difference (p<0.05). Endocrine portion of the pancreas (shown by arrow) was weakly stained in 
comparison to the exocrine and there was no difference in response to pancreatitis (D left = Control, D 
right = pancreatitis) 
3.4.2 CSE & CBS expression in pancreatic acinar fragments in response to caerulein 
stimulation 
Pancreatic acinar cells form the exocrine portion of the pancreas and are thought to play a key role in 
the inflammatory response associated with pancreatitis. The in vitro stimulation of primary isolated 
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pancreatic acinar fragments with caerulein mimics the in vivo model of pancreatitis and is used to study 
the pathogenesis and pathophysiology of pancreatitis (366). Here I sought to determine if caerulein 
stimulated pancreatic acinar fragments from mice result in altered CSE and CBS expression using qPCR 
and western blotting as it was possible to obtain good quality RNA from these fresh isolates. Figure 3.3 






















































Figure 3.3 CSE & CBS expression in pancreatic acinar fragments in response to caerulein stimulation. 
qPCR (A) & western blot (B) of CSE and qPCR of CBS (C) in pancreatic acinar cells following 1 h caerulein 
stimulation. There was no significant change in CSE and CBS expression in the caerulein stimulated 
group over saline control. Bars represent mean ± S.E.M. (n=3). 
3.5 Discussion 
This chapter confirms increased pancreatic acini CSE expression in response to acute pancreatitis with 
direct evidence using western blotting and immunohistochemistry to quantify as well as determine the 
location. The contribution of CSE expression in pancreatitis will be the subject of further study in 
chapter 6. 
3.5.1 Pancreatic CSE upregulation following acute pancreatitis 
Both CSE and CBS are expressed in the pancreas; CBS is present in the exocrine as well as the endocrine 
portion of the pancreas while CSE was only detectable in the exocrine portion (17). The exocrine 
portion of the pancreas is mainly made up of pancreatic acinar cells that are responsible for the 
synthesis of digestive enzymes, these cells are also thought to play an active role in the pathogenesis 
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of pancreatitis and propagation of the associated inflammatory response (267). Increased pancreatic 
hydrogen sulfide synthesizing activity has been reported in pancreatitis and was inhibited through the 
use of PAG resulting in an amelioration of the disease (66, 244, 318). This suggests that pancreatic CSE 
expression is upregulated in pancreatitis and plays a key pro-inflammatory role in the disease, there 
was however very little direct evidence of this upregulated response except for an in vitro report of 
caerulein stimulated pancreatic acinar cells (304). Here, I have shown that pancreatic CSE expression 
is upregulated by western blotting following caerulein induced acute pancreatitis in mice and this is 
supported by immunohistochemistry that shows increased staining in the exocrine portion of the 
pancreas (Figure 3.1 & Figure 3.2). These results are supported by a recent publication that used a 
sodium taurocholate model of pancreatitis in rats (69). Taken together, these findings affirm the 
upregulation of pancreatic CSE in response to pancreatitis and this occurs in the pancreatic acinar cells.  
3.5.2 CSE expression in caerulein stimulated pancreatic acini 
Following confirmation that CSE is upregulated in the pancreas during pancreatitis, the next step was 
to investigate the molecular mechanisms leading up to this increased CSE expression using an in vitro 
system. Primary pancreatic acinar fragments were prepared according to an established protocol (362) 
and hyperstimulated with caerulein for 1 h to induce a pancreatitis like state. In contrast to the in vivo 
findings, there was no detectable change in CSE expression by qPCR and western blotting. This 
discrepancy could be due to limitations of the in vitro system that does not include the complex 
interaction of pancreatic acinar cells with other components of the inflammatory response such as 
resident tissue macrophages and circulating neutrophils. Another factor could be due to the shorter 
induction period used in the in vitro system. However it is interesting to note that there has been one 
study that reported caerulein mediated upregulation in pancreatic acinar CSE expression using 
standard PCR (304). The protocols of isolation and stimulation used in that study and this thesis are 
essentially the same with the exception that the study resuspended pancreatic acini in media 
containing epidermal growth factor (EGF). EGF is used to support long term culture of pancreatic acini 
for up to 5 days (367) and has been shown to activate MAPKs in a pathway distinct from caerulein 
(368). The use of EGF could possibly have a synergistic or alternate activation effect on pancreatic acini 
stimulated with caerulein resulting in the observed CSE dysregulation. 
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4 Investigating macrophage CSE dysregulation in response to acute pancreatitis 
4.1 Introduction 
The inflammatory response comprises a complex interplay between inflammatory cues/stimuli such 
as cytokines, chemokine and eicosanoids with immune effector cells that include granulocytes (innate 
response) and lymphocytes (adaptive response). Macrophages represent a major component of the 
innate response system consisting of closely related cells of bone marrow origin, including blood 
monocytes, and tissue macrophages. Macrophages play a critical role in the initiation, maintenance, 
and resolution of inflammation through antigen presentation, phagocytosis, and immunomodulation 
by producing various cytokines and growth factors (313). In pancreatitis, macrophages are thought to 
play a key role in the initiation and propagation of the inflammatory response (297). Resident 
peritoneal macrophages have been implicated as the initial target due to their proximity to the 
pancreas and exposure to the ascitic fluid generated during pancreatitis. Studies have shown the 
activation of peritoneal macrophages in response to pancreatitis and to in vitro exposure with 
pancreatitis associated ascitic fluid (PAAF) (300, 310-312, 369, 370). This activation was found to be 
intense and occur in the early stages of pancreatitis (370) causing a massive release of pro-
inflammatory mediators into the peritoneal ascitic fluid (369) that in turn propagates the inflammatory 
response. 
There have been limited studies on the effect of CSE expression and endogenous hydrogen sulfide 
synthesis in macrophages, 6 in total. The first study by Oh et al (201) showed increased CSE expression 
following 4 h of LPS (1 M) stimulation in RAW 264.7 cells. The expression of CSE was associated with 
a decrease in iNOS synthesis and NO production; this was supported by a subsequent study that also 
measured increased hydrogen sulfide synthesis in LPS stimulated RAW 264.7 cells using a hydrogen 
sulfide specific electrode (55). There have been a couple of studies investigating ox-LDL stimulated 
macrophages; these studies have shown basal CSE & CBS/endogenous hydrogen sulfide to play a role 
in suppression of NFB activation through sulfhydration of the cysteine-38 residue of the p65 subunit 
and ox-LDL stimulation was found to decrease CSE & CBS expression/endogenous hydrogen sulfide 
leading to activation of these macrophages (205, 321). Conversely, there have been reports on the role 
of CSE expression as a pro-inflammatory mediator in macrophages; CSE was shown to be a positive 
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regulator of TNF-, IL-1, IL-6 and MCP-1 release through activation of NFB in response to LPS 
stimulation (249, 250). 
These initial studies provide an insight to the possible role of CSE and hydrogen sulfide in the regulation 
of macrophage function. However with the exception of LPS and ox-LDL stimulation of macrophages, 
the role of macrophage CSE expression has not been investigated in any inflammatory disease. 
Additionally there have been no studies that attempt to elucidate the pathway leading up to increased 
CSE expression in macrophages which could shed light on the upstream regulator of hydrogen sulfide 
synthesis in macrophages; a key effector cell of the innate immune response.  
Studies on the effect of exogenous hydrogen sulfide on macrophages in vitro have employed hydrogen 
sulfide concentrations between 50 to 100 M (55, 201, 203, 205, 321). All of these studies have shown 
that exogenous hydrogen sulfide dampens the effect of LPS and ox-LDL activated macrophages by 
decreasing the nitric oxide, cytokine and cell adhesion molecule production. However, these hydrogen 
sulfide concentrations are multiple orders higher than the levels currently detectable in tissue and the 
circulation (discussed in section 2.4.5) thus putting its physiological relevance to question. If so, what 
is the role of CSE/endogenous hydrogen sulfide in macrophages in inflammation? There are currently 
a handful of studies that attempt to address this question. Inflammatory stimuli have been shown to 
alter CSE expression levels in primary and macrophage cell lines; LPS stimulation caused an increase 
(55, 201, 249) while ox-LDL elicited a decrease (321) in CSE expression. Using gene knockdown and 
over expression models, this dysregulation of CSE expression was reported to have both a pro and anti-
inflammatory effect in stimulated macrophages; increased CSE expression decreased NO production 
(55) and TNF- release (321) in response to LPS and ox-LDL stimulation respectively but was also 
associated with increased cytokine release following LPS stimulation (249). In this chapter, I 
investigated macrophage CSE expression levels in response to LPS and acute pancreatitis as well as the 
molecular mechanisms involved. 
4.2 Aim 
This chapters aims were to determine changes in CSE expression in macrophages under inflammatory 
conditions associated with pancreatitis as well as the pathway leading up to this. For these studies, 
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RAW264.7 mouse macrophage cell line were used and stimulated with LPS as a classic activator for 
optimisation purposes. Finally these cells will be stimulated with plasma from pancreatitic mice in an 
attempt to replicate the in vivo activation of macrophages during pancreatitis. 
4.3 Materials and methods 
4.3.1 Materials 
General cell culture reagents and PCR primers were purchased from Life Technologies, USA. LPS 
purified by phenol extraction was purchased from Sigma-Aldrich, USA. The sp1 inhibitor, Mithramycin 
A was purchased from Tocris Bioscience, UK. The Akt inhibitor, Triciribine and PI3K inhibitor, LY294002 
were purchased from Sigma, USA. Caerulein was obtained from Bachem, Switzerland. 
 
4.3.2 RAW264.7 culture and experiments 
The mouse macrophage cell line was maintained in DMEM supplemented with 10% FBS and antibiotics. 
For the LPS stimulation experiments, cells were seeded at 50x104 cells/cm2 and the media was 
refreshed following day with or without 1 g/mL LPS. Cells were harvested 24 h later with cell 
scrappers and rinsed once with PBS before freezing the pellets at -80oC for further analysis. In 
experiments involving inhibitors, cells were treated with the inhibitors 1 h prior as well as throughout 
the course of LPS stimulation at the concentrations mentioned. For the plasma stimulation 
experiments, the cells were treated with DMEM supplemented with 10% plasma from either saline or 
caerulein treated mice and harvested 24 h later. In some experiments, the harvested cells were divided 
to be analysed by qPCR and western blotting. 
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4.3.3 RT-PCR and real-time quantitative PCR (qPCR) 
4.3.3.1 RNA extraction 
Pellets of RAW264.7 were analysed for CSE and CBS expression using conventional PCR and qPCR. Total 
RNA was extracted using the phenol-chlorofom method with Trizol purchased from Life Technologies, 
USA. Frozen RAW 264.7 cell pellets were triturated in 500L Trizol and left at RT for 5mins. 100 L 
chlorofom was added and tubes were shaken vigorously for 15 s and incubated at RT for 10 mins after 
which they were centrifuged at 12,000 g for 15 mins at 4 oC. The clear supernatant was then transferred 
to a fresh 1.5mL microfuge tube. 100 L isopropanol was added, tubes were mixed gently and 
incubated at RT for 10mins followed by centrifugation at 12,000 g for 10 mins at 4 oC. The supernatant 
was discarded, the RNA pellets rinsed with 1 mL chilled 70% ethanol and pelleted again at 7,500 g for 
5 mins at 4 oC. The supernatant was then discarded and the tubes air dried at RT. Finally the RNA pellets 
were reconstituted with an appropriate volume of Milli-Q water and read on a nano drop to determine 
RNA quantity and quality. 
4.3.3.2 cDNA synthesis 
cDNA synthesis was carried out with the High-Capacity cDNA Reverse Transcription Kit (Life 
Technologies, USA) using an MMLV reverse transcriptase enzyme. A master mix of the reaction mixture 
was prepared according to the manufacturers protocol, this consisted of 2 L reaction buffer, 0.8 L 
dNTP mix (4mM), 1 L random primers, 1 L Oligo(dT)20, 1 L reverse transcriptase enzyme and 4.2 L 
Milli-Q water per reaction. Template was prepared by using 1 g of total RNA and topping up with 
Milli-Q water to a total of 10 L. For each sample, 10 L of the master mix was added to 10 L of the 
prepared template for a final reaction of 20 L in PCR tubes. Reverse transcription was performed on 
a thermal cycler (Applied Biosystems 2720, USA) using the following conditions; 25OC for 25 mins > 
37OC for 120 mins > 85OC for 5 mins > 4OC hold. Samples were then stored at -80 oC for further use. 
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4.3.3.3 PCR and qPCR 
Primers for CSE, CBS, -actin were designed using the NCBI primer blast software and 18S was based 
on a publication (363) and purchased from Life Technologies (USA), details are shown in Table 5. PCR 
and qPCR were carried out with the BIOTAQ PCR kit using a TAQ polymerase enzyme (Bioline, UK). 
Amplifications were run in 20 L reaction volumes with 1 L of cDNA as the template. For conventional 
PCR, each reaction consisted of 0.5 U of Biotaq DNA polymerase, 1x NH4 reaction buffer, 2.5 mM MgCl2, 
0.2 mM dNTP, 5 M of forward primer and 5 M of reverse primer. For qPCR, a DNA dye Eva Green 
(Biotium, USA) was added to the reaction mixture described. To determine primer specificity, samples 
were run on a 1.5 % agarose gel for 35 cycles and visualised on a gel-doc system (Uvitec, UK) to assess 
the amplicon size and presence of non-specific bands. qPCR was performed on a Roche Light Cycler 
480 II. Comparative levels of CSE expression was quantified using -actin or 18S as the reference gene 
and based on calculations described by Pfaffl et al (364). 
4.3.4 Western blotting 
Pellets of RAW264.7 cells were analysed for CSE expression by western blot. Total cell lysate was 
prepared by triturating pellets in ice cold RIPA buffer (50 mM TRIS pH7.5, 150 mM NaCl, 1% v/v NP-40, 
0.5% w/v sodium deoxycholate, 0.1% w/v sodium dodecylsulfate supplemented with protease 
inhibitors (HALT by Pierce Biotechnology, USA)) and incubating on ice and vortexed vigorously 
periodically. Pancreatic tissue lysate was prepared by homogenising ~50 mg tissue in ice cold RIPA 
buffer supplemented with protease inhibitors with a Labserv homogeniser and incubated on ice. After 
30 mins, samples were centrifuged at 30,000 g for 30 mins at 4 oC. The clear supernatant (total cell or 
tissue lysate) was collected and measured for protein content using the Bio-rad DC Protein Assay (Bio-
rad, USA) and BSA protein standards as a reference. Samples were run on a 10 % w/v SDS-PAGE gel 
under reducing conditions with equal loading of 20 g of protein of each sample per well. Gels were 
run at a constant 200 V until the gel front had run out and then transferred onto a 0.45 m 
nitrocellulose membrane (Whatman, USA) at a constant 100 V for 1 h using a Bio-rad system. Running 
buffer consisted of 25 mM TRIS, 192 mM Glycine and 0.1 % w/v SDS while transfer buffer consisted of 
25 mM TRIS and 192 mM Glycine. Blots were then rinsed in TBS supplemented with 0.05% Tween-20 
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(TBST) and blocked with 5% non fat dry milk made in TBST. Blots were cut at the 37 kDa Mw marking 
and each portion of the membrane was probed for either CSE (~42 kDa) or GAPDH (~35 kDa) and HPRT 
(~23 kDa) at 1:1000 dilutions in blocking buffer at 4 oC overnight. Blots were then washed 4 times with 
TBST for 5 mins each and probed with the corresponding HRP conjugated secondary antibody 
(1:20,000) for 2 h at RT. Blots were then washed 4 times with TBST for 5 mins each with a final TBS 
rinse for 5 mins. Blots were then incubated with a chemiluminescence substrate (Western Lightning 
Ultra by Perkin Ellmer, Netherlands) for 1 min and visualized on a chemi-doc system (Uvitec, UK). Bands 
were semi quantitated using the Alliance 4.2 software and compared for relative intensities. Primary 
mouse anti CSE antibody was from Abnova (Taiwan), primary rabbit anti GAPDH and HPRT antibodies 
were from Santa Cruz Biotechnology (USA), secondary goat anti mouse HRP conjugated antibody was 
from Pierce Biotechnology (USA) and secondary goat anti rabbit HRP conjugated antibody was from 
Santa Cruz Biotechnology (USA). 
4.3.5 Statistical analysis 
Data are presented as means + S.E.M. Statistical analysis was performed using the Graphpad Prism 
Software version 5.03. Multiple comparisons were made using ANOVA with a Bonferoni post-hoc 
analysis. 
4.4 Results 
4.4.1 Macrophage CSE expression in response to acute pancreatitis and molecular 
mechanisms 
Previous reports have shown increased CSE expression in RAW 264.7 murine macrophage cells in 
response to LPS stimulation using qPCR and western blotting (55, 201). I therefore chose to use this 
cell line to investigate the response of macrophages to pancreatitis with regards to CSE expression. 
Initial experiments were conducted using LPS as the stimulant in order to optimise experimental 
methods and inhibitor concentrations. In the following experiments, qPCR was used to measure CSE 
expression in RAW 264.7 cells due to its sensitivity, specificity and quantitative ability. 
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4.4.1.1 Measuring CSE expression in RAW 264.7 macrophage cells 
A previous report has shown a dose dependent increase in RAW 264.7 CSE expression in response to 
LPS with the highest dose of 1 g/mL (55), therefore this concentration was used for these 
experiments. RAW 264.7 cells stimulated with 1 g/mL LPS showed increased CSE expression over 
corresponding saline control at 6, 12 and 24 h post stimulation using qPCR with -actin as the reference 
gene (Figure 4.1). Significant differences between saline and LPS treatment were found at 6 and 24 h 
(p<0.05). The largest increase was observed at 24 h post stimulation, ~ 9 ± 2 fold increase, and was 



























Figure 4.1 Time course CSE expression in LPS stimulated RAW 264.7 cells. qPCR shows increased 
expression of CSE in RAW 264.7 cells over time when stimulated with 1 g/mL LPS over time. Bars 
represent mean ± S.E.M. (n=3) * denotes significant differences between LPS and saline treatment 
(p<0.05) 
4.4.1.2 Molecular mechanisms of LPS stimulated CSE expression in RAW 264.7 cells 
Having corroborated previous findings and established a method of measuring CSE expression in RAW 
264.7 cells, the next step was to investigate the pathway leading up to increased CSE expression in 
macrophages. The pathway of interest was PI3K-Akt-sp1 and LPS was used as the stimulant in order to 
test the effect of the pathway inhibitors. RAW264.7 cells were pretreated with pharmacological 
inhibitors of sp1 (Mithramycin A), PI3K (LY294002) and Akt (Triciribine) at concentrations previously 
reported in this cell line (371-374). There was a dose dependent reduction of LPS stimulated increase 
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of CSE expression using all three inhibitors (Figure 4.1a-c). This shows that the PI3K-Akt-sp1 pathway 
is involved in the upregulation of CSE expression in LPS stimulated macrophages and the inhibitor 
concentrations were effective. The highest inhibitor concentration dose was used for further 
experiments. 





















































































Figure 4.2 Pathway of LPS mediated CSE upregulation in RAW 264.7 cells. qPCR of CSE expression in 
LPS stimulated RAW 264.7 cells using -actin as a reference gene. Relative expression of LPS and 
inhibitor treated groups were compared to untreated vehicle. Cells were treated with various inhibitors 
1 h prior to and throughout LPS (1 g/mL) stimulation. Mithramycin A, LY294002 and Triciribine showed 
does dependent inhibition of LPS mediated CSE expression in RAW 264.7 cells (A – C). Bars represent 
mean ± S.E.M. (n=3). # denotes significant difference over vehicle untreated cells while * denotes 
significant difference over vehicle LPS treated cells (p<0.05). 
4.4.1.3 CSE expression in RAW 264.7 macrophage cells in response to stimulation with plasma of 
control mice or mice with acute pancreatitis 
In order to observe the effect of pancreatitis on macrophage activation and CSE expression in vitro, 
RAW 264.7 cells were stimulated with plasma harvested from mice induced with acute pancreatitis. 
Ideally, peritoneal ascitic fluid would be the choice of stimulant given the location of the pancreas and 
the presence of resident peritoneal macrophages making it more pathophysiologically relevant. 
However plasma was chosen as the source of stimulant over pancreatic ascitic fluid because of its 
larger available volume making extraction more practical and also the fact that the peritoneal fluid 
would eventually drain into the blood circulation via the lymphatics. The effect of plasma stimulation 
on RAW 264.7 was studied by measuring the cytokine TNF- as well as chemokines MCP-1 and MIP-
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2 release. These are part of the key inflammatory mediators believed to be primarily responsible for 
the systemic manifestations of acute pancreatitis and its associated distant organ dysfunction (301, 
307). RAW 264.7 cells stimulated with plasma from pancreatitic mice showed a substantial and 
significant increase in pro-inflammatory cytokine secretion after 24 h when compared with plasma 
from control mice (p<0.05) (Figure 4.3 d to f). These levels were also marked higher compared to 
corresponding media only controls (p<0.05) (Figure 4.3 a to c). However it is interesting to note that 
the MCP-1 levels in the media only controls (Figure 4.3 b) were significantly higher in the caerulein 
group. This suggests that substantial levels of MCP-1 is present in the plasma of pancreatitic mice 
compared to the saline control; however these levels of MCP-1 are substantially increased upon 
treatment with RAW 264.7 cell, ~175 pg/mL compared to ~25 pg/mL (Figure 4.3 e). Taken together, 
this would suggest that plasma from pancreatitic mice was able to stimulate the RAW 264.7 
macrophage cell line presumably through pro-inflammatory mediators present in the plasma as a 
































































































Figure 4.3 Cytokines released by RAW 264.7 cells following stimulation with plasma of control mice 
or mice with acute pancreatitis. Plasma was obtained from mice treated with saline (control) or 
caerulein (pancreatitis) and used to stimulate RAW 264.7 cells by culturing cells in DMEM 
supplemented with 10 % vlv of pooled plasma for 24 h. The media was then assayed for pro-
inflammatory cytokines by ELISA. Panel (A) to (C) represent media only controls that consist of plasma 
supplemented media without cells cultured for 24 h, panel (D) to (F) represent plasma supplemented 
media cultured with RAW 264.7 cells for 24 h. Plasma from caerulein mice substantially increased pro-
inflammatory cytokine secretion by RAW 264.7 cells over corresponding saline controls. These levels 
were also markedly higher than media only controls. Bars represent mean ± S.E.M. (n=3). * denotes 
significant difference compared to saline group (p<0.05) 
Next, I sought to determine if the RAW 264.7 cells had altered CSE expression levels in response to 
plasma stimulation. It was found that stimulation of cells with plasma from pancreatitic mice resulted 
in increased CSE expression after 24 h. There was a 1.9 ± 0.12 fold increase in gene expression as 
determined by qPCR and this was corroborated with protein levels as determined by western blot (2.3 


















































Figure 4.4 CSE expression in plasma stimulated RAW 264.7 cells. Plasma was obtained from mice 
treated with saline (control) or caerulein (pancreatitis) and used to stimulate RAW 264.7 cells by 
culturing cells in DMEM supplemented with 10 % vlv of pooled plasma for 24 h. Cells were harvested 
and measured for CSE expression by western blot (A) and (B) and qPCR (C). Bars represent mean ± 
S.E.M. (n=3). * denotes significant difference compared to saline group (p<0.05) 
Finally, RAW264.7 cells were pre-treated with the same pharmacological inhibitors used in the LPS 
stimulation experiments to determine if a similar signalling pathway is involved in the upregulation of 
CSE expression in response to pancreatitic plasma stimulation. The concentration of inhibitors used 
were 2 M Mithramycin A, 20 M LY294002 and 0.4 M Triciribine based on the dose dependent LPS 
stimulation experiments (Figure 4.2). Pancreatitic plasma mediated upregulation of CSE expression in 
RAW264.7 cells was attenuated with the sp1 and PI3K inhibitors, Mithramycin A and LY294002. 
However there was a substantial potentiation of CSE upregulation following pre-treatment with the 































































































Figure 4.5 Pathway of pancreatitic plasma mediated CSE upregulation in RAW 264.7 cells. Western 
blot analysis of CSE expression in LPS stimulated RAW 264.7 cells using GAPDH as an internal control, 
(A) western blot (B) densitometry analysis. Relative expression of pancreatitic plasma (Cae plasma) and 
inhibitor treated groups were compared to control plasma treatment (Sal plasma). Cells were treated 
with various inhibitors 1 h prior to and throughout plasma stimulation (10 % v/v), Mithramycin (2 M) 
and LY294002 (20 M) showed inhibition of pancreatitic plasma mediated CSE expression in RAW 264.7 
cells while the Triciribine (0.4 M) caused a further upregulation of CSE expression. Bars represent 
mean ± S.E.M. (n=3). * denotes significant difference over vehicle treated control plasma stimulated 
cells (p<0.05). # denotes significant difference over vehicle treated pancreatitic plasma stimulated cells 
(p<0.05) 
These results suggest CSE expression is significantly upregulated in macrophages during pancreatitis. 
The pathway leading to this increased expression is positively regulated by PI3K and sp1 and is 
negatively regulated by Akt. 
4.4.2 Macrophage CBS expression in response to LPS and acute pancreatitis 
CBS is another hydrogen sulfide synthesizing enzyme that is present in the peripheral tissue. Therefore 
it would be of interest to determine CBS expression in RAW 264.7 cells in response to an inflammatory 
stimulus. Basal CBS gene expression along with LPS and plasma stimulated cell expression were 
determined using PCR by observing products on an agarose gel (Figure 4.6). There was no detectable 
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expression of CBS in the untreated or plasma and LPS stimulated cells. The positive control using mouse 
liver template showed the expected splice variants of CBS at 172 and 214 bp. Due to the lack of CBS 
expression, the focus remained on CSE. 




Figure 4.6 CBS expression in RAW 264.7 cells. A PCR was performed to detect basal as well as plasma 
and LPS stimulated CBS expression in RAW 264.7 cells. PCR was carried out for 30 cycles using mouse 
liver template as a positive control (+ve) and -actin as a reference gene. CBS expression was not 
detectable in basal (Untreated) or plasma (Saline and Caerulein) and LPS stimulated cells. 
4.5 Discussion 
Understanding the molecular and cellular basis of diseases is vital for dissecting the mechanisms of 
disease pathogenesis and for designing appropriate and effective treatments. The molecular 
mechanisms involved in regulating macrophage CSE expression are poorly studied; there are only two 
very recent publications to date that describe the pathway involved in LPS (375) and statin (376) 
mediated upregulation of CSE. In this chapter, I have investigated the molecular mechanism leading to 
macrophage CSE expression in response to the classical endotoxin activator, LPS and extended these 
findings to stimulation with plasma from pancreatitic mice. I chose to study the PI3K signalling pathway 
as this has been reported to both positively and negatively regulate the expression of pro-
inflammatory mediators in LPS stimulated macrophages (373, 377), and could therefore account for 
the dual roles of CSE/endogenous hydrogen sulfide reported in macrophages (201, 249). 
The findings of this chapter highlight the increased expression of CSE in macrophages under 
inflammatory conditions such as LPS stimulation as well as pancreatitis. These results represent the 
only report that links macrophage CSE upregulation to an in vivo model of inflammatory disease. This 
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shows that CSE/endogenous hydrogen sulfide may play a role in macrophage function and therefore 
the inflammatory response at large. This chapter has also elucidated the molecular mechanisms 
leading up to CSE over expression in macrophages in response to LPS and pancreatitis involving PI3K, 
Akt and sp1 which have not been previously shown. The LPS mediated PI3K-Akt-sp1 mechanism 
described here ties in with recent findings of LPS mediated TLR4-p38 and TLR4-NFB dependent 
upregulation of CSE in macrophages (379,380) to suggest a TLR4-PI3K-Akt-p38-sp1 pathway. 
4.5.1 Molecular mechanisms leading to LPS induced CSE upregulation in macrophages 
Genetic characterization of the murine CSE cDNA in transfected HEK-293 and Cos-7 cell lines revealed 
several transcription factor binding sites in the core promoter region, among them sp1 and n-myc were 
found to play major roles in the basal transcription (16). LPS is known to activate sp1 in macrophages 
and has been shown to regulate the expression of pro-inflammatory related proteins such as histidine 
decarboxylase (HDC) (371), MIP-2 (378) and TNF- (379) as well as anti-inflammatory ones such as IL-
10 (380, 381). Therefore I had chosen investigate the involvement of sp1 in the regulation of 
macrophage CSE expression. Here, I have also shown that sp1 is a key transcription factor responsible 
for LPS mediated CSE upregulation in the murine macrophage cell line, RAW264.7 (Figure 4.2). 
Classical macrophage activation by LPS occurs via the TLR-4 receptor and activation of two major 
intracellular signalling pathways involving the mitogen-activated protein kinases (MAPKs) and NFB 
respectively leading to the expression of pro-inflammatory cytokines and effector molecules (382). 
TLR-4 activation by LPS has also been shown to activate phosphoinositide 3-kinase (PI3K) signalling in 
macrophages although it is still unclear if this positively or negatively regulates the expression of pro-
inflammatory mediators in LPS stimulated macrophages (373, 383). PI3K signalling has been shown to 
phosphorylate and activate sp1 via PI3K-Akt and PI3K-PKC- (reviewed by (384)) and this has been 
demonstrated in IFN- and LDL stimulated macrophages (385, 386). Here, I have shown that CSE 
upregulation in LPS stimulated RAW264.7 cells is dependent on PI3K signalling and its downstream 
effector kinase, Akt (Figure 4.2). Taken together, these results suggest that the LPS stimulated 
expression of CSE in RAW264.7 cells occurs via a PI3K-Akt-sp1 dependent pathway (Figure 4.7).  
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These results are supported by recent findings showing a TLR4-p38 and TLR4-NFB mediated 
upregulation of CSE expression in LPS stimulated macrophages (322). TLR4 is known to stimulate PI3K 
signalling in LPS stimulated macrophages (379,380) and this has been shown to activate both p38 
(381,382) as well as NFB (380) via Akt; phosphorylation of p38 has also been shown to activate sp1 
leading to gene expression in macrophages (383). Taken together this suggests that LPS stimulation of 
macrophage leads to CSE upregulation via a TLR4-PI3K-Akt-p38-sp1 signalling pathway. 
4.5.2 CSE upregulation in pancreatitic plasma stimulated macrophages and the molecular 
mechanisms involved 
The role of CSE and endogenous hydrogen sulfide in macrophages are still poorly understood within 
the context of pancreatitis. An in vitro method of studying the macrophage activation in pancreatitis 
involves the application of peritoneal ascitic fluid from experimental severe acute pancreatitis in rats 
onto cultured macrophages (310). This has been shown to stimulate macrophages by activating NFB 
and increasing TNF- production (310, 311). The caveat of using PAAF is the limited quantities available 
particularly in smaller experimental animals such as mice; therefore I elected to use pooled plasma 
instead, as the peritoneal fluid would eventually drain into the circulation via the lymphatics. The 
drawback of using plasma however is that it contains ~ 10 times less pancreatic enzymes and cytokines 
than PAAF following pancreatitis (297). 
Therefore initial experiments were carried out to ascertain the ability of pancreatitis derived plasma 
to stimulate macrophages in vitro. RAW264.7 cells cultured in serum free media supplemented with 
10 % v/v plasma from pancreatitic mice showed a dramatic increase of up to several orders in MCP-1, 
MIP-2 and TNF- release over a 24 h period in comparison to plasma from control mice (Figure 4.3). 
These molecules are released by activated macrophages (387, 388) and represent key inflammatory 
mediators that are believed to be primarily responsible for the systemic manifestations of acute 
pancreatitis and its associated distant organ dysfunction (301, 307). Having established the ability of 
pancreatitic plasma in stimulating RAW264.7 cells in vitro, I then employed this model as an 
approximation to ascertain the CSE expression status of macrophages during pancreatitis. The results 
show about ~2 fold increase in RAW264.7 CSE expression in response to plasma stimulation from 
pancreatitic mice compared to control mice over a 24 h period (Figure 4.4). This increase could 
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potentially be higher bearing in mind that plasma levels of pro-inflammatory mediators are 
substantially lower than in the PAAF in pancreatitis (297). 
Using the optimal inhibitor concentrations determined from the LPS stimulation experiments (Figure 
4.2), I have shown that increased CSE expression in RAW264.7 cells in response to plasma stimulation 
from pancreatitic mice was dependent on sp1 and PI3K activation (Figure 4.5). These findings were 
similar to the LPS mediated increase however in contrast, the Akt inhibitor Triciribine potentiated 
plasma stimulated increase in CSE expression. This unexpected outcome raises two issues; the ability 
of Akt to mediate both up and downregulation of CSE expression and the differential regulation of CSE 
expression by PI3K and Akt respectively. Apart from phosphorylating and activating sp1 (reviewed by 
(384)), Akt is also known to phosphorylate and inactivate glycogen synthase kinase 3 (GSK3) (389), 
which is constitutively active in unstimulated cells and phosphorylates N-myc among other proteins, 
to promote GSK3 degradation and increase the availability of N-myc (390). N-myc has been shown to 
be a repressor of CSE expression (16) and is found to be constitutively expressed in RAW264.7 cells 
(391). Taken together, the Akt-GSK3-N-myc pathway could be a method by which CSE expression is 
repressed or downregulated by activation of Akt, and this explains how Akt activation could both up 
and downregulate CSE expression. PI3K activation leads to the activation of a large number of proteins 
and lipids that contain a plekstrin homology domain (reviewed in (392)). Among them is 
phosphoinositide-dependent kinase 1 (PDK1) which is capable of phosphorylating numerous proteins 
including Akt and PKC-. As mentioned above, both Akt and PKC- are capable of phosphorylating and 
activating sp1 (reviewed in (384)). Therefore there are and could be other mechanisms by which PI3K 
could activate sp1 independent of Akt owing to the diverse signalling targets of PI3K and Akt (reviewed 
in (392)). In the case of pancreatitic plasma stimulated RAW264.7 cells, there appears to be a 
simultaneous upregulation of CSE expression via PI3K and downregulation by Akt signalling. In 
comparison to LPS stimulation, the plasma from pancreatitic mice consists of a complex combination 
of molecules that could contain both pro and anti-inflammatory cues. This could explain the observed 
divergent roles of PI3K and Akt on CSE expression possible mediated by separate signalling events from 
the plasma and the net effect of this differential regulation is the increased expression of CSE in 




Figure 4.7 Molecular mechanisms of LPS and pancreatitic plasma stimulated upregulation of CSE 
expression in RAW 264.7 cells. This diagram summarises this chapters findings on the pathway leading 
up to LPS and pancreatitic plasma stimulated CSE expression in macrophages. LPS was shown to elicit 
CSE expression via PI3K-Akt-sp1. Plasma from pancreatitic mice however appears to elicit a complex 
activation of macrophage signalling resulting in a net increase of CSE expression via a PI3K-sp1 
pathway. This does not involve the classical PI3K signalling partner, Akt, which was shown to negatively 
regulate CSE expression instead. This could possibly occur via phosphorylation of GSK-3 resulting in 
activation of N-myc which is a known transcriptional deactivator of the CSE gene. 
4.5.3 CBS expression in macrophages 
CBS is another major endogenous hydrogen sulfide synthesizing enzyme apart from CSE. There have 
been conflicting reports on the expression of CBS in macrophages; two studies have reported 
undetectable CBS levels in murine primary peritoneal macrophages as well as the RAW264.7 
macrophage cell line (55, 321), while one report has shown basal CBS expression in the human THP-1 
macrophage cell line (205). In order to determine the relevance of CSE as an inducible source of 
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endogenous hydrogen sulfide in macrophages, I sought to detect CBS expression in RAW264.7 cells 
under basal and stimulated conditions. Using PCR, there was no detectable expression of CBS in 
unstimulated cells or upon 24 h stimulation with LPS and plasma from pancreatitic mice (Figure 4.6). 
These results are in agreement with previous studies (55, 321) and shows that CSE is the main hydrogen 
sulfide synthesizing enzyme present and upregulated in macrophages upon stimulation and could 




5 The effect of CSE gene deletion in caerulein-induced pancreatitis in the mouse 
5.1 Introduction 
5.1.1 CSE dysregulation and endogenous hydrogen sulfide synthesis in pathological 
conditions  
CSE is classically known for its role in the transsulfuration pathway for the ,-elimination of 
cystathionine to yield cysteine, -ketobutyrate and ammonia (393). However, CSE is also capable of 
generating hydrogen sulfide as a byproduct through cysteine-dependent -reactions and 
homocysteine-dependent -reactions (21). In experimental models the induction of pathological 
conditions such as sepsis (189), LPS-induced endotoxaemia (44, 375, 394), hepatic ischemia-
reperfusion injury (395), burn injury (45), renal injury (217), colitis (328), gall bladder inflammation 
(329), pancreatitis (69, 322) and chronic rhinitis (396) are associated with upregulation of CSE 
expression in the target organ of the respective disease. Increased CSE expression has also been 
detected in immune response cells such as macrophages when stimulated with LPS (55, 201, 375). Not 
all inflammatory conditions are associated with upregulation of CSE and endogenous hydrogen sulfide; 
asthma (397, 398), gastropathy (327), hepatotoxicity (223), kidney ischemia reperfusion injury (399) 
and ox-LDL stimulated macrophages (321) have shown a down-regulation of CSE instead along with 
the reduction in endogenous hydrogen sulfide synthesis (223, 397). 
5.1.2 The role of CSE and endogenous hydrogen sulfide in the inflammatory response 
Recent insights into the physiological aspects of hydrogen sulfide and its direct mediated effects have 
revealed potential ways in which it could influence an inflammatory response. hydrogen sulfide has 
been shown to be a physiologically relevant vasodilator (18, 80), cytoprotectant (reviewed by (191)) 
via its antioxidant and anti-apoptotic roles as well as a pro-nociceptor which could lead to neurogenic 
inflammation (105, 112, 113) (discussed in further detail in section 1.3). Hydrogen sulfide has also been 
reported to directly modify thiol containing proteins through s-sulfhydration, function as a direct 
antioxidant and bind to metal ion containing proteins. These direct interactions have been shown to 
modulate activity of key inflammatory mediators such as reactive oxygen/nitrogen species, 
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transcription factors NFB and Nrf2, neutrophilic myeloperoxidase enzyme as well as the renin-
angiotensin system (discussed in further detail in section 1.4). 
The effect of CSE/endogenous hydrogen sulfide dysregulation on the inflammatory response has been 
the subject numerous studies. The use of a selective pharmacological CSE inhibitor, PAG, in animal 
models of disease have reported both pro (44, 45, 66, 189, 216-219, 400) and anti (124, 187, 220-223, 
401) inflammatory effects. Increased CSE expression/endogenous hydrogen sulfide has been 
associated with both increased and decreased circulating inflammatory cytokines/ chemokines (44, 66, 
200, 217, 223), pro and anti-apoptotic effect (69, 124), increased and decreased oxidative stress (218, 
223) as well as increased and decreased iNOS expression and NO production (55, 201, 222). These 
conflicting results could be due to several factors such as the difference between the pathology of 
diseases studied, the dosage regime of PAG as well as route of administration and that PAG itself is not 
specific towards CSE and targets other pyridoxal-5-phosphate dependent enzymes (discussed further 
in introduction 1.5.4). Therefore an alternative and more specific approach towards inhibiting 
CSE/endogenous hydrogen sulfide would be beneficial in enhancing our understanding of the role of 
CSE/endogenous hydrogen sulfide in inflammation. 
5.1.3 Caerulein induced acute pancreatitis: an inflammatory response model 
Pancreatitis is a clinical condition that is thought to stem from the intracellular activation of digestive 
enzymes and autodigestion of the pancreas (298) and is regarded as a sterile inflammatory response 
in the initial stages; intracellular contents released from damaged necrotic acinar cells into the 
extracellular space serve as DAMPs that trigger inflammation and is a key determinant of further 
pancreatic injury, remote organ injury, and disease resolution in experimental models (276). This non-
pathogenic destruction of pancreatic parenchyma rapidly elicits an inflammatory reaction at the site 
of injury and has the potential to amplify this localised process resulting in a generalised systemic 
inflammatory response. Sterile inflammation is very similar to microbial induced inflammation, both 
instances result in the recruitment and activation of the innate immune response cells as well as 
production of pro-inflammatory cytokines and chemokines via PRR mediated pathways (402). 
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The benefit of using a sterile inflammatory model of disease provides the opportunity to study the 
inflammatory response independent of interaction with a pathogen, this is particularly pertinent in the 
field of hydrogen sulfide. Most, if not all bacteria have orthologs of mammalian CBS, CSE or 3MST and 
the capacity for hydrogen sulfide synthesis (403, 404). Certain bacteria are also capable of producing 
hydrogen sulfide by using sulfate as the final electron acceptor in the respiration chain thus reducing 
it to hydrogen sulfide (405). In an inflammatory response involving bacteria as the pathogen such as 
sepsis, there is a possibility of interplay between the effect of bacterial derived hydrogen sulfide on 
the host response and vice-versa. For example hydrogen sulfide has been shown to be a universal 
bacterial defence against antibiotics induced oxidative stress (403) and on the other hand, hydrogen 
sulfide metal chelating ability mimics the innate defence system of employing the chelator protein, 
calprotectin as means to starve the invading bacteria of essential ions required for growth (406, 407).  
However as described in section 1.6.1.3, acute pancreatitis is also associated with bacterial infection 
stemming from intestinal permeability. This however, is mostly associated with the severe form of 
acute pancreatitis. In animal models of acute pancreatitis, severe acute models such as sodium 
taurocholate and sodium deoxycholate infusion as well as bilio-pancreatic duct ligation have shown to 
induce bacterial and endotoxin translocation as early as 4 to 18 hours post surgery (408-411). These 
models are also associated with mortality. In contrast the caerulein model involving hyperstimulation 
of the pancreatic acinar cells induces a milder form of acute pancreatitis; bacterial as well as endotoxin 
translocation was reported 24 hours post induction and was found to be less pervasive in comparison 
to the severe acute models (411, 412). It is also not associated with mortality. Therefore, the use of 
caerulein-induced pancreatitis as a model of inflammation would be useful to investigate the role of 
CSE/endogenous hydrogen sulfide in the inflammatory response as it is minimally invasive, involves 
non-pathogenic triggers of inflammation, is severe enough to initiate a systemic inflammatory 
response and is associated with minimal or no secondary bacterial infection. 
Currently, there have been several studies using PAG to determine the role of CSE/endogenous 
hydrogen sulfide in pancreatitis. Although these studies differed in terms of method of induction, the 
dosage of PAG was very similar. Three of these studies employed a minimally invasive caerulein 
hyperstimulation method of induction that involves hourly intraperitoneal injections of caerulein for 
ten hours in mice resulting in acute pancreatitis (66, 244, 318). The remaining two studies adopted a 
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surgical method of retrograde sodium taurocholate infusion into the pancreatobiliary duct in rats 
causing severe acute pancreatitis (69, 322). In all the studies, animals were administered 50-100 mg 
PAG per kg body weight intraperitoneally either before (30 min-1 h) or 1 h after the initial induction of 
pancreatitis. All five studies reported attenuation in disease severity following PAG treatment, this was 
associated with reduction in pancreatic and circulating inflammatory cytokines/ chemokines (318) as 
well as increased acinar cell apoptosis as opposed to necrosis as a more favourable and contained form 
of cell death (69). Although PAG has proved to be a valuable resource to investigate the role of 
hydrogen sulfide synthesised by CSE in inflammation, possible actions of PAG unrelated to CSE 
inhibition lead to criticism of all studies where PAG has been used. 
5.2 Aims 
The previous chapter has shown increased pancreatic CSE expression and hydrogen sulfide 
synthesising activity in response to pancreatitis. Macrophages stimulated with plasma of pancreatitic 
mice also showed increased CSE expression over the corresponding control. This chapter will focus on 
determining the effect of CSE/endogenous hydrogen sulfide in inflammation using caerulein induced 
acute pancreatitis in mice as the model of disease. To do so, I compared the response of wild type and 
CSE deficient mice to pancreatitis in terms of disease severity (characterised by pancreatic and lung 
neutrophil infiltration as evidenced by MPO activity and pancreatic damage as evidenced by acinar cell 
necrosis and oedema), pancreatic sulfide production and pancreatic inflammatory mediator levels 
(cytokines, chemokines, eicosanoids and NFB). The use of knockout mice would eliminate the use of 
pharmacological inhibitors, along with their potential drawbacks, to gain a more definitive insight to 
the role of endogenously synthesized hydrogen sulfide in inflammation. There will also be a secondary 
focus comparing the effect of in vitro stimulated pancreatic acinar cells isolated from wild type and 
CSE deficient mice to investigate the role or CSE/endogenous hydrogen sulfide in the progression of 
this disease at the acinar cell level by comparing their ability to release chemotactic molecules (MCP-
1 and LTB4 in response to caerulein stimulation. 
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5.3 Materials and methods 
5.3.1 Caerulein induction of acute pancreatitis in mice 
Plasma was obtained from mice induced with acute pancreatitis mice using caerulein as described 
below. Plasma was pooled from individual mice treated with saline or caerulein and frozen in aliquots 
to make up a batch of working plasma to treat RAW 264.7 cells. 
All animal experimentation were approved by the Animal Ethics Committee of the University of Otago 
(Protocol C57/11) and performed according to the guidelines. Caerulein was obtained from Bachem 
(Bubendorf, Switzerland) and reconstituted in sterile saline to a final concentration of 1 mg/100 mL 
and frozen in 1.5 mL aliquots. WT and CSE KO C57BL6 mice (male, 20–25 g) were assigned randomly 
to control or experimental groups. WT mice were obtained from the Christchurch Animal Research 
Area, and the CSE KO mice were a gift from Dr. Ishii Isao from the Graduate School of Pharmaceutical 
Sciences, Keio University, Japan. A total of 32 animals was used, WT saline (n = 6), KO saline (n = 4), 
WT caerulein (n = 11), and KO caerulein (n = 11). Animals were given hourly intraperitoneal (i.p.) 
injections of normal saline (0.9% wt/vol NaCl) or caerulein (50 g/kg) for 10 h, as described previously 
(305, 361). For pain relief, all mice were given 3 subcutaneous (s.c.) doses of buprenorphine (0.2 
mg/kg) per hour before treatment, as well as 3 h and 7 h into the treatment. One hour after the last 
caerulein/saline injection, animals were sacrificed by an i.p. injection of sodium pentobarbital. Blood 
samples were drawn from the right ventricle using heparinized syringes and centrifuged (1,000 g for 
10 min, 0–4 °C). Thereafter, plasma was aspirated and stored at -80°C for amylase measurement. 
Random cross sections of the pancreas and lungs were fixed in 4% wt/vol neutral phosphate-buffered 
formalin for subsequent histological analysis. Samples of pancreas and lung were also weighed out 
immediately on preweighed boats for determination of water content. The remaining samples of 
pancreas and lung were stored at -80 °C for subsequent measurement of tissue myeloperoxidase 
(MPO) activity, estimation of CSE expression by Western blotting, as well as measurement of cytokines 
and prostaglandin E2 (PGE2) levels by ELISA. 
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5.3.2 Primary pancreatic acinar fragment preparation and treatment 
The media use for isolating primary pancreatic acinar cells consisted of DMEM supplemented with 
0.1% w/v BSA, 0.05% w/v trypsin inhibitor and oxygenated with 95% oxygen and 5% CO2 before use. 
The method of isolation was based on Bruzzone et al (362). Freshly removed pancreas were placed in 
ice cold media to rinse off excess blood and then transferred to a 1.5 mL microfuge tube on ice 
containing media supplemented with collagenase type IV at a final concentration of ~400 U/mL. The 
pancreas was minced finely using scissors to pieces < 1 mm in diameter. The mined pancreas was then 
transferred to a glass vial, topped up with collagenase solution, sealed tightly and in a 37 oC shaking 
water bath for 10 mins. After that the vial was shaken vigorously by hand for 1 min and placed back 
into the bath for a further 5 mins after which it was vigorously shaken by hand for a final 30 s. The 
digest was then briefly triturated with a large orifice plastic pasteur pipette and layered onto a 4% BSA 
solution in a 15 mL tube. This was then centrifuged at 50 g for 2 mins, the collagenase and BSA layers 
were discarded and the cells were rinsed with fresh media 2 times by centrifuging at 50g for 70 s each 
time. The pellet was the triturated in fresh media and the top layer of fine tissue fragments as the 
bigger clumps settled was transferred to a fresh tube to be used for experiments. These fine fragments 
consisted of cell clusters of 5 to 20 cells and had viability of more than 90 % as determined by trypan 
blue exclusion. 
The final pancreatic fragments were distributed into 1.5 mL microfuge tubes and treated with either 
saline or caerulein at a final concentration of 100 nM. They were incubated at 37 oC on a rotator for 60 
mins after which they were harvested by centrifuging at 1000 g for 5mins. The supernatants were 
assayed for MCP-1 and LTB4 levels by ELISA and corrected for total protein content in the pellet. 
5.3.3 Tissue preparation and processing for histological analysis 
Tissue samples were fixed overnight in 4% wt/vol neutral phosphate-buffered formalin and sent to the 
Christchurch hospital histopathology department to be processed and set into paraffin blocks. 4m 
thick formalin fixed paraffin embedded tissues sections were cut using a Leica microtome and 
immobilized onto superfrost coated glass slides (Menzel-Glaser, Germany). Sections were left to air 
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dry and subsequently stained for hematoxylin/eosin by the Christchurch hospital histopathology 
department or used for immunohistochemistry. 
5.3.4 Plasma amylase activity 
Amylase activity was measured using a standard kinetic spectrophotometric assay. 5 L of plasma 
samples were incubated with 200 L of the ready to use assay mixture containing Ethylidene-pNP-
Glucose-7 (EPS) and -glucosidase (Thermo Fisher Scientific, USA). EPS is the substrate for -amylase, 
upon cleavage the resulting smaller fragments are acted upon by the -glucosidase to yield the final 
chromophore measured at 405nm. Measurements were taken at 60s intervals for a total of 4 min. The 
resulting change in absorbance from the linear portion of the curve was used to calculate amylase 
activity as described by the manufacturer’s protocol. 
5.3.5 Tissue myeloperoxidase measurement 
Leukocyte sequestration in pancreas and lung was quantified by measuring tissue myeloperoxidase 
(MPO) activity. Tissue samples were thawed and homogenised in 20 mM phosphate buffer (pH 7.4) 
(~50mg/mL) supplemented with protease inhibitors (Halt by Thermo Scientific Pierce Protein Biology, 
Rockford, IL, USA) on ice using a Labserv homogeniser. Homogenates were then centrifuged (10,000 
g, 10 min, 4°C) and the resulting pellet resuspended in 50 mM phosphate buffer (pH 6.0) containing 
0.5% w/v hexadecyltrimethylammonium bromide (Sigma). The suspension was subjected to four cycles 
of freezing and thawing and further disrupted by sonication on ice (40 seconds). The samples were 
then centrifuged (10,000 g, 5 min, 4°C) and the clear supernatant was used for the MPO assay. The 
reaction mixture consisted of the supernatant (50 μl) and stabilized tetramethylbenzidine and 
hydrogen peroxide mixture (R&D Systems, USA) (reagent volume: 50 μl). This mixture was incubated 
at room temperature for ~ 10 mins for the colour to develop and the reaction was terminated with 50 
μl of 2N hydrogen sulfideO4. The absorbance was measured at 450 nm with a 570 nm correction. This 
absorbance was then corrected for the protein content of the tissue sample using the Bradford assay 
and results were expressed as fold increase over control. 
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5.3.6 Morphological examination of pancreatic damage 
4 m pancreatic sections were stained with hematoxylin & eosin and mounted by the Christchurch 
Hospital Histopathology Department. Two sections were prepared for each pancreas and two random 
images were taken from each section at 20x magnification. Pancreatic pathology was assessed in a 
blinded manner based on the previously described Schmidt Scoring Criteria (413). Assessment was 
based on three criterion of edema, acinar cell necrosis and leukocyte infiltration. Edema was graded 
on expansion of interlobular and interacinar septae and its distribution (focal or diffused). The extent 
of acinar cell necrosis was determined by both number of necrotic cells per high powered field and its 
distribution (focal or diffused). Leukocyte infiltration was scored based on the number of cells present 
per high powered field. Each of these criterion was then graded from 0 to 4 with increments of 0.5 
based on the severity as described in detail by Schmidt et al (413).  
5.3.7 Pancreatic hydrogen sulfide synthesizing activity 
hydrogen sulfide synthesizing activity in pancreatic homogenates was measured with a modified 
protocol based on methods described previously (365). ~50mg pancreatic tissue was homogenised in 
50 mM ice-cold potassium phosphate buffer (pH 7.4) using a Labserv homogeniser. The reaction 
mixture contained 100 mM potassium phosphate buffer (pH 7.4), L-cysteine (20 μl, 10 mM), pyridoxyal 
5´-phosphate (20 μl, 2 mM), saline (30 μl), and 11% w/v tissue homogenate (430 μl). The reaction was 
performed in tightly parafilm-sealed microfuge tubes (with lids taken off) and initiated by transferring 
the tubes from ice to a water bath at 37oC. After incubation for 30 min, 1% w/v zinc acetate (250 μl) 
was injected in to trap evolved hydrogen sulfide followed by 10% v/v trichloroacetic acid (250 μl) to 
denature the protein and stop the reaction. Subsequently, N,N-dimethyl-p-phenylenediamine sulfate 
(20 μM; 133 μl) in 7.2 M HCl was added, immediately followed by FeCl3 (30 μM; 133 μl) in 1.2 M HCl. 
Samples were left to incubate at room temperature in the dark for 20 min and subsequently pelleted. 
The absorbance of the clear supernatant was measured with a 96-well microplate spectrophotometer 
at 670 nm. The hydrogen sulfide concentration was calculated against a calibration curve of Na2S. 
Results were then corrected for the protein content of the tissue sample determined by the Bio-rad 
DC protein assay and are expressed as nmole hydrogen sulfide formed/mg protein. 
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5.3.8 Cytokine and eicosanoid measurement by ELISA 
Pancreatic IL-6, MCP-1, MIP-2 and PGE2 levels as well as pancreatic acinar cell supernatant MCP-1 
and LTB4 levels were measured using ELISA Duo Set kits from R&D Systems (USA) according to the 
manufacturer’s protocol. Pancreatic homogenates were prepared by homogenizing ~50 mg tissue in 1 
mL of 20 mM sodium phosphate buffer (pH 7.4) supplemented with protease inhibitors (Halt by 
Thermo Scientific Pierce Protein Biology, Rockford, IL, USA) on ice. Homogenates were spun at 30,000 
g for 15 mins at 4oC and 100 L of the clear supernatant was used for each assay. Each kit consisted of 
a capture and biotin conjugated detection antibody pair, standards and streptavidin-HRP conjugate. 
ELISA specific plates (Corning, USA) were first coated with capture antibody in PBS for 1 h at RT 
overnight. Plates were then decanted, washed with PBST (0.05% w/v) and blocked with 300 L of BSA 
(1 % w/v) for 1 h at RT followed by washing and addition of 100 L samples or standards. After 2 h 
incubation, plates were decanted, washed followed by addition of 100 L biotin conjugated detection 
antibody. After 2 h incubation, plates were decanted, washed followed by addition of 100 L 
streptavidin conjugated HRP. After a 30 min incubation, plates were decanted, washed followed by 
addition of 100 L substrate reagent (R&D Systems, USA). Plates were incubated at RT for up to 20 
mins to allow the colour to develop and the reaction was terminated by addition of 50 L sulfuric acid. 
Plates were read at 450 nm on a spectrophotometer (Spectramax, Molecular Devices, USA) with a 570 
nm correction. Cytokine and eicosanoid levels were corrected for total protein and expressed as pg or 
ng per mg of protein. 
5.3.9 Immunohistochemical detection of NFB translocation in pancreatic acinar cells 
Staining was performed on 4m thick formalin fixed paraffin embedded tissues sections using the 
rabbit specific HRP/DAB (ABC) Detection IHC Kit (Abcam, Cambridge UK). Sections were deparaffinized 
in xylene and rehydrated through a graded alcohol series (described in section 3.3.6) followed by an 
antigen retrieval step by incubating in a 10 mM Sodium citrate, 0.05% Tween 20, pH 6.0 solution at 
97oC for 20 mins. Sections were allowed to cool at room temperature for 20 mins followed by 
immunostaining as described in the manufacturers’ protocol. Briefly, sections were serum/protein 
blocked for 30 mins at RT followed by an overnight incubation at 4oC with primary antibody; rabbit 
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anti- NFB p65 (Abcam, Cambridge UK) diluted 1:500 in TBST (0.025% w/v)) with 1% BSA. This was 
followed by a hydrogen peroxide block for 10 mins, secondary antibody incubation for 30 mins, 
streptavidin incubation for 20 mins, DAB substrate incubation for 1 min, rinse in water, brief dip in 
diluted hematoxylin, and final rinse in water. TBST (0.025% w/v) was used as the wash buffer between 
reagents. Sections were then dehydrated through an alcohol series followed by xylene and mounted. 
NFB translocation was determined by positive staining of the acinar cell nuclei for the NFB p65 
subunit. Four random fields of view (FOV) were taken from each section with a 20x objective lens and 
the number of positively stained nuclei was averaged from the four FOVs. 
5.3.10 Statistical analysis 
Data are presented as means + S.E.M. Statistical analysis was performed using the Graphpad Prism 
Software version 5.03. Multiple comparisons were made using ANOVA with a Bonferonni post-hoc 
analysis. Comparisons of two data sets were made with an unpaired student’s t-test. A p value of less 
than 0.05 was considered significant. 
5.4 Results 
5.4.1 Pancreatic injury in acute pancreatitis 
Both WT and CSE KO mice showed typical effects of pancreatic injury following caerulein induced 
pancreatitis. They were characterized by pancreatic oedema, leukocyte infiltration, acinar cell necrosis 
and increased plasma amylase activity (413). 
The WT mice treated with caerulein showed significantly higher plasma amylase activity compared to 
the saline treated WT mice with means of 11351 ± 688 U/L and 1886 ± 117 U/L, respectively (p<0.05) 
(Figure 5.1 a). Pancreatic MPO activity was used as a measure of neutrophil infiltration and this was 
also higher in the WT caerulein mice with a mean fold increase of 19.7 ± 2.1 over the corresponding 
saline control (p<0.05) (Figure 5.1 b). Using the wet-to-dry weight ratio of the pancreas as a measure 
of oedema, the WT caerulein group showed a significantly higher level of oedema compared to the WT 
saline group with mean ratios of 5.0 ± 0.5 and 3.5 ± 0.1, respectively (p<0.05) (Figure 5.1 c). 
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The CSE KO mice treated with caerulein also showed higher levels of pancreatic injury in comparison 
to its saline treated control. There was a significantly higher level of plasma amylase in the caerulein 
treated CSE KO mice with a mean of 6731 ± 514 U/L compared to the CSE KO saline control with a 
mean of 2163 ± 229 U/L (p<0.05) (Figure 5.1 a). Pancreatic MPO levels of caerulein treated CSE KO 
mice were also significantly elevated with an 11.8 ± 1.6 fold increase over the corresponding saline 
treatment (p<0.05) (Figure 5.1 b). Although the pancreatic water content was elevated, this increase 
was not found to be significant (Figure 5.1 c). 
These increases in pancreatic injury were however, found to be less severe in the CSE KO mice 
compared to the WT. The KO caerulein group had significantly lower pancreatic MPO and plasma 
amylase activity than the WT caerulein group (p<0.05) (Figure 5.1 a-b). Pancreatic oedema, as 
measured by wet-to-dry ratios, was slightly elevated but not significantly different between the 


























































































Figure 5.1 Pancreatic injury in acute pancreatitis. Shows the effect of caerulein induced acute 
pancreatitis on A) plasma amylase levels, B) changes in pancreatic MPO activity and C) pancreatic 
oedema. Bars represent mean ± S.E.M. (n=4-11). * denotes significant difference between saline and 
caerulein treated mice of each mouse strain (p<0.05). # denotes significant difference between each 
mouse strain with the same treatment (p<0.05). 
Evidence of pancreatic oedema, leukocyte infiltration as well as acinar cell necrosis was present in 
pancreatic sections stained with hemaxtoxylin and eosin (Figure 5.2). Semi quantitation of these 
parameters according to scoring method developed by Schmidt et al (413) corroborated with the 
findings described above with higher pathological scoring in the WT caerulein treated mice compared 
to the CSE KO caerulein treated mice (Figure 5.3). Although the WT mice had higher scoring in all three 
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parameters of oedema, leukocyte infiltration and acinar cell necrosis as compared to the CSE KO mice, 







Figure 5.2 Haematoxylin & Eosin staining of pancreatic sections. Representative pancreatic sections 
show pancreatic injury as a result of cearulein-induced pancreatitis with oedema, leukocyte infiltration 
and acinar cell necrosis. Haematoxylin (purple) stains nucleic acids (cell nucleus) while eosin (pink) 





















































Figure 5.3 Semi quantitation of pancreatic damage based on H&E stained pancreatic sections. 
Pancreatic injury following caerulein-induced pancreatitis was scored based on a previously established 
method (413) that includes number of necrotic acinar cells per field of view (A), extent of pancreatic 
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oedema (B) and number of leukocytes present in the tissue (C). Bars represent mean ± S.E.M. (n=4). # 
denotes significant difference between WT and KO mice (p<0.05). 
5.4.2 Pancreatic hydrogen sulfide synthesizing activity in WT and CSE KO mice. 
CSE KO mice lacked expression of the CSE protein and showed substantially significant lower pancreatic 
hydrogen sulfide synthesizing activity in comparison to the WT mice (saline treated group) with means 
of 2.87 ± 0.37 and 8.70 ± 0.69 nmol/mg/30min, respectively (p<0.05) (Figure 5.4). This suggests that 
CSE is the major hydrogen sulfide synthesizing enzyme present in the pancreas and is supported by 
previous studies using PAG (66). Following caerulein stimulation, there was a significant ~1.33 ± 8 % 
fold increase in hydrogen sulfide synthesizing activity in the WT mice but this was not observed in the 
CSE KO mice. This implies an increase in CSE mediated hydrogen sulfide synthesizing ability following 
caerulein stimulation which is supported by a detectable increase in pancreatic CSE expression as 












































Figure 5.4 Pancreatic hydrogen sulfide synthesizing activity in WT and CSE KO mice. Pancreatic 
hydrogen sulfide synthesizing activity of WT and CSE KO mice, KO mice had significantly lower hydrogen 
sulfide synthesizing activity compared to the WT. WT hydrogen sulfide synthesizing activity increased 
following caerulein stimulation. Bars represent mean ± S.E.M. (n=5). * denotes significant difference 
between saline and caerulein treated mice of each mouse strain (p<0.05). # denotes significant 
difference between each mouse strain with the same treatment (p<0.05). 
5.4.3 Acute pancreatitis-associated lung injury 
Severe acute pancreatitis often results in the development of lung injury that closely resembles the 
acute respiratory distress syndrome (ARDS) associated with other processes such as shock, 
bacteraemia, ischemia/ reperfusion, and burns (414). In this study, WT mice treated with caerulein 
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showed significantly more MPO activity in the lungs compared to the saline treatment with a mean 
fold increase of 2.36 ± 0.94 (p<0.05) (Figure 5.5 a), demonstrating that leukocyte infiltration occurs 
following caerulein induced pancreatitis. The caerulein treated KO mice showed significantly less MPO 
activity in the lungs compared to the WT with a mean fold increase from each saline control group of 
1.30 ± 0.10 and 2.36 ± 0.28, respectively (p<0.05) (Figure 5.5 a). There was a significant difference in 
wet-to-dry ratios between the WT caerulein treated group compared with WT saline group with mean 
ratios of 4.80 ± 0.08 and 3.96 ± 0.18, respectively (p<0.05) (Figure 5.5 b). However the corresponding 





















































Figure 5.5 Acute pancreatitis associated lung injury. Significantly higher lung MPO activity and water 
content was detected in caerulein-induced WT mice compared to saline treatment. This was not 
observed in the CSE KO mice. Lung MPO activity in caerulein treated KO mice was significantly less 
compared to the corresponding WT mice. Bars represent mean ± S.E.M. (n=4-11). * denotes significant 
difference between saline and caerulein treated mice of each mouse strain (p<0.05). # denotes 
significant difference between each mouse strain with the same treatment (p<0.05). 
5.4.4 Pancreatic pro-inflammatory mediators 
As expected WT mice treated with caerulein showed significantly higher pancreatic levels of 
chemokines (MCP-1 & MIP-2), cytokine (IL-6) and eicosanoid (PGE2) compared to the WT saline group 
(p<0.05) (Figure 5.6). This was also observed in the KO mice with the exception of IL-6 which was not 
significantly elevated following caerulein treatment (Figure 5.6). However the extent of these increases 
were significantly lower in the KO mice in comparison to WT; PGE2 levels were 1.72 ± 0.47 ng/mg and 
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1.05 ± 0.05 ng/mg, MCP-1 were 83.0 ± 9.3 pg/mg and 53.0 ± 5.6 pg/mg and IL-6 were 54.1 ± 9.9 pg/mg 
and 21.8 ± 6.1 pg/mg in the caerulein treated WT and KO mice respectively (p<0.05) (Figure 5.6). MIP-
2 did not show a significant difference between the caerulein treated WT and KO mice, however the 































































































































































Figure 5.6 Pancreatic pro-inflammatory mediators. Caerulein induced pancreatitis resulted in a 
significant increase in pancreatic prostanoid and pro-inflammatory cytokines in the WT mice. The KO 
mice also showed significant increases in pancreatic PGE2, MCP-1, and MIP-2. Additionally there was 
a significant reduction in all these mediators in the KO mice compared to the WT following caerulein 
stimulation with the exception of MIP-2. Bars represent mean ± S.E.M. (n=5) * denotes significant 
difference between saline and caerulein treated mice of each mouse strain (p<0.05). # denotes 
significant difference between each mouse strain with the same treatment (p<0.05). 
5.4.5 NFB translocation in pancreatic acinar cells 
The most prevalent activated form of NFB is a heterodimer consisting of a p65 subunit and a p50 or 
p52 subunit, which contains transactivation domains necessary for gene induction (199). The active 
dimer translocates from the cytoplasm into the nucleus and activates transcription of targeted genes. 
Both WT and CSE KO saline treated mice had low basal NFB activation in pancreatic acinar cells as 
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evidenced by p65 immunostaining in the nuclei, 1.5 ± 0.4 and 2.2 ± 0.4 nucleus per field of view 
respectively (Figure 5.7). Following caerulein treatment, the number of p65 positive nuclei significantly 
increased in both the WT and CSE KO mice, 14.4 ± 1.3 and 8.8 ± 1.0 respectively (p<0.05) (Figure 5.7). 
The caerulein treated CSE KO mice however had significantly less p65 positive nuclei in comparison to 
the corresponding WT mice (p<0.05) (Figure 5.7). This indicates a lower level of pancreatic acinar cell 





































Figure 5.7 NFB activation in pancreatic acinar cells. Section were immunostained for the p65 subunit 
of NFB (brown) and nulcei were lightly counterstained with haematoxylin (purple).Inactivated p65 
remains in the cytoplasm and translocates to the nucleus upon activation. Activated cells were 
determined by p65 positive staining of the nucleus highlighted by the arrows. Caerulein treatment 
resulted in a significant increase in NFB activation for both WT and CSE KO mice. However there was 
a significant reduction in the CSE KO mice in comparison to the WT. Bars represent mean ± S.E.M. (n=4-
5). * denotes significant difference between saline and caerulein treated mice of each mouse strain 
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(p<0.05). # denotes significant difference between each mouse strain with the same treatment 
(p<0.05). 
5.4.6 Pancreatic acini response to caerulein stimulation 
Caerulein hyperstimulation of WT pancreatic acini resulted in increased MCP-1 (1.45 ± 0.09 fold 
increase) and LTB4 (1.47 ± 0.09 fold increase) release. MCP-1 and LTB4 are mediators of the innate 
immune response by serving as potent chemoattractants to innate response cells (415, 416). Caerulein 
mediated release of MCP-1 by pancreatic acini has been previously reported in rat acini (291), however 
this is the first report that shows direct elicitation of LTB4 release by hyperstimulated pancreatic acini. 
As with the in vivo findings (Figure 5.6b), CSE deletion resulted in attenuated MCP-1 secretion (1.45 ± 
0.09 versus 1.18 ± 0.03 fold increase) by caerulein stimulated pancreatic acini and this was also 













































Figure 5.8 MCP-1 and LTB4 release by WT and CSE KO pancreatic acinar cells in response to caerulein 
hyperstimulation. Freshly isolated pancreatic acini fragments from WT and CSE KO mice were treated 
with saline or caerulein (100 nM) for 1 h followed by detection of MCP-1 and LTB4 in the supernatant. 
Caerulein treated pancreatic acini from WT mice showed a significant increase in MCP-1 and LTB4 
release over saline control. MCP-1 and LTB4 release in caerulein treated CSE KO acini was significantly 
lower than the corresponding WT. Bars represent mean ± S.E.M. (n=3) * denotes significant difference 
between saline and caerulein treated mice of each mouse strain (p<0.05). # denotes significant 
difference between each mouse strain with the same treatment (p<0.05). 
5.5 Discussion 
This chapter describes the use of CSE KO mice in a model of acute pancreatitis to elucidate the role of 
CSE/endogenous hydrogen sulfide in inflammation. In this study, caerulein was used to induce 
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pancreatitis in CSE KO mice and their corresponding WT mice. Similar comparative experiments were 
carried out on freshly isolated pancreatic acini hyperstimulated with caerulein. From this we have 
shown that CSE KO mice have significantly less inflammation and subsequent tissue damage than their 
WT counterparts, suggesting that CSE facilitated production of hydrogen sulfide is a regulator of the 
immune system function and that inhibiting CSE may be useful in the clinical setting for treating auto-
inflammatory conditions like pancreatitis. 
5.5.1 CSE genetic deletion versus pharmacological inhibition 
Currently, PAG is the most widely used inhibitor of endogenous hydrogen sulfide synthesis derived 
from CSE. It is a useful pharmacological inhibitor that has so far contributed to expanding our 
knowledge of the role of endogenous hydrogen sulfide under normal and pathological conditions. 
Studies using PAG have suggested that CSE is a major contributor towards increased circulating and 
tissue hydrogen sulfide as well as tissue hydrogen sulfide synthesizing activity in several models of 
inflammation (44, 45, 69, 189, 217). PAG inhibition of endogenous hydrogen sulfide synthesis have 
shown therapeutic effects in models of LPS induced endotoxaemia (44, 216), severe acute pancreatitis 
(66, 69), poly-microbial sepsis (189), burn-injury (45) and renal-injury (217, 218); however there have 
been studies in colitis (221), knee-joint synovitis (222) and liver-injury (223) that yielded contradicting 
results. However, the use of PAG as a specific CSE inhibitor has been implicated as a possible 
confounding factor due to its non-specific inhibition of other pyridoxal-5-phosphate dependent 
enzymes and the apparent pleiotropic effect of hydrogen sulfide could be partly due to this lack of 
specificity (discussed further in 1.5.4). This emphasises the importance of the present study, by using 
KO mice we have specifically targeted the CSE-hydrogen sulfide pathway. In doing so we have 
elucidated the direct effects of this pathway on pancreatitis without the possibility of the non-specific 
effects as seen with PAG based interventions. 
A point to note however, is apart from just abolishing hydrogen sulfide synthesis derived from CSE, 
Ishii et al have also reported increased circulating cystathionine, homocysteine and methionine levels 
as well as a reduction in taurine levels in the knockout mice compared to the wild type (19). The levels 
of homocyteine were substantially higher but not at pathological levels reported in 
hyperhomocystenemia that is associated with a pro-inflammatory state (417-419) resulting in 
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development of atherosclerosis (419-421). Increase in circulating cystathionine and methionine have 
been reported in septic rats (422) and administration of cystathionine has been shown to be protective 
against liver and mucosal injury, presumably via increased synthesis and availability of cyst(e)ine and 
its antioxidative derivatives such as GSH (423, 424). However, in a CSE knockout mouse, the 
hypothesized beneficial antioxidative effect of GSH derived from cystathionine is not possible due to 
the inability to convert cystathionine to cysteine. Taurine, on the other hand, has been shown to be an 
anti-oxidant and play a protective role in tissue protection against oxidative damage (425, 426). Taken 
together, the protective effect of CSE deletion in pancreatitis is most probably not due to the reported 
derangement in circulating amino acids. Additionally, the absence of CSE did not substantially affect 
GSH levels as dietary supplementation of cysteine was adequate at keeping levels similar to that of 
wild types (427). 
5.5.2 The role of CSE in pancreatic hydrogen sulfide synthesis and pancreatitis 
CSE KO mice showed substantially less pancreatic hydrogen sulfide synthesising capacity compared to 
the WT mice (Figure 5.4). This would suggest CSE to be the major (but not the only) enzyme responsible 
for hydrogen sulfide synthesis in the pancreas. Interestingly, there does not seem to be functional 
compensation by other hydrogen sulfide synthesizing enzymes (CBS and 3MST) in the CSE KO mice 
pancreas to increase the hydrogen sulfide synthesizing activity to the levels measured in the WT mice. 
Furthermore, upon induction of acute pancreatitis with caerulein, while the WT mice showed higher 
levels of pancreatic hydrogen sulfide synthesizing enzyme activity as well as CSE expression, whereas 
there was no difference in hydrogen sulfide synthesizing enzyme activity between the saline and 
caerulein treated CSE KO mice (Figure 5.4). This confirms that CSE is the major enzyme responsible for 
the increase in pancreatic hydrogen sulfide synthesis in inflammation. 
There was a significant protection against acute pancreatitis in CSE KO mice compared to the WT mice. 
In all parameters of pancreatitis analysed we found the KO mice were less severely affected by 
caerulein including hyperamylasemia, pancreatic MPO activity (an indicator of neutrophil infiltration) 
and pancreatic water content (an indicator of pancreatic edema) (Figure 5.1). As well as the histological 
analysis of pancreas sections (Figure 5.3) which showed significant reductions in acinar cell necrosis 
and oedema scores in the CSE KO mice compared to the WT mice. 
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5.5.3 Mechanisms of CSE/endogenous hydrogen sulfide regulation of the immune response 
in pancreatitis 
5.5.3.1 CSE/endogenous hydrogen sulfide -substance P release (neurogenic inflammation) 
Recent findings suggest possible mechanisms by which hydrogen sulfide may contribute to the 
inflammatory response observed during pancreatitis at the acinar cell level. It has been shown that 
caerulein hyper stimulation in acinar cells increases CSE expression as well as hydrogen sulfide 
synthesis in the tissue. Furthermore, inhibition of CSE with PAG significantly attenuate caerulein-
induced upregulation of substance P and its receptor neurokinin-1 receptor (NK-1R) in pancreatic acini 
(304). Substance P is a known neurogenic inflammatory mediator that has been shown to play a 
deleterious role in acute pancreatitis (305). It has been shown to directly elicit acinar cell chemokine 
secretion (294), induce pancreatic microcirculatory dysfunction (428) and upregulate pancreatic cell 
adhesion molecule expression (429) in response to caerulein hyper stimulation, thus promoting 
leukocyte recruitment and contributing to the inflammatory response. Therefore inhibition of 
endogenous hydrogen sulfide synthesis in acinar cells could decrease the generation of substance P 
and subsequent leukocyte recruitment. Previous in-vivo findings have shown PAG to attenuate 
hydrogen sulfide and substance P synthesis in the pancreas, plasma and lungs of caerulein induced 
mice (244). In this study we have shown that CSE KO mice have lower MPO activity following acute 
pancreatitis indicating decreased leukocyte recruitment. These findings would further support the 
hypothesis of hydrogen sulfide acting as a positive upstream regulator of substance P expression thus 
contributing to the inflammatory response observed in pancreatitis.  
5.5.3.2 CSE/endogenous hydrogen sulfide - NFB activation 
Increased acinar cell hydrogen sulfide synthesis has been shown to be associated with activation of 
NFB (319, 360). In pancreatic acinar cells, this hydrogen sulfide mediated activation of NFB has been 
thought to occur via activation of Src family kinase (SFKs) (319) and substance P mediated activation 
of TLR-4 receptor (360); while hydrogen sulfide has also been reported to directly sulfhydrate cysteine-
38 of p65, enhancing its binding to the coactivator RPS3 resulting in its activation in macrophages (142). 
Pancreatic NFB activation has been closely linked to the pathogenesis of pancreatitis; its activation 
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has been reported in multiple models of pancreatitis resulting in an upregulation of a plethora of pro-
inflammatory cytokines, chemokines and cell adhesion molecules (reviewed in (430)). In this study we 
have shown a reduction of NFB activation in the pancreatic acinar cells of CSE deficient mice in 
response to pancreatitis (Figure 5.7) as well as the reduction of NFB dependent cytokines, IL-6, MCP-
1 and MIP-2 (Figure 5.6). MCP-1 and MIP-2 are potent chemoattractants that are synthesized by 
pancreatic acinar cells in response to caerulein as well as substance P stimulation (294). Their reduction 
could account for the decreased leukocyte infiltration observed in the CSE KO mice of this study via 
the proposed hydrogen sulfide - substance P - NFB pathway (319, 360). IL-6 however plays a more 
complex role in inflammation as it is thought to not only mediate the acute phase innate immune 
response but also direct the transition to an acquired response thus promoting resolution. However, 
pancreatitis is a non-pathogenic inflammatory event that resembles a more autoimmune like response 
in which case IL-6 is found to play a deleterious role (reviewed in (431)). Indeed high levels of serum 
IL-6 is strongly correlated with severe forms of pancreatitis that leads to greater morbidity and 
mortality (432) though the exact mechanism by which it exerts its effect is not clearly defined. 
5.5.3.3 CSE/endogenous hydrogen sulfide - leukocyte recruitment 
PGE2 is an eicosanoid that promotes vasodilation leading to edema as well as modulates immune 
response cells (323). Increased pancreatic and serum levels of PGE2 have been reported in pancreatitis 
(433-435) and their inhibition results in a protection against inflammation (434, 436). In this study, we 
have detected a significant reduction in pancreatic PGE2 level in the CSE KO mice compared to the WT 
in response to caerulein stimulation (Figure 5.6). This is in agreement with previous studies that show 
an hydrogen sulfide dependent increase in PGE2 and its metabolites in inflammatory models of sepsis 
(437) and hind-paw edema (438). This reduction could account for the observed reduction in edema 
and leukocyte infiltration. Furthermore, the concomitant decrease in MCP-1 could also be attributed 
to the recent evidence that shows PGE2 as a positive modulator of pancreatic acinar cell MCP-1 
synthesis and secretion (439). Taken together, these findings suggest a possible new mechanism by 
which hydrogen sulfide may play a significant upstream role in the acinar cell inflammatory response 
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via modulation of prostanoid levels thus leading to increased chemokine production and subsequent 
recruitment of leukocytes. 
MCP-1 and LTB4 are potent chemoattractants that recruit innate response cells to a site of 
inflammation (415, 416). Here I have shown that 1 h caerulein stimulation resulted in significant 
release of MCP-1 and LTB4 (~1.5 fold, Figure 5.8) in WT pancreatic acini. The release of these molecules 
could be one of the factors that contribute to the massive recruitment of inflammatory cells into the 
pancreas, a key feature of this disease. CSE gene deletion resulted in an almost complete attenuation 
of this observed response and suggests that CSE expression/endogenous hydrogen sulfide may play a 
key role in the progression of the pancreatitis associated inflammatory response at the acinar cell level. 
A point to note here is that I was unable to detect changes in CSE expression levels in primary isolated 
pancreatic acini upon 1 h caerulein stimulation (refer to section 3.4.2). Therefore the observed 
increase in MCP-1 and LTB4 release by wild-type pancreatic acini may not be due to increased hydrogen 
sulfide production via CSE upon caerulein stimulation. However, the decreased MCP-1 and LTB4 release 
by CSE knockout pancreatic acini could be related to the pre-existing lower state of hydrogen sulfide 
exposure. The presence of basal CSE/endogenous hydrogen sulfide in the wild-type pancreatic acini 
could establish a basal ‘hydrogen sulfide modified environment’, i.e. in the form of s-sulfhydrated 
proteins, and in doing so prime these cells towards pathological or inflammatory cues. 
5.5.3.4 Acute pancreatitis associated lung injury 
Severe acute pancreatitis often results in the development of lung injury that closely resembles the 
acute respiratory distress syndrome (ARDS) associated with other processes such as shock, 
bacteraemia, ischemia/ reperfusion, and burns (414). In this study, we found substantial protection in 
the lungs of CSE KO mice compared to the WT mice after 10 h of caerulein administration. There was 
significantly lower lung MPO activity and water content in the KO caerulein group compared to the WT 
group (Figure 5.5). Similar lung protection has been reported in mice treated with NK-1R receptor 
antagonist, CP-96345 (440) and NK1-R receptor knockout mice (305). Therefore the observed lung 
protection in this study could be the result of hydrogen sulfide acting as an upstream regulator of 




In conclusion, the results presented in this chapter show that CSE/endogenous hydrogen sulfide plays 
a key pro-inflammatory role in caerulein induced pancreatitis and that the deletion of this gene results 
in significant protection against acute pancreatitis and associated lung injury. These findings were 
published (441) around the same time as two others (398, 442) and represent the initial reports using 
genetically deficient mice to determine the role of CSE in disease models of inflammation. This study 
also shows that CSE contributes to inflammation in acute pancreatitis at the acinar cell level through 
increased eicosanoid and chemokine synthesis possibly via NFB activation which could contribute to 
the recruitment and activation of immune response cells. This would also imply that hydrogen sulfide, 
a product of CSE, could potentially be mediating these effects. However more work needs to be done 
to establish that these effects are indeed directly related to hydrogen sulfide. 
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6 Discussion and future work 
The aims of this thesis were to investigate the dysregulation of CSE expression and its effect in the 
inflammatory response as well as to correlate these findings with changes in endogenous hydrogen 
sulfide levels. This was accomplished using macrophages in culture and a murine model of acute 
pancreatitis. My findings have shown upregulated CSE expression in pancreatic acini and macrophages 
in association with pancreatitis. These results also show that CSE contributed to the severity of the 
disease. However I was unable to correlate CSE expression with endogenous free hydrogen sulfide 
directly or indirectly as s-sulfhydrated proteins. 
6.1 CSE expression in pancreatitis and the associated inflammatory response: a 
role for endogenous hydrogen sulfide 
CSE dysregulation has been reported in various models of disease and injury (44, 45, 189, 217, 223, 
325-330) but not in pancreatitis at the time this thesis was conceived and carried out apart from an in 
vitro study that showed increased pancreatic acini CSE expression in response to caerulein 
hyperstimulation (304). Here, I have shown that CSE is upregulated in the exocrine portion of the 
pancreas in acute pancreatitis along with increased pancreatic hydrogen sulfide synthesizing activity. 
These findings are corroborated by a recent report in rats using a more severe model of pancreatitis 
(69). However I was unable to detect increased CSE expression in caerulein hyperstimulated pancreatic 
acini in vitro and this could be due to experimental differences and limitations (discussed in section 
2.4.5). Apart from the pancreas, I have also detected increased CSE expression in macrophages 
stimulated with plasma from pancreatitic mice. This result provides the only insight so far into 
macrophage-CSE expression in pancreatitis. 
In spite of numerous studies pointing to CSE dysregulation in models of diseases (44, 45, 69, 189, 217, 
223, 325, 327, 329, 330, 395, 398), there is very little evidence of this relating directly to changes in 
endogenous/tissue hydrogen sulfide levels (328, 394). Therefore the initial interest of this thesis was 
to develop a stronger correlation between observed dysregulation in tissue CSE expression with 
endogenous levels hydrogen sulfide in response to inflammation. However there were issues with 
developing a suitable high-throughput assay that would be specific enough as described in chapter 2. 
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An added layer of complexity is the interaction of hydrogen sulfide within the biological milieu; 
hydrogen sulfide is reported to have a high turnover rate in tissue homogenates with half-lives of 
between 2 to 6 mins depending on tissue type (33). This rapid disappearance of hydrogen sulfide has 
also been demonstrated in this thesis using liver homogenate (refer to 2.3.7). The disappearance of 
hydrogen sulfide was quicker under aerobic conditions due to oxidation resulting in formation of 
thiosulfate and sulfate (33). However, significant depletion was also observed under anaerobic 
conditions (32, 33) thus suggesting other means of hydrogen sulfide consumption/clearance. Two 
potential means of hydrogen sulfide consumption are through reduction of oxidised protein thiols 
(protein s-sulfhydration)(31, 344) or interaction with metal ion proteins (133, 134). A simple protein 
solution of 5% BSA (contains 2 free thiols per molecule and known to form intermolecular disulfide 
bonds) has been shown to rapidly ‘consume’ spiked hydrogen sulfide under anaerobic conditions thus 
further supporting the notion of interaction between hydrogen sulfide and proteins (32). This protein 
bound sulfane sulfur is also thought to be a store of endogenous hydrogen sulfide and has been shown 
to be released under reducing conditions in the brain (28). This highlights the complexity of estimating 
endogenous free hydrogen sulfide due to rapid turnover and contribution from labile sources; this also 
implies a current underestimation of endogenous hydrogen sulfide synthesising rate. As such, I had 
sought to use protein s-sulfhydration as an indirect measure of endogenous hydrogen sulfide levels. 
Another benefit of doing so was the potential of discovering possible hydrogen sulfide targets that are 
modified in the inflammatory response. 
I elected to use a published biotin switch technique of labelling s-sulfhydrated proteins (31) as well as 
its variant, a biotin tag-switch technique that was reported to be more specific (344). Both methods 
involved an initial tagging/blocking of thiols and subsequent labelling of the intended target (protein 
persulfides with an R-S-SH group) with a biotin molecule (described in further detail in section 2.1.2). 
The proteins can then be separated on a western blot and readily probed for direct visualisation. This 
method provides a global overview of all proteins and was therefore an appealing choice since there 
is very little known about protein s-sulfhydration, particularly in the inflammatory context. However I 
was unsuccessful in replicating the protein s-sulfhydration assays based on previously published 
methods (31, 344) using the positive controls described, despite following the laboratory protocol sent 
by the authors.  
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There was substantial signal, however I was unable to detect changes in signal following treatment of 
tissue lysates with hydrogen sulfide (as a positive control) utilising these methods (Figure 2.9). Further 
investigation to try and decrease background signal by increasing MMTS concentration (R-SH blocker), 
decreasing protein ratio as well as varying SDS concentration to modulate protein denaturation (to 
expose free thiols) did not substantially alter or lower the background signal (Figure 8.7). I 
subsequently tried using another thiol blocker, NEM that has been reported to alkylate both R-SH as 
well as R-S-SH and is an irreversible method of blocking free thiols, again there was no change in 
background signal (Figure 8.7). Therefore the evidence points to a possible limitation in the protocol 
that prevents complete blocking of all endogenous free thiols (includes both R-SH as well as R-S-SH). 
Another possibility could be the unfavourable redox state of the protein thiols or hydrogen sulfide 
donor (sodium sulfide). As described in 1.4.2, the sulfur atom from either the thiol group of a protein 
or hydrogen sulfide has to be in a more oxidised state relative to each other in order for a nucleophilic 
attack to occur resulting in the formation of a protein persulfide. Endogenous protein thiols can 
undergo oxidation by reactive oxygen species to form protein sulfenic acids, however basal levels are 
thought to be low as there are numerous mechanisms in place to effectively scavenge reactive oxygen 
species under non-stressed conditions (443, 444). Additionally, the protein sulfenic acids are transient 
and labile. Therefore it would be unlikely that the proteins thiols present in the homogenate of the 
assay would assume the role of the oxidant in the formation of protein persulfides, and if so would 
only constitute a small fraction of the total proteins present. Therefore if the protein thiols are 
predominantly present in the reduced state, the source of hydrogen sulfide should be in a more 
oxidised state for the protein persulfides to form. Sodium sulfide, the source of hydrogen sulfide, 
readily dissolves in solution to form H2S as well as HS-, both of which possess sulfur in the -2 oxidation 
state which is identical to the oxidation state of sulfur in a reduced protein thiol (R-SH), therefore 
making the formation of protein persulfides impractical. However, Nagy et al have reported that the 
commonly used hydrogen sulfide donor, sodium hydrosulfide (NaHS), contains oxidised products such 
as polysulfides which have been suggested to be responsible for oxidation of protein thiols and in this 
case the formation of protein persulfides (74). Sodium sulfide is reported to be a purer form with some 
oxidation on the outer surface of the crystals that is removed by rinsing with water (34), which was 
the standard practice throughout this thesis. Although soluble hydrogen sulfide is susceptible to 
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oxidation by air, this is a slow process that can be catalysed by the presence of metal ions, however 
excess amounts of metal chelators were used in the s-sulfhydrtion expreiments. Taken together, the 
choice of using hydrogen sulfide in its ‘pure’ form could have been a possible reason for not observing 
protein persulfide formation in this thesis. However, this does not mean that endogenous protein 
persulfide formation is not possible, particularly under inflammatory conditions, as large amounts of 
reactive oxygen species are generated leading to oxidative stress and significant increase in protein 
sulfenic acid formation (443-445). 
Having not been able to measure changes in endogenous hydrogen sulfide or protein persulfide levels, 
I will discuss the implications of CSE upregulation on hydrogen sulfide production in the pancreas and 
macrophages in response to pancreatitis in the following sections. CSE is classically known for its 
canonical role in the transsulfuration pathway for the conversion of cystathionine to cysteine, -
ketobutyrate and ammonia. This also represents the sole pathway for endogenous synthesis of 
cysteine; an amino acid required for protein synthesis and the production of other essential molecules 
that include GSH, coenzyme A, taurine, and inorganic sulfur (446). Apart from cysteine synthesis, CSE 
is also capable of generating hydrogen sulfide as a by-product through cysteine-dependent  and 
homocysteine-dependent -reactions (21). Among them, the ,-elimination of cysteine accounts for 
~70% of hydrogen sulfide synthesis under physiological concentrations of cysteine (100 M) and 
homocysteine (10 M) (21). Cysteine is the direct substrate for hydrogen sulfide synthesis via CSE as 
well as the precursor to GSH and taurine synthesis through additional enzymes. This creates a 
competition between GSH, taurine and hydrogen sulfide synthesis from cysteine and the balance 
between substrate-enzyme-product levels determines which molecule(s) is/are made at any one point 




Figure 6.1 Products of CSE mediated pathways. The canonical role of CSE is through the 
transsulfuration pathway leading to endogenous cysteine synthesis. Cysteine is used as a substrate GSH 
synthesis and excess cysteine converted to hypotaurine and taurine, a less toxic product. GSH and 
taurine possess antioxidant properties. Cysteine also functions as a substrate for CSE to yield hydrogen 
sulfide via an alternative pathway. hydrogen sulfide has been shown to have both pro and anti-
inflammatory effects. The balance and shift between CSE mediated synthesis of taurine, GSH and 
hydrogen sulfide depends on the levels of substrate, enzyme and product at any one point (447). (1) 
Betaine homocysteine methyltransferase (2) Methionine adenosyl transferase (3)Methyl transferase 
(4) Adenosyl homocysteinase (5) Cystathoinione -synthase (6) Cysteine dioxygenase (7) Aspartate 
aminotransferase (8) Cysteinesulfinate decarboxylase (9) unknown (10) -Glutamyl cysteine synthetase 
(11) GSH synthetase. 
6.1.1 Pancreatitis induced CSE upregulation in the pancreas 
The results of this thesis have shown the capacity for substantial hydrogen sulfide production in wild 
type pancreatic homogenate (17.4 nmol / mg protein/ h) which was increased (~1.3 fold) upon 
induction of acute pancreatitis (refer to 3.4.1). In pancreatitis, there is a diminished level of pancreatic 
(448) and circulating cysteine (449). This is concomitant with a lowering of GSH levels too probably due 
to increased oxidative stress (450). GSH depletion has been shown to increase CSE expression thus 
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promoting flux through the transsulfuration pathway to increase GSH synthesis (451). This could be a 
reason for the observed upregulation in pancreatic exocrine CSE expression shown in this thesis. This 
would also suggest that the availability of cysteine for hydrogen sulfide synthesis via CSE could be 
limited as it is redirected to support antioxidative mechanisms via GSH and taurine synthesis. However 
it is interesting to note that prevention of cysteine depletion in rats with pancreatitis did not reverse 
GSH loss (448) which could suggest that the impaired GSH production is independent of cysteine levels 
in pancreatitis and the balance of pancreatic cysteine consumption could therefore shift to either 
taurine or hydrogen sulfide synthesis. However it is difficult to speculate as there are currently no 
reports of pancreatic taurine or hydrogen sulfide levels (due to the difficulty in detecting free hydrogen 
sulfide as previously described in chapter 2) in response to pancreatitis. It is unclear at this juncture as 
to the direct consequence of increased pancreatic exocrine CSE expression in pancreatitis and if it 
would serve to alter endogenous taurine, GSH or hydrogen sulfide synthesis. However, the significantly 
impaired pancreatic hydrogen sulfide synthesising ability in CSE knockout mice (refer to section 5.4.2) 
suggests there could be an effect of basal pancreatic hydrogen sulfide levels that would influence the 
ability of the tissue/cells to respond to inflammatory stimuli. For example, I have shown that primary 
isolated pancreatic acini did not upregulate CSE expression upon 1 h caerulein stimulation; however, 
acini lacking the CSE gene had impaired inflammatory response as shown by decreases in chemokine 
and eicosanoid release (refer to section 5.4.6). However, the decreased inflammatory response 
observed in CSE knockout pancreatic acini could be related to the pre-existing lower state of hydrogen 
sulfide exposure. The presence of basal CSE/endogenous hydrogen sulfide in the wild-type pancreatic 
acini could establish a basal ‘hydrogen sulfide modified environment’, i.e. in the form of s-sulfhydrated 
proteins, and in doing so prime these cells towards pathological or inflammatory cues. 
6.1.2 Pancreatitis induced CSE upregulation in the macrophage 
Currently, there is only one report that shows macrophage hydrogen sulfide synthesizing ability in real-
time using a miniaturized hydrogen sulfide micro-respiration sensor under saturating levels of L-
cysteine and PLP and this is increased upon LPS stimulation (55). Macrophages possess the plasma 
membrane cystine transporters, System xc-, therefore enabling the import of extracellular cystine 
which is readily reduced to cysteine under the reducing intracellular environment (452). Plasma 
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contains substantial levels of cysteine (100 – 200 M) and activated macrophages have been shown 
to actively import cystine and release almost equivalent amounts of cysteine (453-455). This large 
influx of cysteine is partly utilised for GSH synthesis though there have been no reports of intracellular 
taurine synthesis although macrophages have been shown to import taurine via taurine transporters 
instead (426). Therefore we could infer that there is a readily available pool of intracellular cysteine in 
macrophages independent of CSE mediated cysteine synthesis via the transulfuration pathway. In fact 
the increase in CSE expression and high intracellular cysteine levels following macrophage activation 
is ideal for hydrogen sulfide synthesis because there is not a need for intracellular cysteine synthesis 
via CSE and cysteine is the preferred substrate for endogenous hydrogen sulfide synthesis via ,-
elimination by CSE (21), particularly due to the lack of CBS expression in macrophages (refer to section 
4.4.2). Taken together, this suggests that the upregulation of CSE in activated macrophages would 
most likely result in the production of hydrogen sulfide and the elicitation of its effects. This also 
highlights the relevance of CSE/endogenous hydrogen sulfide to the inflammatory response as 
macrophages are an important component of the innate immune cells that drive the inflammatory 
response. 
6.2 Role of CSE in acute pancreatitis and associated inflammatory response 
6.2.1 The effect of CSE gene deletion on the severity of acute pancreatitis  
In order to determine the role of CSE in an inflammatory response, I have compared the effect of CSE 
gene deletion in mice using acute pancreatitis as the disease model. Mice genetically deficient in CSE 
displayed normal physical characteristics when fed standard laboratory chow containing L-cysteine 
(16). These mice developed pancreatitis upon induction with caerulein showing typical signs of the 
disease such as elevated plasma amylase levels (a measure of pancreatic dysfunction), increased 
pancreatic and lung MPO activity (a measure of neutrophil infiltration), as well as acinar cell necrosis 
and pancreatic oedema (a measure of pancreatic injury) (refer to sections 5.4.1 and 5.4.3). However 
the magnitude of disease severity was significantly lower when compared to wild type (WT) control 
mice using the parameters described. 
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These results inconvertibly show that CSE plays a pro-inflammatory role in acute pancreatitis. Earlier 
studies (66, 69, 318), using PAG as a pharmacological inhibitor, have indicated that hydrogen sulfide 
synthesised by CSE acts as a pro-inflammatory mediator. However a key contribution of the present 
findings is the use of genetic deletion as opposed to PAG which is known to inhibit other pyridoxal-5-
phosphate dependent enzymes that could directly or indirectly affect the inflammatory response 
(reviewed in (243). A point to note is that apart from just abolishing hydrogen sulfide synthesis derived 
from CSE, substantial increase in circulating cystathionine and homocysteine levels as well as a 
decrease in taurine levels were observed in knockout mice compared to wild type (19). Nonetheless, 
the protective effect of CSE deletion in acute pancreatitis is most probably not due to the reported 
derangement in circulating amino acids; the levels of homocyteine were not at pathological levels 
reported in hyperhomocystenemia (417-419), the hypothesized beneficial antioxidative effect of GSH 
derived from cystathionine (423, 424) is not possible due to the inability to convert cystathionine to 
cysteine, taurine, on the other hand, has been shown to be an anti-oxidant and play a protective role 
in tissue protection against oxidative damage (425, 426) (discussed in section 5.5). 
These findings were published (441) around the same time as two others (398, 442) and represent the 
initial reports using genetically deficient mice to determine the role of CSE in disease models of 
inflammation. The other two reports (398, 442) used CSE deficient mice that were developed by Yang 
et al 2008 (237). Zhang et al 2013 used a model of ovalbumin (OVA)-induced acute asthma and showed 
aggravated airway hyperresponsiveness (AHR), increased airway inflammation, and elevated levels of 
Th2 cytokines in bronchoalveolar lavage fluid after OVA challenge in the CSE deficient mice (398). This 
corroborates with a previous finding that exogenous hydrogen sulfide mitigates the severity of asthma 
(397); however there has not been any prior studies using PAG as a CSE inhibitor in animal experiments 
of asthma to compare with. The second report has shown CSE to protect against renal ischemia-
reperfusion injury presumably by modulating oxidative stress through the production of hydrogen 
sulfide.(442). Again this corroborates with previous findings using a similar ischaemia-reperfusion 
injury model of the kidney with exogenous hydrogen sulfide (228, 247) as well as PAG (124). However 
there are two reports that show a detrimental effect of CSE using gentamicin (218) and cisplatin (217) 
as an inducer of renal injury. Taken together, these gene deletion and pharmacological inhibition 
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studies suggest that CSE does play a role in the inflammatory response; however, the effect of CSE 
inhibition/deletion could vary with the method of disease induction and the targeted organ of damage. 
6.2.2 The effect of CSE gene deletion on the inflammatory response in acute pancreatitis: 
possible roles for endogenous hydrogen sulfide 
An interesting feature of acute pancreatitis is the massive infiltration of leukocytes into the pancreas 
stemming from an uncontrolled immune response. This unleashes the arsenal of tissue destructive 
machinery from the innate immune response cells leading to extensive pancreatic damage and if not 
contained, would result in distant organ damage. Chemokines and leukotrienes are key molecules that 
serve as potent chemoattractants as well activators of leukocytes (416, 456). These molecules are 
synthesised and released in large quantities by activated leukocytes as a means of propagating the 
inflammatory response and has been shown to be elevated in the pancreas during pancreatitis (435, 
457, 458). Although activated leukocytes are the predominant source of chemokines and leukotrienes 
in an inflammatory response, pancreatic acinar cells have also been shown to release chemokines 
MCP-1 and MIP-2 upon caerulein stimulation in vitro (291, 294) though there are no reports on 
leukotriene release as yet. Here, I have shown that stimulation of pancreatic acini with 100 nM 
caerulein for 1 h elicited MCP-1 as well as LTB4 release (refer to section 5.4.6) which could contribute 
to the recruitment and activation of resident and peritoneal macrophages thus initiating the 
inflammatory response. The caerulein induced release of these molecules was substantially reduced 
with CSE gene deletion (refer to section 5.4.4); this could possibly explain the observed decrease in 
pancreatic leukocyte infiltration during pancreatitis thus reducing the extent of pancreatic damage and 
severity of the disease. Attenuation of other classical pro-inflammatory mediators such as the cytokine, 
IL-6 and prostanoid, PGE2 were also observed in the pancreas with CSE gene deletion (refer to section 
5.4.4) and this could be a consequence of lessened disease severity due to lowered pancreatic 
leukocyte recruitment. 
However, a recent report has shown PGE2 as a positive modulator of pancreatic acinar cell MCP-1 
synthesis and secretion (439) thus suggesting that CSE modulation of eicosanoids could be an upstream 
event leading to increased and subsequent MCP-1 synthesis and release in pancreatic acinar cells. The 
initial step in PGE2 and eicosanoid synthesis involves the hydrolysis of membrane glycerophospholipids 
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to arachidonic acid, cytosolic phsopsholipase A2 (cPLA2) is the main enzyme responsible for this 
initiating step and its activation is a major controlling point in the synthesis of eicosanoids (459, 460). 
cPLA2 requires Ca2+ binding for activation (459), endogenously synthesised hydrogen sulfide has been 
shown to increase intracellular Ca2+ levels in pancreatic acinar cells in a concentration dependent 
manner (320). Taken together, the ability for endogenous hydrogen sulfide to modulate pancreatic 
acini intracellular Ca2+ levels offers a possible mechanism for CSE mediated increase in pancreatic MCP-
1 synthesis via PGE2. 
Substance P is a known neurogenic inflammatory mediator that has been shown to play a deleterious 
role in acute pancreatitis (305). The pancreas is innervated with substance P containing peripheral 
nerves (461, 462) and the release of substance P from these nerve endings is mediated by extracellular 
calcium influx (463) via ion channels (464, 465). hydrogen sulfide has been shown to activate a variety 
of ion channels (reviewed in (466)) and among them the nociceptive ion channels TRPA1 (105, 112, 
113) and TRPV1 (114) (79, 198) which are known to induce substance P release (462, 467-469). 
Previous in-vivo and in vitro findings have shown PAG to reduce hydrogen sulfide and substance P 
synthesis in the pancreas and isolated pancreatic acini of caerulein induced pancreatitic mice (244) 
and cells (304) respectively. Taken together, this would suggest another possible mechanism by which 
CSE could contribute to the inflammatory response via hydrogen sulfide activation of ion channels on 
peripheral neuron endings resulting in release of substance P thus causing neurogenic inflammation. 
Substance P has been shown to stimulate chemokine release in pancreatic acinar cells (294) such as 
MCP-1 and MIP-2 which correlates with findings in this thesis. 
NFB represents a family of transcription factors that plays an important role in inflammation by 
promoting the transcription of pro-inflammatory genes (199). Pancreatic NFB activation has been 
closely linked to the pathogenesis of pancreatitis and its activation has been reported in multiple 
models of pancreatitis (reviewed in (430)). Substance P has been shown to activate NFB in pancreatic 
acinar cells (294, 470). Here I have shown that CSE gene deletion results in reduced NFB activation in 
pancreatic acinar cells in acute pancreatitis (refer to section 5.4.5). Taken together, this would suggest 
a CSE-substance P-NFB dependent pathway as a mechanism by which endogenous hydrogen sulfide 
could contribute to the pathogenesis and inflammatory response of acute pancreatitis via NFB 
mediated upregulation of pancreatic MCP-1, MIP-2 and IL-6 synthesis. 
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High mobility group box 1 (HMGB1) is a nuclear protein and a component of DAMPs with extracellular 
inflammatory cytokine activity (471), thus making it a crucial mediator of the response to infection, 
injury and inflammation (472). HMGB1 is sensed by endothelial cells and monocytes/ macrophages via 
TLR2, TLR4 and receptor for advanced glycation endproducts (RAGE) receptors resulting in activation 
of NFB and the increased synthesis and release or pro-inflammatory mediators such as cytokine, 
chemokines and adhesion molecules (471). Increased serum, pancreatic and lung levels of HMGB1 
have been reported in animal models of acute pancreatitis and there is a positive correlation of serum 
HMGB1 levels and disease severity (reviewed by (473)). The inhibition of HMGB1 expression and 
neutralisation of extracellular HMGB1 in acute pancreatitis resulted in marked decrease of pancreatic 
and circulating cytokine and chemokine levels as well as amelioration of the disease (474-476); this 
suggests a pivotal role of HMGB1 as a driver of the uncontrolled inflammatory response in acute 
pancreatitis. The redox state of HMGB1 cysteine 106 residue modulates its activity; a reduced thiol 
state is required for HMGB1 to induce nuclear NFB translocation in macrophages and oxidisation 
results in inhibition of activity (477). It has been hypothesised that hydrogen sulfide could function as 
a reducing agent thus keeping the HMGB1 cysteine 106 thiol in the reduced state and therefore 
maintaining its pro-inflammatory effect (478). This is another mechanism by which hydrogen sulfide 
may function as a pro-inflammatory mediator, particularly in sterile inflammatory conditions where 
extensive tissue damage occur thus releasing DAMPs such as HMGB1. 
Figure 6.2 summarises the proposed mechanism by which endogenous hydrogen sulfide could 






Figure 6.2 Proposed mechanisms of hydrogen sulfide mediated increase in pancreatic pro-
inflammatory mediators in pancreatitis. (A) Activation of ion channels on pancreatic acinar cells 
leading to intracellular Ca2+ increase > activation of PLA2 > synthesis of arachidonic acid, precursor for 
PGE2 and LTB4 > potentiation of MCP-1 transcription by PGE2. (B) Activation of ion channels on nerve 
endings in the pancreas leading to intracellular Ca2+ increase > stimulation of substance P release > 
activation of NK-1 receptors on acini > neurogenic inflammation – transcription of chemokines via 
NFB, increase in microvascular permeability, oedema. (C) Reduction of oxidised HMGB1 on the 
cysteine 106 thiol group thus maintaining its active pro-inflammatory effect on surrounding endothelial 
cells and macrophages; activation of NFB and transcription of cytokines and chemokines. 
6.3 Summary of findings 
My hypotheses were that CSE contributes to the inflammatory response in acute pancreatitis by 
increasing endogenous hydrogen sulfide synthesis and genetic deletion of CSE would lessen the 
severity of acute pancreatitis and the associated inflammatory response. The overall aim was to 
validate previous reports on the inflammatory role of CSE/ endogenous hydrogen sulfide in acute 
pancreatitis by means of genetic deletion instead of pharmacological inhibition and to investigate the 
relevance of CSE expression in the immune response. The specific aims are shown below with a brief 




1) To refine an existing simple high-throughput method that would fulfil the criteria for specific and 
sensitive detection of free hydrogen sulfide in tissue with standard laboratory equipment. 
A method of measuring free hydrogen sulfide was established based on the spectrophotometric 
Methylene Blue method of detection that circumvented the issue of acid labile sulfide release and with 
improved sensitivity by concentrating precipitated hydrogen sulfide. This method should in principle 
be specific towards measuring only free tissue hydrogen sulfide with the added benefits of the simple 
protocol, level of high-throughput and the requirement of a standard spectrophotometer for 
detection. However subsequent measurement of free hydrogen sulfide in murine tissue yielded higher 
than expected values in comparison to currently perceived best method of detection by gas 
chromatography (37). This could be due to endogenous labile sulfide release due to strong alkaline 
conditions of the assay. 
 
2) To correlate CSE dysregulation with changes in hydrogen sulfide mediated protein modifications 
(s-sulfhydrated proteins) as an indicator or footprint of CSE mediated hydrogen sulfide synthesis. 
I was unable to test this correlation due to inability in replicating published methods of proteins s-
sulfhydration detection using the biotin switch assay (31) and a variant, biotin tag-switch assay (344) 
despite various attempts to optimise the conditions of the assays. A recent report by Nagy et al (74) 
suggested that the formation of s-sulfhydrated proteins by treatment with hydrogen sulfide is due to 
its oxidised form present in hydrogen sulfide donors as this would result in a favourable neucleophilic 
substitution reaction. This concept was not explored in this thesis and could be a reason for the inability 
to replicate the published methods of proteins s-sulfhydration detection. Additionally, sodium sulfide 
(Na2S), the source of hydrogen sulfide, was routinely rinsed prior to use to remove ‘oxidised hydrogen 
sulfide contaminants’ as suggested in a previous report (34) in order to obtain a pure source of 
hydrogen sulfide as possible. This could unwittingly support the hypothesis postulated by Nagy et al. 
 
3) To determine changes in CSE expression in the pancreas and macrophages in response to acute 
pancreatitis, the molecular mechanisms involved. 
I have shown that pancreatic CSE expression is upregulated by western blotting (~33 %) following 
caerulein induced acute pancreatitis in mice and this is supported by immunohistochemistry that 
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shows increased staining in the exocrine portion of the pancreas. These results are supported by a 
recent publication that used a sodium taurocholate model of pancreatitis in rats (69). Taken together, 
these findings affirm the upregulation of pancreatic CSE in response to pancreatitis and this occurs in 
the pancreatic acinar cells. In contrast to the in vivo findings, there was no detectable change in in vitro 
caerulein stimulated pancreatic acini CSE expression by qPCR and western blotting. This discrepancy 
could be due to limitations of the in vitro system that does not include the complex interaction of 
pancreatic acinar cells with other components of the inflammatory response such as resident tissue 
macrophages and circulating neutrophils. Another factor could be due to the shorter induction period 
used in the in vitro system. 
Increased expression of CSE in macrophages have also been shown under inflammatory conditions of 
acute pancreatitis (~2 fold), this occurs via a PI3K-sp1 dependent pathway. These results represent the 
only report that links macrophage CSE upregulation to an in vivo model of inflammatory disease. This 
shows that CSE/endogenous hydrogen sulfide may play a role in macrophage function and therefore 
the inflammatory response at large. 
 
4) To determine the effect of CSE on the inflammatory response and disease severity using mice 
genetically deficient in CSE as an alternative to pharmacological inhibition. 
I have shown that CSE plays a key pro-inflammatory role in caerulein induced pancreatitis and that the 
deletion of this gene results in significant protection against acute pancreatitis and associated lung 
injury. These findings were published (441) around the same time as two others (398, 442) and 
represent the initial reports using genetically deficient mice to determine the role of CSE in disease 
models of inflammation. This study shows that CSE contributes to inflammation in acute pancreatitis 
at the acinar cell level through increased eicosanoid and chemokine synthesis possibly via NFB 
activation which could contribute to the recruitment and activation of immune response cells. These 
CSE gene deletion studies serve as confirmation to previous reports of CSE playing a role in the 
inflammatory response without the possible confounding non-specific effects of PAG. 
 




Figure 6.3 Advancement of knowledge from this thesis. The results of this thesis have shown (1) 
Upregulation of pancreatic and macrophage CSE expression in response to acute pancreatitis (2) CSE 
gene deletion to decrease the severity of acute pancreatitis in mice (3) The pathway leading to 
upregulated CSE expression in LPS and pancreatitic plasma stimulated macrophages. 
6.4 Future work 
Although the field of hydrogen sulfide has grown exponentially, there are some fundamental aspects 
that appear to be lagging. More specifically the lack of correlation between CSE dysregulation with 
changes in endogenous hydrogen sulfide levels. This lack of correlation casts doubt as to whether the 
observed effects of CSE dysregulation are actually related to its hydrogen sulfide synthesising ability 
or due to other downstream CSE mediated roles. However the lack of this evidence is understandable 
due to the difficulty in measuring endogenous hydrogen sulfide (discussed in chapter 2). Another 
aspect that should be focused on is the elucidation of the mechanisms by which hydrogen sulfide 
exerts its observed physiological effects. So far, hydrogen sulfide has been reported to function as an 
antioxidant (96, 97, 99, 135) (165) through s-sulfhydration of proteins (102, 141-146) and via 
interaction with metal ion containing proteins (133, 158-163, 168). However there are still very few 
reports of the occurrence of these events as well as the elucidation of its implications in in vivo models 
159 
 
of disease and inflammation. Therefore, future work should be focused on attempting to more 
accurately measure changes in endogenous hydrogen sulfide levels in in vivo models of disease and 
inflammation particularly in tissues where CSE dysregulation is observed as well as determining the 
mechanisms by which hydrogen sulfide may exert its effect. 
6.4.1 Measuring endogenous hydrogen sulfude 
Currently the monobromobimane-HPLC method of hydrogen sulfide detection offers a good balance 
in specificity, sensitivity and level of throughput (36). However the method has been established to 
only detect free hydrogen sulfide in biological solutions such as plasma (26, 46) and therefore needs 
to be adapted for tissues. This method could also be coupled with mass spectrometry to increase the 
specificity of the assay. Once established, this method could be used to measure endogenous hydrogen 
sulfide changes in plasma and the pancreas over the course acute pancreatitis and if so, at what point 
of the disease would it be relevant to. Additionally, it would also be worthwhile to measure hydrogen 
sulfide levels in the lymphatic system, particularly via the thoracic duct, as this is the point where the 
peritoneal fluid is carried into the systemic circulation via the subclavian vein. This could be achieved 
by cannulation of the thoracic duct. Any measured changes in endogenous hydrogen sulfide levels 
could then be correlated to changes in CSE expression to establish a relationship between the enzyme 
and product. While utilising the monobromobimane-HPLC method would provide an estimation of the 
end-point state of endogenous free hydrogen sulfide levels, this may not represent the true potential 
amount hydrogen sulfide being made as it is in a state of constant flux. Therefore a complimentary 
real-time in situ method of detection could provide a better appreciation of the amount of endogenous 
hydrogen sulfide generated. 
This could be achieved via the use of fluorescent probes coupled with real-time imaging. A particularly 
appealing choice of fluorescent probe would be one designed by Chen et al (2014) based on a modified 
form of hsGFP (hydrogen sulfide sensitive green fluorescence protein) that incorporates an unnatural 
amino acid (p-azidophenylalanine) (58). This renders the GFP sensitive to reduction by hydrogen 
sulfide specifically resulting in increased fluorescence intensity. The added benefit of using this system 
is the ability to transfect the hsGFP gene thus getting the cell of interest to generate its own hydrogen 
sulfide probe, a stable transfection and establishment of an hsGFP cell line is also possible. The hsGFP 
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system would however be limited to in vitro cell culture studies which would sit well with the 
macrophage studies. Macrophages reside in numerous tissues and are the first line of sensors, 
initiators and modulators of the immune response. It has already been established that macrophage 
have low basal CSE expression and is upregulated upon stimulation with inflammatory stimuli. 
Additionally, there is no detectable expression of CBS. Therefore this could provide a relatively ‘clean’ 
system to detect changes in CSE mediated endogenous hydrogen sulfide synthesis and identification 
of its targets in response to inflammation. 
6.4.2 Detecting/measuring protein persulfides 
Protein s-sulfhydration or formation of protein persulfides via interaction of hydrogen sulfide 
derivatives and thiol groups of proteins offer a promising mechanism by which hydrogen sulfide may 
directly exert its effects. Although the direct reaction between hydrogen sulfide in its reduced form 
(H2S and HS-) and a protein thiol (R-SH) is not feasible, the inflammatory state is associated with 
generation of reactive oxygen species. These species could in turn oxidise either hydrogen sulfide or 
the thiol group of a protein thus making it favourable for both molecules to react and form protein 
persulfides. Therefore, future experiments testing protein s-sulfhydration would incorporate the use 
of oxidised hydrogen sulfide or protein thiol species to facilitate protein persulfide formation. Follow 
up experiments to test the physiological relevance of these oxidised species could be conducted with 
both reduced protein thiols and hydrogen sulfide in the presence of known endogenous reactive 
oxygen species to determine if the endogenous formation of protein persulfides could indeed be 
feasible. Apart from the biotin switch assay, an alternative method of simultaneous fluorescent 
labelling of protein thiols (R-SH) and protein persulfides (R-S-SH) could be used. This can be achieved 
by first using a known fluorescently tagged alkylating reagent (ie maleamide) that would tag all thiol 
species (R-SH and R-S-SH). This would be followed by a reduction step that would only cleave the 
previously alkylated protein persulfides (R-S-SH) to form a simple thiol (R-SH). There would then be a 
second round of alkylation with a different fluorescent label and this should in theory alkylate/tag the 
reduced protein persulfides. Finally, the samples can be resolved by western blot and visualised on a 
molecular imager. Ideally the two fluorescent tags chosen should be well distinguishable such as near 
infrared tags. The benefit of using this alternative fluorescent method is the ability to observe both 
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thiol and s-sulfhydrated states of the protein simultaneously which could provide a frame of reference 
for the degree of s-sulfhydration. 
While the biotin switch and fluorescent assays would offer a broad view of s-sulfhydration state in a 
complex mixture of proteins such as cell or tissue lysates, it would also be beneficial to employ a 
separate technique that is more sensitive, specific and quantitative to confirm these results. This would 
provide inconvertible evidence of protein s-sulfhydration (formation of protein persulfides). Mass 
spectrometry would satisfy all these criteria but would require a purified source of protein in order to 
function reliably. Therefore this could be a complimentary method to study specific proteins that are 
key to the inflammatory response such as NFB and HMGB1 among others. Here, an antibody specific 
pull down method could also be employed to isolate certain proteins of interest from cell or tissue 
lysates in order to be analysed by mass spectrometry. This analysis could be performed on samples 
from activated or non-activated macrophages as well as non-inflamed and inflamed tissues to compare 
levels of s-sulfhydration. 
6.4.3 Clinical relevance of CSE/ endogenous hydrogen sulfide in acute pancreatitis 
Another future direction would be to investigate CSE/ endogenous hydrogen sulfide in the context of 
clinical acute pancreatitis. The results from this thesis offers a promising avenue of research in the 
understanding of acute pancreatitis pathophysiology and these findings should be investigated in a 
clinical setting to establish its relevance. Needle aspirates of pancreas could be obtained to test for 
changes in CSE expression, endogenous hydrogen sulfide and protein persulfide levels. Since patients 
would generally arrive when the disease has significantly progressed, it would be unclear at that stage 
if the prevailing disease would be in either the SIRS, CARS or MARS state. Therefore samples could be 
taken over the course of recovery as well as a period after to track changes over time and to establish 
a baseline. These samples could also be assayed for pro and anti-inflammatory cytokines in order to 
discern what state of inflammatory response the patient is at. This would help establish a correlation 
between CSE/ endogenous hydrogen sulfide and the inflammatory process thus furthering our 
knowledge on its role in the inflammatory response. In instances where peritoneal drainage or lavage 
is conducted, these samples could also be used to measure levels of hydrogen sulfide and protein 
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persulfides. In addition, inflammatory cells such as neutrophils and macrophages could also be isolated 
from the peritoneal fluid to measure CSE expression and protein persulfide levels. This would provide 
a broader understanding of CSE/ endogenous hydrogen sulfide not only in terms of the pancreatic 
response in acute pancreatitis but the inflammatory response at large. 
6.4.4 Role of CSE/ endogenous hydrogen sulfide in other inflammatory diseases and 
assessing the therapeutic potential? 
In order to further establish the role of CSE in the inflammatory response, it would be useful to conduct 
more pre-clinical studies in other models of inflammatory diseases using mice genetically deficient in 
CSE. This would aid in affirming previous reports using PAG without the confounding effects of its non-
specific activity. Ideally, a variety of diseases with differing aetiologies should be employed in order to 
help differentiate the possible role of CSE/ endogenous hydrogen sulfide in the development of the 
disease as opposed to the associated inflammatory response. In order to effectively compare the effect 
of CSE gene deletion across these various diseases, there needs to be a common set of inflammatory 
outcomes deemed to be relevant to the inflammatory response and pertinent to each disease. These 
could include leukocyte activation and infiltration, cytokine and eicosanoid production as well as 
vascular permeability. 
While the use of CSE deficient mice is useful in establishing its effect, its therapeutic potential would 
be questionable as this deficiency is present prior and during the early phase of the disease. Therefore, 
in order to determine if there could be potential therapeutic value in modulating CSE activity, a 
separate set of experiments involving specific and time dependent inhibition of CSE would be essential. 
Initial experiments could utilise conditional knockout mice which would be more economically viable 
though not clinically relevant yet. This would allow targeted CSE inhibition studies at specific periods 
during the course of the disease where it would be more clinically relevant. The effect of CSE inhibition 
at these different stages may yield different outcomes because immunopathogical diseases may 
comprise of different states of SIR, CARS and a mix of both, MARS. If the outcome was promising, these 
experiments could progress towards the use of small interfering RNA (siRNA) which would be as 
specific but costly. The benefit of siRNA technology is that it can be administered as a drug and has the 




Figure 6.4 summarises the current knowledge and suggested future work. Answering these questions 
would better establish the presence and relevance of CSE and endogenous hydrogen sulfide as well as 
greatly further our understanding of their role in the inflammatory response. 
 
Figure 6.4 Proposed future work. This figure illustrates the current body of knowledge on pancreatic 
and macrophage CSE dysregulation as well as the effect of CSE inhibition in acute pancreatitis. The 
evidence from this thesis warrants subsequent investigation of CSE/endogenous hydrogen sulfide in 
clinical acute pancreatitis. It also highlights future work to correlate these changes in CSE expression 
with endogenous hydrogen sulfide levels and to determine the possible direct targets of hydrogen 
sulfide. Additionally, CSE deficient mice could be used in other animal models of disease and 
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8.1 Assessing specificity of western blot CSE antibody 
 
Figure 8.1 Assessing specificity of primary antibody used to detect CSE protein by western blotting. 
Mouse monoclonal primary antibody towards CSE (Abnova, Taiwan) was paired with a goat anti mouse 
HRP conjugated secondary antibody (Pierce biotechnology, USA). Figure shows a western blot 
performed on mouse pancreatic lysates resolved on a 10% polyacrylamide gel and transferred onto a 
nitrocellulose membrane. The ‘WT’ lane represents lysate prepared from a C57BL6 wild type mouse, 
‘KO’ lane represents lysate prepared from a CSE knockout mouse and lane ‘M’ represents the molecular 
weight marker that has been underlayed. The expected molecular weight of CSE is ~ 43 kDa which 
corresponds to the strong signal observed between the 37 and 50 kDa range in the WT lane but absent 
in the KO lane. 
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8.2 Confirming specificity of CSE and β-actin PCR primers 
 
Figure 8.2 Assessing specificity of -actin and CSE PCR primers control. Primers were designed using 
NCBI Primer blast to recognise and amplify mouse mRNA of -actin and CSE. The predicted amplicon 
sizes were 128bp and 115bp for -actin and CSE respectively. This figure represents a run of PCR 
reaction products performed using total RNA extracted from wildtype (WT) and CSE knockout (KO) mice 
liver on a 1.7% agarose gel. RNA was extracted using TRIZOL and reverse transcribed using Oligo(dT)20 
as the primer. PCR was performed using primers described in Table 5. Sequencing of -actin and CSE 




Figure 8.3 qPCR products resolved on agarose gel. At the end of the qPCR run (40 cycles), products 
were resolved on a 1.7% agarose gel to determine if amplification was specific. This was confirmed by 
the presence of one distinct band for each lane for both -actin and CSE. 
  




Figure 8.4 No primary antibody control. Immunostaining of pancreas without the CSE primary 
antibody and counterstained with hematoxylin. Immunostaining was performed with a rabbit specific 
Horse Radish Peroxidase (HRP) /3,3'-Diaminobenzidine (DAB) Avidin-Biotin Complex (ABC) Detection 
IHC Kit by Abcam, Cambridge UK as described in section 3.3.6. There was no detectable background 




















Figure 8.5 Testing primary antibody dilution for CSE immunostaining in wild type and CSE knockout 
pancreas. Immunostaining was performed with a Rabbit specific HRP/DAB (ABC) Detection IHC Kit by 
Abcam, Cambridge UK as described in section 3.3.6 using serial pancreatic sections of wild type (WT) 
and CSE knockout (CSE KO) mice. There was some background staining in the CSE KO pancreas. The 
1:1,000 dilution factor yielded the highest signal to noise ratio and was used for subsequent 
experiments. 
8.4 Optimisation of the biotin switch protein s-sulfhydration detection assay 
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Figure 8.6 Varying protein and MMTS thiol blocker concentration. The purpose of this experiment was 
to determine if there was adequate thiol blocking by methyl methanethiosulfonate (MMTS). The 
experiment was carried out as described in section 2.3.8 with lysates of wild type and CSE 
overexpressing HEK cells. The protocol by Mustafa et al (31) reported the use of 240 g protein with 20 
mM MMTS, here I have used 160, 250 and 320 g of protein with 20 and 100 mM MMTS. The left panel 
is a biotin blot that should tag s-sulfhydrated proteins as well as endogenously biotinylated proteins 
while the right panel is a coomasie stain of the same blot to ascertain equal protein loading between 
wells. Varying protein and MMTS concentration did not yield any substantial difference in staining 
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Figure 8.7 Comparing different thiol blocker and detergent concentration. The purpose of these 
experiments were to determine the efficacy of thiol blocking of MMTS by using varying concentrations 
and comparing with another thiol blocker, NEM as well as to investigate the effect of detergent 
concentration. These experiments were carried out as described in in section 2.3.8 with liver lysates of 
wild type C57BL6 mice. Both panels show biotin blots that should tag s-sulfhydrated proteins as well as 
endogenously biotinylated proteins. The left panel shows saturating signals in lanes without NEM or 
MMTS blocking due to indiscriminate labelling of thiolated proteins. Both NEM and MMTS significantly 
reduced this signal but there was no substantial difference between the type or concentration of blocker 
used. The protocol by Mustafa et al (31) reported a critical concentration of 2.5 % SDS to be maintained 
during the experiment to ensure effective unfolding of proteins to expose protein thiols. The right panel 
shows no substantial change in signal with varying detergent concentrations (the MMTS + 2.5% SDS 
sample was lost due to accidental aspiration during a washing step). Taken together, these results 





8.5 NFB immunostaining 
 
Figure 8.8 NFB immunotaining of pancreatic sections. Immunostaining was performed on wild type 
mice pancreatic sections with a Rabbit specific HRP/DAB (ABC) Detection IHC Kit (Abcam, Cambridge 
UK) and a rabbit anti- NFB p65 primary antibody (Abcam, Cambridge UK) diluted 1:500 as described 
in section 2.3.8. The left panel shows immunostaining with a hematoxylin counterstain and without the 
primary antibody, there was no detectable non-specific staining. The right panel shows immunostaining 
without hematoxylin counterstain, the positive staining was predominantly present in the cytoplasm 
as evidenced by the lack of nuclei staining (arrows). This is characteristic of NFB p65 subunit which 
generally resides in the cytoplasm and translocates into the nucleus only upon activation. 
 
